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Abstract 
The human copper metallochaperone CCS activates Cu,Zn-superoxide dismutase (SOD1) 
through copper transfer and formation of an intramolecular disulfide. CCS is a three 
domain protein with CXXC and CXC Cu(I)-binding motifs in domains 1 and 3, 
respectively. A detailed analysis of copper binding to CCS and variants in which the Cys 
residues of the CXXC and CXC motifs in domains 1 and 3, respectively, have been 
mutated to Ser, and also domain 1 and 3 constructs, using the chromophoric Cu(I) ligands 
bathocuproine disulfonate and bicinchoninic acid has been performed. Competition 
experiments demonstrate that CCS is able to bind a single equivalent of Cu(I) 
independently in both domains 1 and 3. The Cu(I) affinity of domain 1 is approximately 5 
 1017 M-1 at pH 7.5 while that of domain 3 is at least an order of magnitude weaker. The 
order of magnitude difference between the Cu(I) affinities of domains 1 and 3, is 
maintained over the pH range ~6 to 9 and therefore, at physiological pH, in the cell 
cytosol, where copper is limiting, the CXXC site will be preferentially occupied with 
Cu(I). Under such conditions the transfer of Cu(I) from domain 1 to the buried active site 
of SOD1 must be facilitated by the structurally flexible domain 3.  
The mutation of Arg71, located on loop 5 of domain 1, to Ala results in an altered 
pH dependence of the Cu(I) affinity for the CXXC motif due to an increase in the pKa of 
the Cu(I)-binding C-terminal Cys (CysC) residue. Therefore, lowering of the CysC pKa 
through a hydrogen bond with the Arg71 side chain that stabilises the CysC thiolate in 
domain 1, observed in the crystal structure of Cu(I)-bound domain 1, modulates the 
nucleophilicity, and hence Cu(I)-binding affinity of this residue. In addition, high and low 
pKa’s for the domain 3 CXC motif Cys residues were also determined from the pH 
dependence of the Cu(I) affinity for this site. The relative nucleophilicities of the domain 1 
and domain 3 Cu(I)-binding Cys residues, inferred from their pKa’s, suggest copper 
transfer from domain 1 to domain 3 is kinetically favoured. In addition, Zn(II) binding to 
the largest central domain of CCS was investigated to determine its role in affecting the 
quaternary structure of the protein. Zn(II)–binding to domain 2 was found to stabilise the 
dimeric form of the protein and also the CCS:SOD1 heterocomplex which orientates the 
Cu(I)-binding domains 1 and 3 of CCS for activation of SOD1. 
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Units and Abbreviations 
Measurements and Techniques 
 
M  mol dm
-3 
 OD  optical density 
l  litre   A  absorbance 
g  gram   λ  wavelength 
μ  micro   ppm  parts per million 
m  milli   nm  nanometre   
o
C  degrees celsius Da  Dalton 
V  Volt 
 
ε  extinction coefficient (M-1 cm-1) 
rcf  relative centrifugal force 
MW  molecular weight 
MWCO molecular weight cut off 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
CD  circular dichroism 
UV/Vis ultraviolet/visible  
PCR  polymerase chain reaction 
AAS  atomic absorption spectroscopy 
MS  mass spectrometry 
MALDI matrix assisted laser desorption ionisation 
TOF  time of flight 
FT  fourier transform 
ICR  ion cyclotron resonance 
 
Selected Chemicals 
 
Tris  tris(hydroxymethyl)aminoethane 
Mes  2-(N-morpholino)ethanesulphonic acid 
Hepes  4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
Taps  N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid 
Ches  2-(Cyclohexylamino)ethanesulfonic acid 
Caps  3-(cyclohexylamino)-1-propanesulfonic acid 
EDTA  ethylenediaminetetraacetic acid  
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Units and Abbreviations (Continued) 
 
DTT  dithiothreitol  
BCS  bathocuproine disulfonic acid 
BCA  bicinchoninic acid 
DTNB  5,5'-dithiobis-(2-nitrobenzoic acid) (Ellman’s reagent) 
 
Selected Proteins  
 
CCS   copper metallochaperone for Cu,Zn-superoxide dismutase 
WT-CCS  wild-type CCS from H.sapiens 
C22S/C25S-CCS Cys to Ser CCS mutant  
C244S/C246S-CCS Cys to Ser CCS mutant 
D1-CCS  CCS N-terminal domain (CCS amino acid residues 1-79) 
D3-CCS  CCS C-terminal peptide (CCS amino acid residues 235-274) 
SOD1   Cu,Zn-superoxide dismutase from H.sapiens 
Ccs1   CCS from S.cerevisae 
BACE1-CTD  β-secretase C-terminal domain (amino acid residues 478-501) 
HAH1   Atx1 copper metallochaperone from H.sapiens 
  
Amino Acids and Nucleic Acids 
  
Alanine  Ala A  Methionine Met M 
Cysteine  Cys C  Asparagine Asn N 
Aspartic acid  Asp D  Proline  Pro P 
Glutamic acid  Glu E  Glutamine Gln Q 
Phenylalanine  Phe F  Arginine Arg R 
Glycine  Gly G  Serine  Ser S 
Histidine  His H  Threonine Thr T 
Isoleucine  Ile I  Valine  Val V 
Lysine   Lys K  Tryptophan Trp W 
Leucine  Leu L  Tyrosine Tyr Y 
 
Adenine  a Guanine  g 
Cytosine  c Thymine  t 
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1.1 Introduction 
Metal ions are involved in a wide variety of roles in biological systems ranging from 
generating the transmembrane potential of the cell to catalyzing the disproportionation 
of superoxide radicals.(1-3) The metal copper is of particular importance and is an 
essential cofactor for a variety of proteins, especially in those which are involved in 
electron transfer, oxidoreductases activity and antioxidant defense.(4) Despite the 
usefulness of copper to organisms, however, its strict homeostasis is required in order to 
avoid the potential toxicity of the metal which is particularly evident when it is present 
at high cellular concentrations.(5) This has resulted in the reduction of the availability 
copper within the cell cytosol and therefore mechanisms for the uptake, delivery and 
incorporation of the metal into the copper requiring proteins are present.(6-15)  
 
1.1.1 Copper Coordination Chemistry and Metalloproteins 
Copper is a first row transition metal and in its ground state has an electronic valence shell 
composition of 4s
1
 3d
10
.(16) It is one of the only first row metals to exhibit a stable 1+ 
oxidation state which occurs through the loss of the electron residing in the 4s orbital. 
However, in aqueous solutions, Cu(I) is unstable and quickly disproportionates to Cu(0) 
and Cu(II). The disproportionation reaction is fast but is slower in the absence of O2. Cu(I) 
and Cu(II) form a variety of coordination complexes. Cu(I) is a soft lewis acid and prefers 
soft bases as ligands such as those containing sulfur donor atoms that are found in the 
amino acids Cys and Met. The co-ordination geometries formed by this oxidation state are 
predominantly tetrahedral and trigonal planar complexes.(17) On the other hand Cu(I), 
formed from the loss of an electron in a 3d orbital, is a hard lewis acid and as a result 
prefers hard bases as ligands such as those containing nitrogen and oxygen donor atoms 
such as those found in His and the carboxylate based amino acids Asp and Glu. Cu(II) 
complexes prefer mainly tetragonal co-ordination environments that include geometries 
such as square planar and axially elongated octahedral.(17) An axially elongated 
octahedron is favoured over that of a perfect octahedral geometry for the d
9
 configuration 
of Cu(II)
 
due to the incomplete filling of degenerate orbitals in the latter causing 
instability.  The instability is overcome through Jahn-Teller distortions that remove the 
orbital degeneracy through a reduction in symmetry by forming an axially distorted 
octahedron.(1) 
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Copper plays a role in proteins usually as an active centre in those with functions 
including oxidase and oxygenase activities, electron transfer and superoxide 
dismutation.(1) The use of copper mainly relates to its redox chemistry due to the 
interconversion between Cu(I) (cuprous) and Cu(II) (cupric) being suitable for essential 
redox processes and the ability of the amino acid ligands to fine tune the relative stabilities 
of the two oxidation states.(1-3,18) The copper binding centres commonly found in 
metalloproteins exist as one of three main types that were originally based on their spectral 
properties.(1) The characteristics of the Type 1 to 3 copper binding sites are as follows; 
 
Type 1 
Type 1 sites consist of a copper coordinated trigonally by two His and a Cys through 
nitrogen and sulfur donor atoms respectively. They are characterised by an intense 
absorption band at 600 nm resulting from a ligand to metal charge transition (LMCT) 
from the bound cysteine. They exhibit an EPR spectrum as a result of an unpaired 
electron that is also very distinct due to a decreased hyperfine splitting compared to that 
of normal Cu(II)
 
centres. Plastocyanin is an example of a protein that contains a type 1 
copper site.(19) 
 
Type 2 
In Type 2 metal centres the copper is coordinated by mainly His residues with a square 
planar or pyramidal geometry. This centre also exhibits an EPR spectrum that is very 
different to the Type 1 centre but which is typical of Cu(II) co-ordination compounds.  The 
copper bound to four His residues in Cu/Zn-superoxide dismutase is an example of this 
type of copper centre.(20) 
 
Type 3  
Type 3 sites consist of two copper centres which are each bound to three His residues 
which are antiferromagnetically coupled, and so compared to the first two types of copper 
centres exhibit no observable EPR spectrum. These metal centres are found in multi-
copper oxidases such as ceruloplasmin that is important in iron uptake in cells through 
catalysis of the formation of Fe(III) from Fe(II) allowing its uptake by transporters bound 
within the plasma membrane.(21)  
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Other copper binding sites, which cannot be classified as Type 1,2 or 3 also exist. These 
include the CuA centre in cytochrome c oxidase (CcO) and the CuZ centre of nitrous oxide 
reductase.(2,3) Furthermore, the copper-binding proteins that participate in metal 
trafficking within the cell, discussed in the remainder of this chapter, have copper-binding 
sites that cannot be classified into any of the above metal centre categories.(6-15) One 
feature in common to all copper binding sites, however, is that they appear to have 
evolved to tune the metals chemical properties, through selection of ligating residues and 
co-ordination geometry allowing for the reactivity of the bound copper to be highly 
tuned.(1) For example, the reduction potentials for Type 1,2 and 3 copper containing 
proteins covers a wide range. The reduction potential (Em) of the Type 1 site in 
plastocyanin has been measured at 370 mV while other Type 1 proteins including 
nitrosocyanin and rusticyanin have Em values covering the range ~90-670 mV.(22,23) The 
Type 2 copper site of Cu,Zn-superoxide dismutase has reported Em values between 200-
400 mV, while tyrosinase that contains a Type 3 copper centre has a reported Em value of 
360 mV.(24-26) The large range of Em values for the copper containing proteins resulting 
from the combined effect of the ligand set, coordination geometry and surrounding protein 
scaffold on the Cu(II)/Cu(I) redox couple.(17,22) 
 
1.1.2 Copper Toxicity 
The very same reasons that make copper so useful to living organisms also make it 
potentially dangerous. Copper in living cells has the ability to both bind adventitiously to 
biomolecules, causing damaging structural perturbations and preventing the correct metal 
cofactors binding to proteins, and mediates increased production of harmful free radical 
species such as superoxide which oxidise biomolecules including proteins, lipids and 
nucleic acids.(27-30) Reactions leading to the production of free radicals involve the metal 
shuttling between its oxidation states of 1+ and 2+ through Fenton and Haber-Weiss 
reactions.(29,31) For example reactions like those shown in equations (1.1-1.3) are 
possible.(30) 
 
Cu(II) + O2
-.
   Cu(I) + O2       (1.1) 
Cu(I) + H2O2  Cu(II) + OH
-
 + OH
.
 (Fenton reaction)  (1.2) 
O2
-.
 +H2O2    O2 + OH
-
 + OH
.
 (Haber-Weiss reaction) (1.3) 
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Chronic oxidative damage caused by these harmful free radicals usually results in 
carcinogenesis, aging and neurological disorders.(31) This potential for toxicity is 
highlighted by Wilson’s disease which is characterised by copper accumulation to levels 
that cause damage to critical organs such as the liver and brain that is so severe that it is 
eventually fatal unless treated.(32) Therefore tight control over copper homeostasis is 
required so that in particular excess copper within the cell does not accumulate. Indeed, it 
has been discovered that the levels of ‘free’ copper, that is copper uncomplexed by 
proteins and other biomolecules, within the cytosol is extremely limited.(6) This high 
chelation capacity of the cytosol, through Cu(I) binding to glutathione (Cys containing 
tripeptide) and the metallothioneins (Cys rich proteins), aids in reducing the potential for 
copper toxicity.(32) 
 
1.1.3 Mechanisms for the Specific Metallation of Proteins 
A result of the low availability of ‘free’ copper within the eukaryotic cytosol means that 
mechanisms for loading the copper metalloproteins with the correct metal cofactor are 
required.(6) In general it could be thought that the specificity of a metal-binding site 
within a protein scaffold is determined by the availability and coordination geometry of 
suitable set of amino acid side chains that would have the highest metal affinity (Kb), 
equation (1.4), for a particular metal.(33) 
 
 b   
    
       
        (1.4) 
 
Where, in equation 1.4, [M], [P] and [MP] are the concentrations of the metal, the apo-
protein and metallated protein respectively. The Irving-Williams series (shown below) that 
refers to the relative stabilities of complexes formed by the first row divalent transition 
metals, however, shows that this strategy for metalloprotein metallation cannot be the 
primary means for metal selectivity.(34,35) 
 
 
Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II) 
 
Going along the first row of the transition metals the stability constant for complex 
formation increases and peaks for Cu(II). This trend is found to hold irrespective of the 
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nature of the co-ordinating ligands and also the number of the ligands involved. 
Furthermore, Cu(I), which predominates in the reducing environment of the cytosol, is 
also highly competitive and positioned to the right of the Irving-William series together 
with Cu(II) and Zn(II).(2,6) It has been shown that a combination of covalent and 
electrostatic contributions to metal-ligand binding results in this observed series of 
complex stabilities for the divalent metals.(36) The ligand set and co-ordination geometry 
alone of proteins is therefore insufficient to achieve specific metallation when an 
abundance of different metals are present.(37)  
To achieve specific metallation of proteins cells use one of two currently known 
mechanisms. The first takes advantage of the compartmentalisation of the cell. For 
example, in Synechocystis, the manganese and copper containing metalloproteins MncA 
and CucA, respectively, contain ligand sets, three His and one Glu, that populate 
preferentially with copper in vitro.(37) In vivo, however, they populate with their native 
metals. This was found to result from their folding in different compartments of the cell. 
MncA depends on incorporation of manganese in the cytosol where both copper and zinc 
are limiting, whereas CucA is metallated in the periplasm where copper is more 
available.(37) The secondary means for protein metallation, in contrast, involves the use of 
cellular components that direct or traffic the distribution of the required metal to the place 
of protein synthesis.(10-13) This mechanism is of particular importance for cellular targets 
for copper metallation in the eukaryotic cytosol where copper is limited.(6) Copper, as 
Cu(I), is transported to the copper requiring targets by soluble cytoplasmic proteins that 
shuttle the copper from the cell membrane.(10-13) These Cu(I)-binding proteins have been 
termed the copper metallochaperones and play a crucial role in the trafficking of copper 
within the cell. 
 
1.1.4 Cellular Copper Trafficking 
Intracellular copper trafficking is achieved mainly through a combination of the actions of 
membrane bound transporters and copper metallochaperones.(10,12,13) A simplified 
picture of the three major copper trafficking routes that are present a eukaryotic cell is 
shown in Figure 1.1. Copper is acquired from the extracellular environment by members 
of the copper transporter (Ctr) family.(38,39) These transporters bind and translocate 
copper across the plasma membrane of the cell. Once inside the cell the copper is then 
transferred to the copper metallochaperones which bind the metal in the Cu(I) state and 
transport it to specific cellular destinations.(13) In the first route the Atx1 class of 
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metallochaperones deliver Cu(I) to membrane-bound copper-transporting ATPases of the 
Golgi compartment.(13) In S. cerevisiae Atx1 transports copper to the copper-transporting 
ATPase Ccc2 for metallation of copper requiring proteins in the Golgi.(40) In humans the 
Atx1 homologue is HAH1 and this metallochaperone transports Cu(I) to the copper-
transporting ATPases ATP7A and ATP7B for Cu(I) import to the Golgi compartment and 
also the secretory vesicles.(41) In the second route the copper chaperone for superoxide 
dismutase (CCS in humans and Ccs1 in S. cerevisiae) transports Cu(I) to the copper 
requiring protein Cu,Zn-superoxide dismutase (SOD1 in H. Sapiens and Sod1 in S. 
cerevisiae), an enzyme involved in intracellular antioxidant defence.(42,43)  Although 
generally not considered a metallochaperone, as discussed in section 1.5, Cox17 is a 
soluble Cu(I)-binding protein that mediates delivery of the metal within the mitochondria 
for loading into CcO and is included here due to the importance of this copper trafficking 
route.(44)  
 
Figure 1.1  
The main copper trafficking pathways in a typical eukaryotic cell. The Ctr1 transporter 
transports across the cell membrane into the cell cytoplasm. The copper metallochaperones 
CCS and Atx1 then transport Cu(I) to copper requiring cellular targets SOD1, a mainly 
cytosolic antioxidant enzyme, and the copper-transporting ATPases (ATP7A and ATP7B), 
respectively. Cox17 is a small soluble protein implicated in the metallation of CcO. 
 
1.2 The Ctr Copper Transporters  
The Ctr copper transporters are currently the only known major copper importing system 
in eukaryotic organisms.(7-9) Ctr transporters were originally identified in S. cerevisiae 
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(45-46) and subsequently homologues were found in humans.(47)  Of the transporters Ctr1 
and Ctr2 identified in humans only Ctr1 has been shown to be involved in cellular copper 
uptake.(48) Ctr1 is plasma cell membrane localised and has a domain structure consisting 
of three transmembrane domains and N-terminal extracellular and C-terminal intracellular 
extensions (Figure 1.2).(49-51)  
 
Figure 1.2  
Schematic showing the domain structure of mammalian Ctr1. 
 
Three monomers of Ctr1 form a trimeric complex which has been found to a requirement 
for functioning of the transporter.(51) Methionine rich motifs (MXM and MXXM) in the 
extracellular N-terminus and a MX3M motif located on trans-membrane helix 2 are 
implicated in the uptake and transport of copper by the transporter.(52,53) The C-terminal 
region also contains metal binding residues including an HCH motif.(53) Although the 
Cys residue of human Ctr1 is not required for functioning of the transporter the S. 
cerevisiae homologue contains numerous Cys residues that are implicated in homeostatic 
responses of the transporter to intracellular copper levels.(54) The structures of the 
transporter complex have provided insights into the mechanism of copper transport. The 
structures show a pore like structure through which the copper ions are thought to traverse 
the plasma membrane.(49,50) In addition, the transmembrane helix 2 which contains the 
MX3M Cu(I)-binding motif lines the interior of the pore.(49) This together with extended 
X-ray absorption fine structure (EXAFS) spectroscopy which indicates the presence of 
two Cu(I)-binding sites involving sulphur ligand donors suggests copper transfer through 
Cu(I) exchange between the metal binding sites of the N-terminal and transmembrane 
regions.(50) 
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 A metalloreductase for reduction of extracellular Cu(II) to Cu(I) for uptake by the 
Ctr1 transporter in S. cerevisiae is required although it is unknown whether this is also a 
requirement for the human transporter.(54) In either case it is likely that copper transport 
through the Ctr transporters is a passive process as metabolic inhibitors have no effect on 
their functioning.(55) Although the Cys residue of the C-terminal domain of human Ctr1 is 
not required it has been shown that Cu(I) transfer between this domain of the transporter 
(S. cerevisiae) and Atx1 is possible in vitro.(56) The Ctr1 transporters are currently 
considered the entry point for copper uptake into the cell cytoplasm although it is 
unknown how the metallochaperones acquire Cu(I) from the these transporters.(38) 
 
1.3 Copper Delivery to the Secretory Pathway 
Copper delivery to the secretory pathway is by the Atx1 family of metallochaperones.(15) 
The first copper chaperone to be isolated was Atx1 from S. cerevisiae.(40) The protein so 
called due to the initial functioning of the protein thought to be involved in oxygen 
sensitivity responses in cells lacking superoxide dismutase through an antioxidant-like 
behaviour.(40) Around the same time a homologue was also discovered in the bacterium 
E. hirae and designated CopZ and subsequently also in humans (HAH1) and a range of 
other organisms.(31,57,15) The proteins are soluble, cytoplasmic, Cu(I)-binding species 
that deliver copper to the copper-transporting ATPases that transport copper into the Golgi 
compartment, for subsequent metallation of secreted proteins, and secretory 
vesicles.(10,13,15,40) The importance of the pathway is highlighted by the effects of 
disruption to this system. For example, yeast deficient in Atx1 display impaired iron 
uptake due to the inability to load Fet3 with copper in the Golgi vesicles.(58) Fet3 is a 
copper containing metalloreductase protein involved in iron uptake by the cell. Without 
Atx1 the supply of copper in the Golgi is restricted resulting in a failure to complement the 
secreted protein with the copper cofactor.(58) In humans disruptions to this pathway can 
be severe for health with mutations of the genes for ATP7A and ATP7B resulting in 
Menkes syndrome and Wilson’s disease respectively.(59,60,61) Menkes syndrome results 
from a copper deficiency while Wilson’s disease is associated with copper accumulation 
as described earlier.(61)  
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1.3.1 The Atx1 Metallochaperones 
Most homologues of Atx1 metallochaperones are relatively small proteins with Atx1 and 
HAH1 being 73 and 68 amino acids in length, respectively.(40,41) The Atx1 
metallochaperones contain a conserved CXXC motif which, in most cases, binds a single 
equivalent of Cu(I) with exceptionally high affinity (typically ~ 10
17 
M
-1
).(62-65) A 
significant amount of research has been directed towards characterising the Atx1 proteins 
in order to determine the nature of Cu(I)-binding and transfer to the copper-transporting 
ATPases. 
Details of the protein fold of Atx1 (S. cerevisiae) were first reported with the 
acquisition of the crystal structures for apo and Hg(II)-bound proteins.(66) The structures 
show the overall fold of Atx1 to consist of a βαββαβ fold with the CXXC Cu(I)-binding 
motif located on a surface exposed loop region between α1 and β1. The Cys residues 
(Cys15 and Cys18) of the CXXC motif are involved in coordination to Hg(II) in the 
Hg(II)-Atx1 structure through coordination in a near linear digonal coordination geometry. 
For the apo-Atx1 oxidised (Cys15-Cys18) structure the overall fold is almost identical but 
there are distortions to the metal binding loop region caused by the disulfide between the 
two Cys residues of the CXXC motif that result in displacement of the residues between 
and immediately adjacent Cys15. In both of the above structures it was found that residues 
in close proximity of the metal-binding site included Thr14 and Lys65 may be involved in 
interacting with the metal binding site. More revealing, however, are the NMR solution 
structures for apo reduced and Cu(I)-bound Atx1 (Figure 1.3).(67) Both structures reveal 
the same overall fold of the protein but demonstrate the digonal binding of Cu(I) to the 
Cys residues of the CXXC motif orders this region of the protein relative to the apo form 
with only minor changes to the remainder of the protein fold.(67) Subsequent studies of 
the Cu(I) coordination in Atx1 by extended x-ray absorption fine structure spectroscopy 
(EXAFS) indicate that the metal is coordinated trigonally by three S atoms, two of these 
being from the Cys residues of the CXXC motif, and a third from a yet unidentified source 
but which is most likely an exogenous thiol from a small thiol containing molecule or 
neighbouring protein.(40) 
Overall the structures for Atx1 highlighted the conformational flexibility of the 
protein and the possible involvement of residues (specifically Thr14 and Lys65) in Cu(I)-
binding through interactions that balance the negative charge generated by metal-
binding.(66,67) 
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Figure 1.3  
Solution structures for Apo (A) and Cu(I)-bound Atx1 (B) (PDB accession codes 1FES 
and 1FD8, respectively) drawn in Pymol. The Cys residues of the CXXC motifs and 
Lys65 of loop 5 are shown as stick representations and the copper ion in Cu(I)-Atx1 is 
shown as a gold sphere.  
 
Structures for HAH1 include the Hg(II), Cd(II) and Cu(I)-bound crystal structures 
and apo and Cu(I)-bound NMR solution structures.(68,69) The crystal structures all 
crystallise as dimers with the metals bound between the CXXC motifs of two HAH1 
monomers that have an overall protein fold similar to that for Atx1.While the Cd(II) 
structure shows co-ordination of the metal by all four Cys residues of two HAH1 
monomers in a tetrahedral geometry, the structures for Hg(II) and Cu(I)-bound (Figure 
1.4) forms display trigonal coordination by three Cys residues (Cys12 of one HAH1 
monomer and Cys12 and Cys15 of the adjacent monomer).(68) Further analysis of Cu(I)-
binding to HAH1 by EXAFS indicates digonal coordination of Cu(I) by the CXXC motif 
of one HAH1 monomer with trigonal coordination observed only in the presence of small 
thiol containing molecules GSH and dithiothreitol (DTT).(70) Intriguingly a hydrogen 
bonding network at the interface of the two monomers for all three structures is 
present.(68) A hydrogen bond interaction is present between the Thr11 side-chain of each 
monomer with the adjacent monomers Cys12 residues sulphur atom. In addition, a 
hydrogen bond between Lys60 and Cys15 of one monomer is mediated by an intervening 
water molecule. As seen for Atx1, the apo and Cu(I)-bound HAH1 NMR solution 
structures show conformational changes to the CXXC containing loop region upon Cu(I)-
Cys15 
Cys18 
Lys65 
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binding, although, the changes are not as severe as only one Cys residue deviates from its 
positioning relative to that observed in the apo structure to bind Cu(I).(69) The Lys60 
residue, in the NMR solution structure, is also orientated toward the metal binding site in 
the Cu(I)-loaded form indicating a role for the residue in modulating copper binding.  
 Crystal structures have also been obtained for Atx1 homologues CopZ (B.subtilis) 
and ScAtx1 (Synechocystis).(71-74) CopZ functions in Cu(I) delivery to CopA, a copper-
transporting ATPase involved in export of copper from the cell whereas ScAtx1 functions 
in Cu(I) delivery to PacS, another copper-transporting ATPase, which is involved in 
copper import into the thylakoid for ultimate incorporation into Plastocyanin.(71,73) The 
structure for Cu(I)-bound CopZ shows a trimeric complex containing three copper ions 
coordinated by the Cys residues of the CXXC motifs within each monomer.(72) For 
ScAtx1 two Cu2ScAtx12 forms were obtained in the absence and presence of NaCl and 
also a Cu4ScAtx2 structure.(74) The Cu(I)-bound trimer observed for CopZ was suggested 
to represent a form of the metallochaperone involved in Cu(I)-transfer to the target CopA 
while the Cu(I) clusters observed in ScAtx1 were proposed have roles in Cu(I) trafficking 
regulation and intracellular Cu(I) buffering.(72,74) 
 Overall the structures of the Atx1 metallochaperones verified a role for the CXXC 
motif in binding the Cu(I) ion and provided the insights regarding  modulation of Cu(I)-
binding through the interaction of the residues such as Lys65 in HAH1 with the CXXC 
Cu(I)-binding motif (discussed further in Chapter 3).(10,12,13) In addition, the crystal 
structure of Cu(I)-bound HAH1 provided insight into a possible mechanism of copper 
transfer from the Atx1 metallochaperones to the copper-transporting ATPases.(68) This 
has subsequently led to the determination of the nature of interaction between these 
metallochaperones and the ATPases discussed in section 1.3.3. 
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Figure 1.4  
Crystal structure for Cu(I)-bound HAH1 dimer (PDB accession code 1FEE) The Cys 
residues of the CXXC motifs in each monomer and the Lys60 residue of loop5 are shown 
as stick representations and the copper ion is shown as a gold sphere. 
 
1.3.2 Copper-transporting ATPases 
In prokaryotic and eukaryotic organisms the copper-transporting ATPases function to 
transfer copper through membranous compartments of the cell.(75) In eukaryotes the 
copper-transporting ATPases efflux copper from the cell via vesicles and import copper 
into the Golgi compartment for metallation of secreted proteins. The structure of a typical 
copper-transporting ATPase is shown in Figure 1.5.(75) The transporter consists of eight 
transmembrane domains (TMDs), metal binding domains (MBDs), a nucleotide binding 
domain (N domain), a phosphorylation domain (P domain) and an actuator domain (A 
domain) that couples nucleotide hydrolysis to copper ion transport.(75-79) A CPC motif in 
TMD6 is present and is suggested to represent a copper binding site within the transporter 
that is important for copper translocation. The number of MBDs varies between 
organisms, for example the transporter Ccc2 (S. cerevisiae) contains two while ATP7A 
and ATP7B (human) contain 6.(76) The MBDs are proposed to be the recipient of Cu(I) 
from the copper metallochaperones and also participate in regulation of the ATPases 
activity through copper responsive intracellular localisation.(76,80-85) A recent crystal 
structure for the copper-transporting ATPase CopA from L. pneumophila has been 
 
Cys12a 
Cys15a 
Lys60a 
Cys12b 
Lys60b 
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determined which indicates a three stage copper transport mechanism. It is proposed the 
N-terminal transmembrane regions in concert with the MBDs aid in the capture of copper 
with subsequent transfer of this copper to the high affinity transmembrane region for 
eventual release through an exit site.(86) Structures for Ccc2, ATP7A and ATP7B MBDs 
show that the folds of the these components of the transporter consist of a βαββαβ fold, as 
for the Atx1 metallochaperones themselves, with the CXXC motif located on the 
analogous loop to that found in Atx1 and HAH1.(78) 
 
Figure 1.5  
Schematic showing the general domain structure of a mammalian copper-transporting 
ATPase. The eight trans-membrane domains (TMDs), the nucleotide-binding domain (N), 
the phosphorylation domain (P), the actuator domain (A) and the 6 metal-binding domains 
(MBDs) located in the cell cytosol at the N-terminus of the transporter are indicated. 
 
 
1.3.3 Atx1 Metallochaperones in Complex with their Cognate Copper-
transporting ATPase MBDs 
Solution structures of the Atx1 metallochaperones in complex with the copper-transporting 
ATPase MBDs in the presence of Cu(I) have been solved for Atx1 and Ccc2 and HAH1 
and MNK1 (1
st
 MBD of ATP7A). The NMR solution structure of the Atx1-Cu(I)-Ccc2 
heterocomplex indicates coordination of two Cys residues from Ccc2 and one Cys from 
Atx1 (Cys13 and Cys16 of Ccc2 and Cys15 of Atx1) to the Cu(I) ion (Figure 1.6) with 
formation of the heterocomplex being dependent on bound Cu(I).(87) In addition, the 
interface region consists of both hydrophobic interactions and also complementary surface 
charges on either monomer unit. Atx1 contains a positively charged patch, consisting 
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mainly of Lys residues, on the surface of the protein that forms the dimer interface region 
that is complementary to a negatively charged patch on Ccc2.(67,68,88) These 
complementary surface interactions between Atx1 and Ccc2 were proposed to be 
important for mediating complex formation and indeed mutagenesis studies have shown 
that loss of the Lys residues that form the positively charged surface patch of Atx1 disrupt 
the function of this protein in vivo, resulting in reduced iron uptake and loss of Atx1:Ccc2 
interaction studied by yeast two-hybrid interactions.(88) 
The NMR solution structure for the analogous Cu(I)-bound heterocomplex 
between HAH1 and the first MBD of the ATB7B transporter (MNK1) also shows a similar 
coordination of the Cu(I) ion (Figure 1.6). Both Cys residues of the MNK1 (Cys15 and 
Cys18) coordinate Cu(I) but only Cys12 of HAH1 is involved in copper binding (89). As 
for the Atx1:Ccc2 heterocomplex the proteins exhibit complementary surface charges in 
the interface region with HAH1 having a positively charged patch and MNK1 a negatively 
charged patch.(68,69,89) Therefore the importance of protein-protein interactions is 
highlighted for copper transfer via this pathway and the structures suggest a mode of direct 
copper transfer between the partner proteins.(68,89,90) In support of this mechanism of 
copper transfer is the observation that in vitro copper transfer between Atx1 and Ccc2 can 
occur even in the presence of an excess of GSH.(91) Therefore Atx1 binds and retains 
Cu(I) but only releases it to the target protein. It has been shown that copper release by the 
HAH1 is slow to GSH but is fast to the bis-chelate Cu(I)-binding ligand bicinchoninic acid 
(BCA) indicating that the metal binding sites of the Atx1-like metallochaperones are 
optimised for rapid transfer of Cu(I) between partner proteins (BCA was used as a Cu(I)-
binding protein mimic for studying Cu(I) transfer from HAH1).(92) Once copper is bound 
to the MBD of the copper-transporting ATPase it is thought that subsequent transfer of the 
metal by an ATP dependent process drives the uptake of copper into the Golgi 
compartment.(76) 
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Figure 1.6  
Solution structure of the Cu(I)-bound Atx1:Ccc2 (A) and HAH1:MNK1 heterodimers 
(PDB accession codes 2GGP and 2K1R, respectively) drawn in Pymol. The Cys residues 
of the CXXC motifs in Atx1/HAH1 (blue) and Ccc2/MNK1 (red) are shown as stick 
representations and the copper ions are shown as gold spheres. The Lys60 and Phe67 of 
HAH1 and MNK1, respectively, are shown as stick representations. 
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1.3.4 A Model for Copper Transfer between Atx1 Metallochaperones and Copper 
Transporting ATPase MBDs 
Based on the available structures of the Cu(I)-bound Atx1 metallochaperones and 
heterocomplexes between these and their cognate copper-transporting ATPase MBDs  the 
current model for Cu(I) transfer involves a sequence of ligand exchange reactions whereby 
Cu(I) transferred from the CXXC Cu(I)-binding motif of the Atx1 (Cu(I) donor) to the 
MBD (Cu(I) acceptor).(68,87,89) Computational studies have recently investigated the 
Cu(I) transfer process by considering the Cu(I)-bound heterocomplex structures as models 
for reaction intermediates.(93) The reaction pathway for copper transfer from Cu(I)-HAH1 
to the fourth MBD of the ATP7A transporter (WD4) was investigated by quantum 
mechanical/molecular mechanics simulations.(93) A reaction pathway was considered 
between Cu(I)-bound HAH1 and apo-WD4 that included 2,3 and 4 coordinate 
intermediate species. It was found that the most favourable pathway for formation of 
Cu(I)-WD4 involved two 3-co-ordinate intermediate complexes. The first intermediate 
corresponds to Cu(I) co-ordinated by Cys12 and Cys15 of HAH1 and Cys14 of WD4. The 
second intermediate is more product like and involves Cu(I) co-ordination by Cys12 of 
HAH1 and Cys 15 and Cys17 of WD4. The second intermediate is then proposed to 
dissociate and leave apo-HAH1 and Cu(I)-bound WD4. It is notable that in both 
intermediates both Cys12 and Cys14 of HAH1 and WD4, respectively, are co-ordinated to 
the Cu(I) ion and correspond to the most solvent accessible Cys residue of each proteins 
CXXC motif. The intermediates proposed have been validated as being possible in vitro as 
mutagenesis studies show only three of the four Cys residues are required for HAH1-
Cu(I)-MBD complex formation.(87) The homodimeric Cu(I)-bound form of HAH1 is also 
consistent for a role for Cys14 of WD4 in being the first Cys residue of the MBD that 
coordinates to the Cu(I) ion bound by HAH1.(68) Finally, the HAH1-Cu(I)-MNK1 
structure shows a product like intermediate where both Cys residues of the target MBD are 
bound to the Cu(I) ion while only one Cys residue of HAH1 is coordinated.(89) The 
current model for transfer between Atx1-like metallochaperones and MBDs is as shown in 
Figure 1.7.(68,87,89,93) 
 
 
 
18 
 
Figure 1.7  
Model for Cu(I)-transfer between an Atx1-like metallochaperone and the MBD of a 
copper-transporting ATPase. Cu(I)-bound Atx1 forms an intermediate 3 co-ordinate 
complex with a copper-transporting ATPase MBD which undergoes rearrangement so that 
both Cys residues of the target MBD coordinate Cu(I). Dissociation of the intermediate 
then occurs leaving apo-Atx1 and Cu(I)-bound MBD. 
 
 
1.4 Copper Delivery to Cu,Zn-Superoxide Dismutase  
The CCS metallochaperones deliver copper to the antioxidant enzyme SOD1.(94) SOD1 is 
a homodimeric copper and zinc requiring protein that is mainly localised in the cell cytosol 
although a small but significant fraction is also present in the mitochondrial inter 
membrane space (IMS).(95,96) The enzyme catalyses the disproportionation of damaging 
superoxide radicals by redox cycling of the copper bound in the active site of the protein, 
equations (1.5-1.6), resulting in the overall production of hydrogen peroxide and oxygen, 
equation (1.7), the hydrogen peroxide being subsequently converted to oxygen and water 
by catalase.(94) 
 
Cu(II)-SOD1 + O2
-   
Cu(I)-SOD1 + O2    (1.5) 
Cu(I)-SOD1 + O2
- 
+ 2H
+  
Cu(II)-SOD1 + H2O2   (1.6) 
2O2
-
 + 2H
+
   O2 +  H2O2      (1.7) 
 
The main fold of SOD1 consists of a β-barrel composed of 8 anti-parallel 
sheets.(97,98) These are connected by intervening connecting loops that also form the 
copper and zinc metal binding sites and define the active site cavity through which the 
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superoxide substrate is guided to the copper ion.(94,99) Copper is bound by four His 
residues and a water molecule when in the +2 oxidation state and zinc is bound by three 
His residues, of which one is shared with that of the copper ion, and a fourth Asp 
ligand.(98) A conserved Cys disulfide is also present, between Cys57 and Cys146 in 
humans, and connects the metal binding loop region to that of the β-barrel.(97) Both the 
binding of copper and zinc and oxidation of the disulfide lead to increased stability of the 
protein resulting in an active homodimer.(100-102)  
The CCS metallochaperones are implicated in both copper metallation of SOD1 
and formation of the intramolecular disulfide.(6,42,103) Ccs1 was first discovered as a 
requirement for Sod1 activation in yeast through the identification of the S. cerevisiae 
LYS7 gene.(42) Without this gene encoding Ccs1 the Sod1 enzyme expressed at normal 
levels, is inactive as it lacks the necessary copper cofactor to carry out the required redox 
chemistry. The same gene, but in humans, encoding a similar protein was also discovered 
and activates human SOD1.(42) As in the case for yeast, mutations of this gene in 
mammals result in a drastic reduction of SOD1 activity. In mice containing a CCS deletion 
the incorporation of radiolabelled copper into SOD1 is severely attenuated and highlights 
the importance of the metallochaperone for activation of SOD1.(104)  
 
1.4.1 The CCS Metallochaperones 
The CCS metallochaperone is a ~30 kDa multidomain protein that located predominantly 
in the cell cytosol.(42,105) Initial characterisation of the protein led to the identification 
three distinct domains.(6,42,105) The N-terminal domain 1 (D1) is similar in sequence to 
the Atx1 metallochaperones and contains a conserved CXXC Cu(I)-binding motif which 
in Ccs1 is required for Ccs1 activation of Sod1 under copper limiting conditions while in 
humans is required under all conditions.(104,106,107) The central domain 2 (D2) is the 
largest domain and is similar in sequence to the SOD1 target protein itself and found to be 
essential for CCS activation of SOD1 in vivo.(104,107) The C-terminal domain (D3) is the 
shortest and contains an essential CXC Cu(I)-binding motif that was found to be 
absolutely essential for CCS activation of SOD1 in vivo both in yeast and 
humans.(104,107) 
 The determination of the crystal structure for Ccs1(108) (Figure 1.8) shows the N-
terminal D1 to consist of an βαββαβ-fold with the CXXC Cu(I)-binding motif located on a 
loop analogous to that on which the same motif is located in Atx1.(66) Domain 2 consists 
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of an eight-stranded β-barrel fold which is analogous to that found in Sod1 however is 
missing all of the copper and zinc binding residues and so binds no metals within this 
region.(97,108) In addition this domain formed the dimerisation interface between the 
dimers of Ccs1 observed in this crystal structure through several hydrophobic residues and 
four main chain hydrogen bonding interactions.(108) The C-terminal D3 is not observed in 
this structure of Ccs1. A notable observation, however, is that the four Cys residues 
present in D1 are oxidised, forming disulfide bonds between Cys17 and Cys20 (CXXC 
Cys residues) and Cys27 and Cys64. Other Cys residues present in the structure being 
those residues of the CXC motif in D3 (Cys229 and Cys 231) and Cys159 (D2).(108) The 
subsequent determination of D2 of CCS showed the domain in the human homologue to 
be of a similar overall fold but to contain a zinc ion in a site analogous to that found in 
SOD1 but to lack, however, a His residue of the copper ligand set so that no copper was 
bound.(109) It is notable that a single Asp201 to His mutation in CCS results in a full 
ligand set for copper within this domain and the resulting species displays superoxide 
dismutase activity, albeit at a much lower level than for SOD1 itself.  Intriguingly the CCS 
structure showed there to be four Cys residues located within this domain with two of 
these (Cys141 and Cys227) involved in a disulfide bond analogous to that found in 
SOD1.(97,109) 
The crystal structure of Ccs1 in complex with a His48Phe Sod1 mutant led to the 
full structural characterisation of a CCS metallochaperone (Figure 1.8).(110) The proteins 
crystallised as a Ccs1:Sod1 heterodimer with the interface region consisting mainly of 
contacts between D2 of Ccs1 and that of the corresponding dimer interface in Sod1. The 
interface region is held together by hydrophobic regions and 4 main chain hydrogen bonds 
as is found between the monomers in the Ccs1 homodimer structure. D1 in the 
heterodimer structure is orientated differently to that of the same domain in the 
homodimer structure and highlights the flexibility of the linker region between D1 and 
D2.(108,110) Interestingly, the structure shows a disulfide bond between Cys229 of the 
CXC motif of D3 and Cys57 of the Sod1 monomer. Furthermore, there are a number of 
interactions between the D3 region and the active site channel of Sod1 indicating that 
these may help facilitate the delivery of copper to the sunken metal binding site in Sod1.  
The positioning of D1 and D3 within the heterodimeric structure and the interactions 
between D2 and Sod1 dimerisation interfaces have suggested that this complex may 
represent an important intermediate for activation of Sod1 by Ccs1.(110) In support of this 
a Ccs1:Sod1 heterocomplex has also been observed in solution.(111,112) 
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Although both CCS and Ccs1 are observed as dimers in their crystal structures the 
oligomeric behaviour of the proteins in solution differs with CCS existing as a dimer when 
apo but which forms tetrameric species when loaded with Cu(I).(113) In contrast, Ccs1 is 
a monomer when apo but is a dimer in the presence of Cu(I).(111) It has also been shown 
that at high Cu(I) loadings (~3 equivalents of Cu(I) per CCS) that CCS reverts to a dimer 
in which the D3 CXC motif forms the dimer interface through formation of a Cu(I) cluster 
between the motifs of two monomers of CCS.(113) This was proposed to open up the D2 
dimerisation interface for interaction with the analogous dimer interface region of SOD1 
however it is currently unknown whether this oligomeric form of CCS would form in 
vivo.(113) 
The precise details of Cu(I) binding to CCS remains unclear due to the 
unavailability of structural characterisation of either D1 or D3 with the native metal. The 
apo structures, however, suggest D1 and D3, that contain the Cu(I)-binding CXXC and 
CXC motifs, respectively, are involved in binding copper and transferring it to SOD1, 
particularly D3, due to its close proximity to the copper binding site in Sod1 and the 
essential requirement of the CXC Cys residues in vivo.(103,105,110) In support of this, 
proteolytic trypsin digests of Cu(I)-bound Ccs1 have indicated that copper only binds to 
D1 and D3.(107) Furthermore, EXAFS analysis of Cu(I)-bound CCS and its CXXC and 
CXC Cys to Ser mutants has shown copper to be coordinated by these Cys residues.(114) 
The EXAFS data indicated a single Cu(I) resides in an environment indicative of that 
provided by the two Cys residues of the D1 CXXC motif with co-ordination by a third 
unidentified ligand whereas a copper cluster was attributed to binding of Cu(I) to the D3 
CXC motif.(113,114) Analysis of x-ray absorption spectroscopy (XAS) data for Cys to 
Ala variants of CCS demonstrated that this cluster formation could be eliminated by 
mutation of either Cys residues of the CXC motif. A Cu2S6 adamantane-like structure has 
been proposed as the best fit to the XAS data for cluster formation between two D3 CXC 
motifs with two unidentified sulphur ligands. Subsequent studies of CCS variants in which 
the Cys residues of D2 are mutated have indicated a role for these residues in cluster 
formation, although the physiological significance of the D3 Cu(I) cluster is currently 
unknown.(115) 
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Figure 1.8  
Crystal structures of apo-Ccs1 homodimer (A) and apo-Ccs1:H48FSOD1 heterodimer (B) 
(PDB accession codes 1QUP and 1JK9, respectively) drawn in Pymol. In (A) D2 of the 
two Ccs1 monomers are shown blue and red with associated D1 shown in green and 
magenta, respectively. In (B) Sod1 is shown in blue, Ccs1 D2 in red with D1 and D3 in 
magenta. The Cys residues of the CXXC and CXC motifs in each monomer of Ccs1 are 
shown as stick representations and the zinc ion of Sod1 is shown as a grey sphere. 
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1.4.2 Oxygen Dependence of CCS Activation of SOD1 
In addition to copper transfer CCS is also involved in facilitating the oxidation of the 
essential intramolecular disulfide in SOD1 between Cys57 and Cys146.(103) Oxidation of 
the disulfide has been found to require copper bound CCS and dioxygen. Furthermore, 
copper-bound CCS activation is dose dependant with respect to dioxygen and under 
anaerobic conditions SOD1 is unable to be activated by the CCS pathway.(116) The 
oxygen dependence of Sod1 activation by Ccs1 in particular has provided significant 
insights into the nature of this activity of the CCS metallochaperone in general and the 
intimate link between formation of the disulfide and metallation. Formation of the Sod1 
disulfide by Ccs1 is rapidly accelerated for copper-bound reduced Ccs1 compared to either 
reduced or oxidised apo-Ccs1.(103) Therefore, the presence of copper is a requirement for 
the oxidation of the disulfide itself and copper binding to D3 is not only required for 
insertion into the Sod1 active site but also contributes to an disulfide forming function of 
the D3 CXC motif. This disulfide forming function of the CXC motif is highlighted by the 
presence of a disulfide between Cys229 of Ccs1 and Cys57 of Sod1 in the heterodimeric 
Ccs1:Sod1 crystal structure.(110) A disulfide linked heterodimer between Ccs1 and Sod1 
is observed for a Cys146 to Ser mutation in Sod1 whereas no such form is found in the 
corresponding Cys57 mutant.(103) Therefore disulfide bond formation between Ccs1 and 
SOD1 appears to be regioselective for the two Sod1 Cys residues. This behaviour suggests 
a precise function for Ccs1 facilitated disulfide formation in Sod1 and that interaction 
between D3 and Sod1 during Ccs1:Sod1 heterocomplex formation may be important 
factors regarding this specificity. It has also been shown that Ccs1 distinguishes between 
reduced and oxidised apo-SOD1. Only the apo reduced form of Sod1 can be activated by 
copper-bound Ccs1 suggesting that the formation of the disulfide imposes structural 
changes to the protein fold of Sod1 that abrogates interaction with the Ccs1 
metallochaperone.(103) The dose responsive nature of the oxygen dependent activation of 
CCS is proposed to be a major mechanism for posttranslational control of SOD1 activity 
with the activation of a pool of SOD1 within the cytoplasm providing for rapid response to 
changes in oxygen tension in the cell.(116) The available data so far indicates that copper 
transfer to SOD1 from CCS precedes or is concomitant with disulfide formation.(104) 
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1.4.3 CCS Activation of SOD1 in the Mitochondrial IMS 
A small fraction of Ccs1 localises to the mitochondrial IMS and is has been shown to be 
important for the uptake of Sod1 and subsequent maturation and retention within this 
cellular compartment.(105) Ccs1 is transported into the IMS by the Mia40/Erv1 disulfide 
relay system and the presence of Sod1 within the mitochondria is dependent on this uptake 
of Ccs1 (117,118). Mia40 is a mitochondrial outer membrane import receptor and Erv1 is 
a thiol oxidase and both proteins play essential roles for uptake of Ccs1.(44) In the absence 
of Ccs1, Sod1 levels within the IMS are diminished.  Furthermore, only the most 
immature form of Sod1 lacking the metal binding ions and the intramolecular disulfide can 
be transported into the IMS.(105) It has been shown that Ccs1 is a substrate for Mia40 and 
forms a mixed disulfide containing complex. Mia40 itself is oxidised by Erv1 and it has 
been proposed that the three proteins work in concert to transfer a disulfide bond to 
imported Ccs1.(118) 
 Until recently it was unknown which Cys residues of Ccs1 were required for 
import of the protein into the IMS. It has recently been discovered, however, that Cys27 
and Cys64 of D1 play a role in mitochondrial uptake.(119,120) Cys to Ala mutations to 
either of the residues in D1 results in alterations to the localisation of the protein between 
the cytosol and the IMS but do not affect the activation of Sod1 itself in vitro.(119) It has 
been shown that Mia40 forms a disulfide bond with Cys67 of Ccs1 and that subsequently 
the majority of IMS localised Ccs1 is present as an oxidised form involving Cys27 and 
Cys64.(120) It has been proposed that this disulfide serves a structural role and stabilises 
this region of Ccs1 and prevents its removal from the IMS.(120) Transfer of this disulfide 
to Sod1 is then expected to then trap activated Sod1 within the IMS and then Ccs1 is 
oxidised by the Mia40/Erv1 system for subsequent turnover of newly imported immature 
Sod1. It is currently unknown how the human CCS is imported and retained in the IMS as 
this homologue does not contain the Cys pair present in Ccs1 that contribute to IMS 
import.  
 
1.4.4 CCS Independent Activation of SOD1 
In S. cerevisiae Ccs1 deletion results in undetectable Sod1 activity, whereas a CCS 
deletion in mice results in residual SOD1 activity.(121) Furthermore, there is lack of a 
CCS homologue in C.elegans which expresses a fully active SOD1 enzyme and a number 
of other organisms lacking a gene for CCS, yet which still express active SOD1 have also 
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been discovered and suggest an alternative route for SOD1 activation that is independent 
of CCS.(122,123) The cause of this difference in CCS dependence between organisms 
results from the absence of a Pro residue in the C-terminus of SOD1 in those species 
capable of CCS independent activation.(124) Sod1 (S. cerevisiae) contains a Pro144 
residue in this C-terminal region which has been found to confer complete Ccs1 
dependence for SOD1 activation in S. cerevisiae.(124) Interestingly, mutation of this 
single residue to the corresponding residue of the human homologue (Leu) results in the 
loss of this CCS dependence and a fully active Sod1 results in the absence of Ccs1. 
Mutating the corresponding residue in human SOD1 to a Pro results in complete CCS 
dependent activation. Due to the close proximity of the Pro residue of Sod1 to the essential 
intramolecular disulfide a role for the Pro in modulating the Sod1 Cys disulfide redox 
potential has been proposed.(124) In SOD1s lacking the C-terminal Pro residue the 
reduction potential for the disulfide was lowered and therefore resulting in a greater 
propensity for the disulfide to form. This CCS independence does not require the copper 
metallochaperones Atx1 or Cox17, and instead, roles for reduced glutathione and a low 
redox potential for the cell have been implicated.(125)  It appears that most SOD1s, 
however, lack a total dependence on CCS and that Sod1 in S. cerevisiae is a rare 
exception. It is speculated that having two pathways for SOD1 activation allows 
organisms to maintain a basal level of SOD1 activity independently of CCS.(124) 
 
1.4.5 Interaction of CCS with BACE1 
CCS has recently been linked with Alzheimer’s disease through interactions of the 
metallochaperone with β-secretase (BACE1).(126) BACE1 is one of many enzymes 
involved in the processing of the amyloid precursor protein (APP) which results in Aβ 
peptides, the main constituents of the plaques which are a pathological hallmark of the 
disease.(127)
 The Aβ peptides are small 40-42 amino acid chains that result from the 
cleavage of the membrane bound amyloid precursor protein (APP) through the 
consecutive action of the secretases which cut APP at specific sites.(127) The Aβ 
peptides are generally accepted to be neurotoxic and their release has been termed the 
amyloid cascade hypothesis.(128) 
Recent evidence has suggested that altered uptake and metabolism of copper is 
strongly implicated in the processing of APP with binding of copper to various proteins 
involved in the biochemical pathway, including Aβ, APP.(127) BACE1 is a membrane 
spanning protein that has a cytosolic C-terminal domain containing a CXXC Cu(I)-
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binding motif.(127) The BACE1-CCS interaction was found to occur through the C-
terminal domain of the former and D1 of the latter.(126)
 
It was found that the C-terminal 
cytoplasmic domain of BACE1 binds Cu(I) with high affinity. Metal binding 
investigated by UV/Vis spectroscopic titrations of a C-terminal peptide fragment of 
BACE1 with Cu(I) showed that the metal were coordinated by Cys residues, most likely 
from the CXXC motif and/or another nearby Cys residue as determined by titrations 
with a series of Cys to Ala mutants. The expression of BACE1 was found to reduce 
SOD1 activity in cells consistent with competition between SOD1 and BACE1 for CSS 
as overexpression of CCS enabled the restoration of SOD1 activity.(126) It was also 
found that both proteins co-immunoprecipitated from rat brain extracts and visualisation 
of the co-transport of BACE1 and CCS through nerve axons was observed.(126) 
Therefore, the binding of Cu(I) and CCS to BACE1 may be a mechanism for regulation 
of APP processing by BACE1 and hence Aβ production.  
 
1.5 Copper Delivery to Cytochrome c Oxidase 
Delivery of copper to the mitochondria is required for metallation of CcO, an essential 
membrane bound enzyme that is participates in the last stage of the mitochondrial electron 
transport chain.(44) The protein requires a total of three copper ions for formation of the 
CuA and CuB metal centres. It is proposed that Cox17 transfers and imparts specific Cu(I) 
metallation of the proteins Sco1 and Cox11 for subsequent transfer of the Cu(I) to Cox2 
and Cox1, respectively, which form the initial building blocks of the CcO complex.(129) 
 
1.5.1 Cox17 
Cox17 is an 8 kDa protein with a helical hairpin fold that is stabilised by four Cys residues 
from two CX9C motifs.(44) The protein contains a further two Cys residues in a CC Cu(I)-
binding motif. Cox17 was found in the yeast cytoplasm, initially indicating that this 
protein may represent a copper metallochaperone that traffics copper from the cell surface 
transporters to the mitochondria.(130) Although Cox17 is localised to both the cytosol and 
inner membrane space of the mitochondria the tethering of the protein to the mitochondrial 
membrane does not disrupt metallation of CcO, hence it is uncertain whether this protein 
can be considered a true copper metallochaperone.(131)  
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1.5.2 Copper Ligand (CuL) 
Due to the ability of Cox17 tethered to the mitochondrial membrane to maintain CcO 
biogenesis it became clear that another species in the cell must be responsible for copper 
transfer to this compartment. Copper has been found to be available within the 
mitochondria as a small soluble copper ligand complex (CuL).(132,133) CuL is present in 
the mitochondria of both yeast and humans and has been found in the apo state within the 
cytoplasm, indicating that this species may represent a route for copper entry into the 
mitochondria.(133) Little data is available for this potential copper metallochaperone and 
it is unknown if mechanisms for translocation of a copper-bound form into the 
mitochondria exist.  
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Chapter 2 
Binding Affinities of the CXXC and CXC Copper Binding Motifs of the 
Human Metallochaperone for Cu,Zn-Superoxide Dismutase
1
 
 
 
 
 
 
 
 
 
 
 
The work presented in this Chapter has been published in the following article: 
Allen, S.; Badarau, A.; Dennison, C. Biochemistry 2012, 51, 1439-1448. 
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2.1 Introduction 
The copper metallochaperone for Cu,Zn-superoxide dismutase; CCS in humans and 
Ccs1 in S. cerevisiae, is responsible for the activation of Cu,Zn-superoxide dismutase 
(designated SOD1 in humans and Sod1 in S. cerevisiae), the only currently known 
eukaryotic enzyme that acquires copper in the cytosol.(1-11) Activation of this enzyme 
not only involves the transfer of copper, but also the formation of an essential disulfide 
bond.(9-11) These are important reactions given that copper mis-handling is associated 
with a range of disorders,(12-15) including Alzheimer’s disease (AD), and that 
mutations in SOD1, which can lead to misfolding, result in amyotrophic lateral 
sclerosis.(14,15) CCS and Ccs1 consist of a three domain structure (Figure 
1.8B).(3,6,7,16) The N-terminal domain 1 (D1) has a βαββαβ-fold as found in the other 
cytosolic copper metallochaperone HAH1 (Atx1 in S. cerevisiae) that is involved in 
Cu(I) delivery to the secretory pathway.(6,16-18) HAH1 and D1 of CCS both bind Cu(I) 
via a CXXC motif. Domain 2 (D2) of the metallochaperone is structurally similar to the 
target enzyme (16,19) and is the main region of interaction between these partners.(20) 
CCS contains a Zn(II) site in D2 at the same location as that of SOD1 (19) which is 
absent in Ccs1.(16) The short C-terminal domain 3 (D3) contains a CXC Cu(I)-binding 
sequence. D3 of apo-Ccs1 is largely unstructured,(16) but some -helical content is 
observed in the complex with Sod1, with the Cys residues of this domain ideally placed 
for copper insertion into the target enzyme.(20) Apo-CCS is a dimer whereas apo-Ccs1 
is monomeric, with alterations in quaternary structure observed for both in the presence 
of Cu(I).(3,21,22) The transfer of metal to the target enzyme is thought to involve 
hetero-dimeric complexes (20,21,23,24) although a hetero-tetramer has also been 
suggested for CCS.(22) 
The functional importance of the domains of CCS and Ccs1 has been studied in 
vivo. The CXXC motif of D1 of CCS is required for copper incorporation into 
SOD1.(25) In S. cerevisiae D1 is essential only under copper limiting conditions,(3) 
although it is required for optimal Ccs1 activity (Atx1 is also more important for copper 
transfer under limiting conditions(26)). Domain 3 is essential for Cu(I) transfer and 
disulfide formation in humans and S. cerevisiae.(3,25) Both of the Cu(I)-binding 
domains of CCS must play a role in Cu(I) transfer to SOD1, but the mechanism of this 
process is poorly understood. In particular, the details of the way in which the two 
domains containing the CXXC and CXC Cu(I)-binding motifs bind copper is lacking. 
As yet no detailed investigation into the metal binding stoichiometries and relative Cu(I) 
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affinities (Kb) of the of these two motifs has been performed. These are important 
biophysical parameters considering the events of copper binding and transfer between 
the D1 and D3 are crucial for the activity of the CCS. It has recently been reported that 
SOD1 has a 10-fold higher Cu(I) affinity than CCS loaded with 1 equivalent of Cu(I), 
providing a thermodynamic driving force for copper transfer.(27) However, no 
discrimination between Cu(I)-binding to the individual domains of CCS was made and 
therefore the roles of D1 and D3 in mediating what appears to be thermodynamically 
driven copper transfer from CCS to SOD1 have not been fully resolved. 
A number of approaches for the determination of Cu(I) affinities for proteins 
involved in copper trafficking have led to insights into the mechanism of Cu(I) 
acquisition and transfer to target proteins (See chapter 3).(28,29) Direct approaches, 
such as the use of isothermal titration calorimetry, to determine Kb have been used, 
however, due to limitations in the techniques and the exceptionally high metal affinity of 
the copper metallochaperones (Kb ~ 10
17 
M
-1
) means that the values reported only 
represent lower limits of the metal affinity of the proteins.(29) Even at M 
concentrations of protein the detection of the free metal is highly problematic. Therefore, 
the use of indirect equilibrium competition methods has become the technique of choice 
for accurate measurement of Kb values. In this approach, competition between a ligand 
(L) and the protein (P) for the metal (M) is used in order to determine Kb.  
 
 MP + 2L  ML2  + P     (2.1) 
 
By varying only the concentration of either P or L and if ML2 can be quantified by 
spectroscopic techniques the equilibrium concentrations of each species can be found. In 
addition, by considering the concentration of ‘free’ uncomplexed Cu(I) to be negligible, 
compared to that bound by the ligand and protein, the contribution of this species to the 
equilibrium can be ignored and therefore, in the absence of formation of protein-Cu(I)-
ligand ternary complexes, a Kb value can be determined.(28,30) Bathocuproine 
disulfonate (BCS) and bicinchoninic acid (BCA) represent two chromophoric bi-dentate 
ligands that specifically bind Cu(I) in a tetrahedral CuL2
 
complex and have been widely 
used to enable determination of Cu(I) Kb values by this and similar techniques.(31-35) 
BCA and BCS bind Cu(I) specifically with high affinity due to their preference for bis-
chelate, tetrahedral coordination and their Cu(I)-bound complexes display characteristic 
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absorbance in the visible spectrum (λmax of 562 and 483 nm respectively) and therefore 
represent ideal ligand probes for Cu(I).(31) 
In this chapter a detailed investigation into Cu(I) binding by CCS is presented. 
Double Cys to Ser mutants of the CXXC and CXC motifs, in the full length protein, and 
D1 and D3 constructs have been prepared to allow the determination of Cu(I) binding 
stoichiometries and Kb values for D1 and D3 using the Cu(I) ligands BCS and BCA. In 
addition, the analysis of partitioning and transfer of Cu(I) between D1 and D3 has been 
performed to verify the determined Kb values. The Kb values of two related Cu(I) 
binding proteins HAH1 and the C-terminal domain of -Secretase (BACE1), an enzyme 
involved in copper homeostasis and the development of AD (36), are also presented and 
highlight the interconnectivity of the copper trafficking pathways. Implications of the 
determined Kb values for D1 and D3 of CCS with regard to the mechanism of copper 
transfer from CCS to SOD1 are discussed.  
 
Figure 2.1.1  
Structures of the chromophoric Cu(I)-binding ligands BCS and BCA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BCS BCA 
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2.2 Experimental 
2.2.1 Cloning and Mutagenesis  
The gene for wild type (WT) CCS (pGEMT_WT-CCS) (see section 6.8) was cloned into 
pET29a via the Nde1/BamH1 sites giving pET29a_WT-CCS. The C22S/C25S-CCS and 
C244S/C246S-CCS mutations were prepared using Quikchange mutagenesis 
(Stratagene) and the primers listed in Table 2.2.1, giving pET29a_C22S/C25S-CCS and 
pET29a_C244S/C246S-CCS respectively. The DNA coding for residues 1-79 of CCS, 
corresponding to D1, was cloned (primers listed in Table 2.2.1), into the Nde1/BamH1 
sites of pET29a to generate pET29a_D1-CCS. The gene for WT S. cerevisiae Ccs1 was 
cloned into pET29a using the Nde1/BamH1 sites of pET29a (pET29a_Ccs1) and the 
primers listed in Table 2.2.1.  
 
2.2.2 Expression and Purification of Proteins 
The proteins WT-CCS, C244S/C246S-CCS, C22S/C25S-CCS, D1-CCS and Ccs1 were 
expressed and purified as described in section 6.1. The protein HAH1 was provided by 
Dr Adriana Badarau. 
 
2.2.3 The D3 and CE1 C-Terminal Domain Peptides 
The peptides GLFQNPKQICSCDGLTIWEERGRPIAGKGRKESAQPPAHL, which 
corresponds to D3 (Gly235 to Leu274) of CCS (D3-CCS), and 
CQWRCLRCLRQQHDDFADDISLLK, which corresponds to the cytoplasmic C-
terminal domain (Cys478 to Lys501) of BACE1 (BACE1-CTD) (36) were purchased 
from GeneCust Europe (purity ≥ 95% and ≥ 90% respectively). The solid peptide, stored 
anaerobically, was dissolved directly in buffer immediately prior to use. 
 
2.2.4 Protein Reduction and Quantification 
Proteins (200-800 M) were reduced by incubation with 10 mM DTT in 20 mM Tris pH 
7.5 in an anaerobic chamber (Belle Technology, O2 << 2 parts per million), typically for 
2-3 h. These samples were desalted and exchanged into the required buffer using a PD10 
column (GE Healthcare). Thiol quantification using 5,5'-dithiobis-(2-nitrobenzoic acid) 
(DTNB, Ellman’s reagent) was routinely used for determining the concentration of D1-
CCS (three thiols per monomer) which has little absorbance at 280 nm, and for the 
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assessment of the number of thiols in WT (WT-CCS), C244S/C246S (C244S/C246S-
CCS) and C22S/C25S (C22S/C25S-CCS) CCS and Ccs1 as described in section 6.15. 
The concentrations of WT-CCS, C22S/C25S-CCS, C244S/C246S-CCS and Ccs1 were 
routinely determined using calculated  values at 280 nm of 12,490 (CCS) and 30,940 
(Ccs1) M
-1
cm
-1
.(37) Concentrations determined from Bradford assays (Coomassie Plus 
protein assay kit; Thermo Scientific) for WT-CCS, C22S/C25S-CCS and C244S/C246S-
CCS using BSA standards required correction factors of 1.1-1.3 against values obtained 
using the absorbance at 280 nm. Bradford assays of D1-CCS using BSA standards 
required a correction factor of 1.5 compared to concentrations determined from Ellman’s 
assays. A set of D1-CCS standards, whose concentrations were determined using DTNB, 
were also used for Bradford assays of mixtures of apo- and Cu(I)-D1-CCS. 
The D3-CCS and BACE1-CTD peptides and HAH1 were quantified using 
DTNB assuming 2, 3 and 3 thiols, respectively. Bradford assays of D3-CCS using BSA 
standards required a correction factor of 1.7 compared to concentrations determined with 
DTNB (concentrations were approximately 20 % higher using a calculated (37)  
value of 5,500 M
-1
 cm
-1
 than those obtained from thiol quantifications). Reduction of the 
peptide with immobilized tris(2-carboxyethyl)phosphine gel (Thermo Scientific) 
overnight did not alter the thiol concentration. The concentration of the BACE1-CTD 
peptide determined using a calculated (37) 280 of 5,500 M
-1
 cm
-1
 was within 10 % of 
that obtained from thiol quantification. 
 
2.2.5 Cu(I) Binding Stoichiometries 
High affinity Cu(I)-binding stoichiometries were performed as described in section 
6.16.2. Titrations of Cu(I) into protein samples (10 M) in the presence of 50-500 M 
bicinchoninic acid (BCA) were performed in 20 mM Mes pH 6.5 or 20 mM Hepes pH 
7.5, containing 200 mM NaCl. 
 
2.2.6 Cu(I) Affinity Determinations 
Cu(I) affinity (Kb) determinations were performed as described in section 6.16.3 except 
for those determined for WT-CCS, C22S/C25S-CCS, D3-CCS, Ccs1 and the BACE1-
CTD. For WT-CCS, Ccs1 and BACE1-CTD competition experiments were performed 
only for titration of BCS and or BCA into the Cu(I)-protein. For D3-CCS, the apo-
peptide was titrated into [Cu(BCA)2]
3-
 only. In all titrations equilibration for each point 
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was reached within 10 to 30 min, except for Cu(I) removal from C22S/C25S-CCS by 
BCA which required much longer. Therefore, mixtures containing different BCA 
concentrations and fixed amounts of Cu(I) and C22S/C25S-CCS were incubated for the 
required amount of time in the anaerobic chamber (≤ 48 h). Titrations were performed in 
either 20 mM Mes pH 6.5 or 20 mM Hepes pH 7.5, in the presence of 200 mM NaCl (20 
mM Hepes pH 7.5 plus 200 mM KCl for the BACE1-CTD peptide as precipitation was 
observed in the presence of NaCl).  
 
2.2.7 Cu(I) Partitioning Assays 
[Cu(BCA)2]
3-
 (1:2.5 Cu(I):BCA) was added to mixtures of D1-CCS plus either WT-
CCS, C22S/C25S-CCS or C244S/C246S-CCS (100-200 M of each) in 20 mM Mes pH 
6.5 containing 150 mM NaCl (total volume 0.5 mL). The mixtures were incubated for up 
to 4 h, loaded onto a HiTrap Q HP anion exchange column (1 mL, GE Healthcare) pre-
equilibrated in 20 mM Mes pH 6.5 containing 150 mM NaCl. D1-CCS did not bind to 
the column and WT-CCS, C22S/C25S-CCS and C244S/C246S-CCS were eluted with 
buffer plus 300 mM NaCl (2.0 mL fractions). The partitioning of Cu(I) (also supplied as 
[Cu(BCA)2]
3-
) between D1-CCS and D3-CCS (75 M of each) was performed in 20 mM 
Mes pH 6.5 (total volume 0.5 mL). D3-CCS does not bind to the HiTrap Q column 
under these conditions whilst D1-CCS was eluted with buffer plus 150 mM NaCl (2.0 
mL fractions). The protein concentrations in the fractions were determined using 
Bradford assays and checked, for D1-CCS only, by thiol quantification, and copper 
concentrations were measured with BCS and AAS. The partitioning of Cu(I) is 
expressed as an exchange equilibrium constant (Kex value) for copper transfer from D1-
CCS to CCS (either WT-CCS, C22S/C25S-CCS, C244S/C246S-CCS, or D3-CCS) 
according to equation (2.2);  
 
  
    1)(
)( 1
CCSapoCCSDICu
CCSICuCCSDapo
Kex


       (2.2) 
 
in which [apo-D1-CCS] and [Cu(I)-D1-CCS] are the concentrations of apo- and Cu(I)-
D1-CCS and [Cu(I)-CCS] and [apo-CCS] are the concentrations of the Cu(I)- and apo-
forms of the partner protein (WT-CCS, C22S/C25S-CCS, C244SC246S-CCS or D3-
CCS).  
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2.2.8  Cu(I) Transfer Assays 
Cu(I) exchange between D1-CCS and C244S/C246S-CCS and C22S/C25S-CCS was 
performed by mixing Cu(I)–loaded protein with the partner apo-protein in 20 mM Mes 
pH 6.5 containing 150 mM NaCl (total volume 0.5 mL).  The mixtures were incubated 
for up to 48 h, loaded onto a HiTrap Q HP anion column pre-equilibrated in the same 
buffer. Separation and quantification of protein and copper in fractions was performed as 
for the Cu(I) partitioning assays involving full length WT-CCS and Cys to Ser mutants. 
The equilibrium concentrations for each set of partner proteins Kex was calculated using 
equation (2.3). Cu(I) exchange between D1-CCS and HAH1 was performed by mixing 
Cu(I)-loaded protein with the partner apo-protein in 20 mM Hepes pH 7.5 (total volume 
1.0 mL). Mixtures were incubated for < 5 min prior to loading onto a HiTrap Q HP 
column pre-equilibrated in the same buffer. Buffer plus 100 and 200 mM NaCl were 
used to elute HAH1 and D1-CCS (apo- and Cu(I)-forms in both cases), respectively (2.0 
mL fractions). The protein and copper content in fractions was determined by thiol 
quantification and AAS respectively, with Kex calculated using eq (2.4): 
 
  
  1)( 1
1 1)(
HAHICuCCSDapo
HAHapoCCSDICu
Kex


       (2.3) 
 
2.2.9  Cu(I) Removal from Cu(I)-Bound Proteins by BCA and BCS 
Cu(I) removal from Cu(I)-C22S/C25S-CCS (20 M) by BCA (500M) in 20 mM Mes 
pH 6.5 containing 200 mM NaCl was performed by measuring the increase in absorbance 
at 562 nm as a function of time to monitor the formation of the [Cu(BCA)2]
3-
complex. 
Similar reactions were performed for Cu(I) removal from WT-CCS, C244S/C246S-CCS 
and C22S/C25S-CCS (20 M) with 0.5 and 1.0 equivalents [and also 2.0 equivalents for 
WT-CCS] of bound Cu(I) by BCS (2.5 mM) in the same buffer, and the increase in 
absorbance at 483 nm measured to monitor formation of [Cu(BCS)2]
3- 
. The reactions were 
initiated by injecting the appropriate amount of concentrated BCA or BCS, from a gas 
tight syringe (Hamilton), into a 1 ml septum sealed gas tight cuvette (Hellma) containing 
the Cu(I)-bound protein.  
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Table 2.2.1  
Primers used for making the C244S/C246S-CCS and C22S/C25S-CCS mutants and cloning D1-CCS and Ccs1 
Construct Primer Sequence 5’ to 3’ 
pET29a_C244S/C246S-CCS CCAAGCAGATCTCCTCTTCCGATGGCCTCACC (Forward) 
GGTGAGGCC ATCGGAAGAGGAGATCTGCTTGG (Reverse) 
pET29a_C22S/C25S-CCS GCAGATGACCTCTCAGAGCTCTGTGGACGCG (Forward) 
CGCGTCCACAGAGCTCTGAGAGGTCATCTGC (Reverse) 
pET29a_D1-CCS GAACATATGGCTTCGGATTCGGGGAAC (Forward) 
GAAGGATCCTCAGCCCATGCCCTTGAG (Reverse) 
pET29a_Ccs1 GAAGGATCCCTATTTGATGTTGTTGGCCAAGGC (Forward) 
GAACATATGACCACGAACGATACATACGAGGC (Reverse) 
 
 
 
 
 
4
4
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2.3 Results 
2.3.1 Purification and Initial Characterisation of Proteins  
The purity of all final protein samples was determined by SDS-PAGE to be > 90 % and 
the molecular weights determined to be within 4 Da of expected values (Table 2.3.1). 
WT-CCS, C22S/C25S-CCS and C244S/C246S-CCS were isolated with 0.8 ± 0.2 zinc 
equivalents per monomer (protein concentrations determined using the 280 value) and 
negligible copper. D1-CCS and Ccs1 were isolated with negligible zinc and copper. For 
reduced apo-samples the number of thiols, determined by Ellmans assay, ranged from 
4.5-5.6, 2.4-3.3 and 3.5-4.6 for WT-CCS, C22S/C25S-CCS and C244S/C246S-CCS 
respectively (4.5-5.0 for Ccs1), based on protein concentrations determined from the 
absorbance at 280 nm. Using the Zn(II) concentrations, and assuming 1 Zn(II) per 
monomer for all proteins, gave 5.6-6.8, 3.3-4.6 and 4.4-5.8 thiols per Zn(II) ion, 
respectively. The number of thiols present in D1-CCS (used for protein concentration 
determination by Ellmans assay) was verified by a Cu(I)-binding stoichiometry of 1.0 
Cu(I):D1-CCS (section 2.3.4).  
 
2.3.2 CD Spectra 
Far-UV CD spectra (Figure 2.3.1) show that the Cys to Ser mutations in the CXXC and 
CXC motifs of D1 and D3 respectively do not perturb the secondary structure of the 
proteins relative to WT-CCS. The far-UV CD spectrum of Ccs1 resembles that of CCS, 
as is expected due to the similar content of secondary structure elements, whilst that of 
D1-CCS is similar to those previously reported for HAH1 and related domains.(38,39) 
 
2.3.3  Analytical Gel Filtration 
Analytical gel filtration chromatography was used to determine the speciation of the 
proteins (see section 6.4) which demonstrates that, in the absence of Cu(I), WT-CCS and 
the Cys to Ser variants are all dimers, and D1-CCS is a monomer (Figure 2.3.2, Figure 
2.3.3, Figure 2.3.4 and Table 2.3.2). D1-CCS and C244S/C246S-CCS remain 
monomeric and dimeric respectively upon the addition of 1 equivalent of Cu(I), while a 
mixture of dimeric and tetrameric forms are found for Cu(I)-WT-CCS and Cu(I)-
C22S/C25S-CCS (Figure 2.3.3, Figure 2.3.5 and Table 2.3.2),(22) with tetramer 
formation favored by increasing the Cu(I):CCS ratio (Figures 2.3.3 and 2.3.5). 
Negligible amounts of tetrameric WT-CCS form below a Cu(I):CCS ratio of 0.5. The 
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tetrameric form of WT-CCS binds two Cu(I) ions per monomer, whilst only a single 
Cu(I) ion is bound per monomer in tetrameric C22S/C25S-CCS (Figure 2.3.6). Apo-
Ccs1 is monomeric (Figure 2.3.2) as expected.(3,21)  
 
2.3.4 Cu(I) Binding Stoichiometries 
The  high affinity Cu(I)-binding stoichiometry for WT-CCS, the Cys to Ser variants and 
D1-CCS was determined by titrating Cu(I) into the apo-proteins in the presence of BCA. 
WT-CCS binds two equivalents of Cu(I) tightly (Figure 2.3.7). C22S/C25S-CCS, 
C244S/C246S-CCS and D1-CCS all bind a single Cu(I) equivalent under the same 
conditions (Figure 2.3.7 B-D). For WT-CCS the first equivalent of Cu(I) is bound at a site 
with a much higher affinity than BCA (the affinity of the Cu(I) site in C244S/C246S-CCS 
and D1-CCS is also considerably tighter than that of BCA). The second Cu(I) equivalent 
binds to a lower affinity site in WT-CCS, similar to that seen for C22S/C25S-CCS. Similar 
results are obtained for pH 7.5 (Figure 2.3.8). Cu(I)-binding to WT-CCS, C244S/C246S-
CCS and C22S/C25S-CCS was also monitored by measuring the increase in absorbance 
within the UV region and results showed that significant absorption occurred around 230-
280 nm (Appendix A Figure 1). Increases in absorbance in the region of 265 nm are 
diagnostic of ligand to metal charge transfer involving thiol ligands bound to Cu(I) and in 
this case are attributed to Cu(I)-bound Cys residues in D1 and/or D3 of CCS. The Cu(I)-
binding stoichiometry for Ccs1 (Figure 2.3.8) was almost identical to that obtained for 
WT-CCS, with one high affinity and one low affinity Cu(I)-binding sites. Cu(I)-binding 
stoichiometries for the D3-CCS and BACE1-CTD peptides were also determined (Figure 
2.3.9) and show the binding of a single Cu(I) in each case. BACE1-CTD shows tight 
binding similar to that observed for D1-CCS and C244S/C246S-CCS whilst Cu(I)-binding 
to D3-CCS is weaker and compares favourably to that observed for C22S/C25S-CCS.  
 
2.3.5 Cu(I) Binding Affinities  
The Kb values for Cu(I)-binding to D1 and D3 were determined from competition 
titrations with BCS and BCA at pH 6.5 and 7.5. Experiments at pH 7.5 provide Cu(I) 
affinities that can be readily compared with literature values for related systems 
(typically measured at pH 7-8). Measuring affinities at pH 6.5 allows the same ligand 
(BCA) to be used for all proteins. The Cu(I) affinity for the first equivalent of Cu(I) 
bound to WT-CCS at pH 6.5 is (4.4 ± 1.0) × 10
16
 M
-1
 (Figure 2.3.10) and almost 
identical values are found for C244S/C246S-CCS and D1-CCS (Figures 2.3.11 , 2.3.12 
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and Table 2.3.3). The Cu(I) affinities for these three proteins are also the same at pH 7.5, 
albeit the values are approximately 10-fold greater (Figures 2.3.10 to 2.3.12 and Table 
2.3.3). The first equivalent of Cu(I) bound to Ccs1 from S. cerevisiae has a Cu(I) affinity 
of (2.7 ± 1.0) × 10
16
 M
-1
 at pH 6.5, which increases ~ 10-fold at pH 7.5 (Figure 2.3.13). 
Very similar Kb values were also obtained for the BACE1-CTD peptide at pH 7.5. 
Fitting of the data for titrations of apo D1-CCS into [Cu(BCA)2]
3-
 and of BCA 
into Cu(I)-D1-CCS at pH 6.5 (Figure 2.2.14) allowed a mean β value for [Cu(BCA)2]
3-
 
of (5.4 ± 2.7) ×10
16
 M
-2
 to be determined from titrations in both directions using the Kb 
of D1-CCS determined using BCS. A β value of (5.6 ± 3.4) ×1016 M-2 was obtained at 
pH 7.5 and therefore the Cu(I) affinity of BCA exhibits no dependence on pH in the 
range studied. These values are in good agreement with those determined previously at 
pH 7.0 and the value determined at pH 6.5 was therefore used for all subsequent Kb 
determinations using BCA (28). Cu(I) affinities of (1.1 ± 0.6) × 10
17
 and (0.9 ± 0.5) × 
10
17
 M
-1 
were determined at pH 6.5 for WT-CCS and C244S/C246S-CCS, respectively, 
and the Kb value for the latter was 10-fold greater at pH 7.5 (Figures 2.3.15 and 2.3.16 
and Table 2.3.3). The minor differences (2-3 fold) between the Cu(I) affinities for WT-
CCS and C244S/C246S-CCS measured at both pH values with BCA and BCS (Table 
2.3.3) are within the error of the determination of the  value for [Cu(BCA)2]
3-
 [(5.4 ± 
2.7) × 10
16
 M
-2
.  The Cu(I) affinity of C22S/C25S-CCS was determined to be  (2.9 ± 
1.7) × 10
16
 M
-1 
at pH 6.5 and the Kb value, as in the case for C244S/C246S-CCS, also 
10-fold greater at pH 7.5  (Figure 2.3.16 and Table 2.3.3). Similar Kb values are obtained 
for the D3-CCS peptide at both pH values (Figure 2.3.17 and Table 2.3.3).  
 
2.3.6 Cu(I) Partitioning between CCS domains 1 and 3 
Copper was added as [Cu(BCA)2]
3-
 to D1-CCS and either WT-CCS, C22S/C25S-CCS, 
C244S/C246S-CCS or D3-CCS. These mixtures were separated and copper partitioning, 
expressed as an equilibrium constant for Cu(I) exchange (Kex), determined (Tables 2.3.4-
2.3.7). In all cases these reactions are largely complete within minutes, indicating that 
Cu(I) equilibration from [Cu(BCA)2]
3-
 between domains is relatively fast (occurs within 
the dead time of the experiment which is approximately 2 min). The Cu(I) partitioning 
between D1-CCS and either WT-CCS or C244S/C246S-CCS gave average Kex values 
1.9 and 1.7 respectively. Partitioning between D1-CCS and either C22S/C25S-CCS or 
D3-CCS gave average Kex values of 0.05 and 0.08 respectively that are consistent with 
the Kb values for the same partner proteins in section 2.3.5.  
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2.3.7 Cu(I) Transfer between CCS domains 1 and 3 
Copper transfer between D1-CCS and either C244S/C246S-CCS or C22S/C25S-CCS at 
pH 6.5 was performed in both directions and Kex values determined (Tables 2.3.8 and 
2.3.9). The transfer of Cu(I) between D1-CCS and C244S/C246S-CCS in both 
directions, that is from D1-CCS to C244S/C246S-CCS and vice versa, was found to be 
almost complete within the dead time of the experiment (approximately 2 minutes), and 
gives Kex values of similar to those obtained from the Cu(I) partitioning experiments. 
The Cu(I) transfer between D1-CCS and C22S/C25S-CCS was much slower and 
required significantly longer incubation periods. The transfer of Cu(I) from D1-CCS to 
apo-C22S/C25S-CCS was faster than that observed in the opposite direction, with 
transfer of Cu(I) from C22S/C25S-CCS to D1-CCS requiring incubation periods of ~48 
hours (Table 2.3.9). 
 
2.3.8 Cu(I) Transfer between D1-CCS and HAH1 
Copper transfer was performed between D1-CCS and HAH1 at pH 7.5 and found to be 
complete within the dead time of the experiment (approximately 2 minutes). Copper 
transfer performed in both directions, from Cu(I)-D1-CCS to apo-HAH1 and Cu(I)-
HAH1 to apo-D1-CCS, and gave a Kex of 1.1 (Table 2.3.10), consistent with their 
independently determined Kb values of (5.4 ± 0.2) × 10
17
 and (9.3 ± 0.1) × 10
17
 M
-1
 
respectively at pH 7.5 (experiments performed by by Dr Adriana Badarau). The Kex 
values for Cu(I) transfer between D1-CCS and HAH1 are also similar to those obtained 
for the Cu(I) partitioning experiments between WT-CCS and C244S/C246S (Figure 
2.3.11) 
 
2.3.9 Cu(I) Removal from Cu(I)-Bound Proteins by BCA and BCS 
Cu(I) transfer from Cu(I)-C22S/C25S-CCS to BCA is slow and for 20 M Cu(I)-
C22S/C25S-CCS in the presence of 500 mM BCA at pH 6.5 (Figure 2.2.18) equilibrium 
takes ~ 48 hours to be established.  Cu(I) transfer to BCS from WT-CCS, C244S/C246S-
CCS and C22S/C25S-CCS with various metal stoichiometries (Figure 2.2.18) was more 
convenient due to the higher β value of the  [Cu(BCS)2]
3-
, compared to [Cu(BCA)2]
3-
, 
allowing for almost complete Cu(I) transfer to BCS. Cu(I) transfer from Cu(I)-WT-CCS 
was fast (~5 mins for ~95% transfer) for Cu(I):CCS ratios of ≤ 0.5 but significantly 
slower at ratios ≥ 1.0 (~15 mins for 90 % transfer). Cu(I) transfer from Cu(I)-
49 
 
C244S/C246S-CCS to BCS up to Cu(I):CCS ratios of 1.0 were comparable to that 
observed for Cu(I)-WT-CCS ≤ 0.5. The Cu(I) transfer from 0.5 and 1.0 Cu(I)-bound 
C22S/C25S-CCS to BCS was slower than that observed for Cu(I)-WT-CCS at 
Cu(I):CCS ratios ≥ 1.0, taking up to ~60 minutes for ~90% transfer. 
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Table 2.3.1  
Fourier transform ion cyclotron resonance (FT-ICR) and matrix assisted laser desorption 
ionization time of flight (MALDI-TOF) mass spectrometry (MS) data for purified 
proteins 
protein technique experimental mass 
(kDa) 
theoretical mass (kDa) 
WT-CCS
a
 FT-ICR MS 28903.3 28907.4 (-Met) 
244S/C246S-
CCS
a
 
FT-ICR MS 28873.3 28875.2 (-Met) 
C22S/C25S-
CCS
a
 
FT-ICR MS 28871.3 28875.2 (-Met) 
D1-CCS FT-ICR MS 8215.1 8215.3 (-Met) 
Ccs1
b,c
 MALDI-TOF 
MS 
27195.5 (-Met) and 
27328.7 
27196.7 (-Met) and 
27327.9 
a 
Theoretical mass considers the presence of a disulfide in D2 of WT-CCS, 
C244S/C246S-CCS and C22S/C25S-CCS. 
b
 Ccs1 was purified as a mixture of full 
length and a truncated form missing the N-terminal Met residue. 
c
 Theoretical mass 
considers the presence of a disulfide in domain 1 of Ccs1. 
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Table 2.3.2  
Elution volumes and apparent molecular weights for apo and Cu(I)-bound WT-CCS, 
C244S/C246S-CCS,C22S/C25S-CCS, D1-CCS and Ccs1 determined on a Superdex 75 
10/300 GL column in 20 mM Mes pH 6.5 containing 200 mM NaCl.  
protein Cu(I):protein ratio elution volume(s)  
(± 0.1 ml) 
apparent mass 
a
 
(kDa) 
WT-CCS 0 9.7 64 (± 2) 
 
WT-CCS 0.5 9.6, 8.6 (shoulder) 67 (± 2), 100 (± 4) 
WT-CCS 1.0 9.7, 8.6 64 (± 2), 100 (± 4) 
    
C244S/C246S-CCS 0 9.6 67 (± 2) 
C244S/C246S-CCS 1.0 9.7 64 (± 2) 
    
C22S/C25S-CCS 0 9.7 64 (± 2) 
C22S/C25S-CCS 0.5 9.7, 8.6 64 (± 2), 100 (± 4) 
C22S/C25S-CCS 1.0 9.6, 8.6 67 (± 2), 100 (± 4) 
    
D1-CCS
b
 0 13.5 14 (± 0.5) 
D1-CCS
b
 1.0 13.5 14 (± 0.5) 
    
Ccs1 0 11.7 29 (± 1) 
a
 The errors indicated for the apparent masses of proteins are deduced from the error in 
the measurement of the elution volumes and therefore will be significantly lower than 
the real error observed (see section 6.4). 
b
 The high apparent molecular weight of D1-
CCS is expected to be caused by the asymmetrical dimensions of this protein.  
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Table 2.3.3  
Summary of mean Cu(I) affinities (Kb Values) at pH 6.5 and 7.5 
protein pH Kb (BCA)(M
-1
) Kb (BCS)(M
-1
) 
D1-CCS
a
 6.5 - (5.6 ± 2.6) × 10
16
 
 7.5 - (5.5 ± 3.5) × 10
17
 
WT-CCS
b
 6.5 (1.1 ± 0.6) × 10
17
 (4.4 ± 1.0) × 10
16
 
 7.5 - (5.5 ± 0.6) × 10
17
 
C244S/C246S-CCS
c
 6.5 (0.9 ± 0.5) × 10
17
 (4.6 ± 2.5) × 10
16
 
 7.5 (1.1 ± 0.6) × 10
18
 (4.6 ± 1.0) × 10
17
 
C22S/C25S-CCS
d
 6.5 (2.9 ± 1.7) × 10
15
 - 
 7.5 (2.7 ± 1.4) × 10
16
 - 
D3-CCS
e
 6.5 (4.2 ± 1.0) × 10
15
  
 7.5 (6.4 ± 0.3) × 10
16
  
Ccs1
b
 6.5 - (2.7 ± 1.0) × 10
16
 
 7.5 - (2.4 ± 0.5) × 10
17
 
a
 D1-CCS was used for the calculation of an overall formation constant (β) for 
[Cu(BCA)2]
3-
 (see section 2.3.5) and therefore Kb values using this ligand are not 
included. 
b
 Data only acquired from titrations of BCA and/or BCS into Cu(I)-protein. 
Titrations in this direction at pH 7.5 were only determined with BCS due to Cu(I) 
affinities being too high to be measured with BCA. 
c
 The Kb value at pH 7.5 using BCA 
was obtained only by titrating [Cu(BCA)2]
3-
 with apo-C244S/C246S-CCS. 
d
 Data from 
competition experiments with BCS are not included due to the possible formation of a 
BCS-Cu(I)-C22S/C25S-CCS complex. 
e
 From titrations of the apo-peptide into 
[Cu(BCA)2]
3-
 only. 
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Table 2.3.4  
Exchange equilibrium constant determinations for Cu(I) partitioning from [Cu(BCA)2]
3-
 between a mixture of  D1-CCS and WT-CCS 
initial concentrations (µM)  equilibrium concentrations (µM)
b
 incubation 
time 
Kex 
Cu(I)
a
 D1-CCS WT-CCS  Cu(I)-D1-CCS D1-CCS Cu(I)-WT-
CCS 
WT-CCS 
 
100 100 100  50 42 59 30 min
c
 1.7 
100 100 100  55 62 50 33 min
c
 1.7 
75 150 150  32 101 45 77 1 h 1.8 
100 100 100  52 69 49 43 1 h 1.5 
75 150 150  32 98 45 76 4 h 1.8 
a
 Cu(I) is present as the [Cu(BCA)2]
3-
 complex prior to addition to the protein mixture [2.5 molar excess of BCA over Cu(I)]. 
b
 Concentrations corrected 
for dilutions. 
c
 Proteins were separated in approximately 2 min. 
 
 
 
 
 
 
 
5
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Table 2.3.5 
 Exchange equilibrium constant determinations for Cu(I) partitioning from [Cu(BCA)2]
3-
 between a mixture of D1-CCS and C244S/C246S-CCS 
initial concentrations (µM)  equilibrium concentrations (µM)
b
 incubation 
time 
Kex 
Cu(I)
a
 D1-CCS C244S/C246S-
CCS 
 Cu(I)-D1-
CCS 
D1-CCS Cu(I)-C244S 
/C246S-CCS 
C244S/C246S-
CCS 
 
100 100 100  48 61 58 35 min
c
 2.1 
100 100 100  42 46 51 31 1 h 1.8 
a
 Cu(I) is present as the [Cu(BCA)2]
3-
 complex prior to addition to the protein mixture [2.5 molar excess of BCA over Cu(I)]. 
b
 Concentrations corrected 
for dilutions. 
c
 Proteins were separated in approximately 2 min. 
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Table 2.3.6 
Exchange equilibrium constant determinations for Cu(I) partitioning from [Cu(BCA)2]
3-
 to a mixture of D1-CCS and C22S/C25S-CCS 
initial concentrations (µM)  equilibrium concentrations (µM)
b
 incubation time Kex 
Cu(I)
a
 D1-CCS C22S/C25S-
CCS 
 Cu(I)-D1-
CCS 
D1-CCS Cu(I)-CCSC22 
/25S-CCS 
C22S/C25S-
CCS 
 
180 200 200  152 68 28 156 min
c
 0.08 
75 100 200  58 44 16 140 min
c
 0.09 
112 100 200  60 44 24 153 1 h 0.12 
75 150 150  67 77 12 116 1 h 0.12 
100 100 100  77 26 26 57 1 h 0.15 
75 150 150  65 77 11 116 4 h 0.11 
a
 Cu(I) is present as the [Cu(BCA)2]
3-
 complex prior to addition to the protein mixture [2.5 molar excess of BCA over Cu(I)]. 
b
 Concentrations corrected 
for dilutions. 
c
 Proteins were separated in approximately 2 min.
5
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Table 2.3.7 
 Exchange equilibrium constant determination for Cu(I) partitioning from [Cu(BCA)2]
3-
 to a mixture D1-CCS and D3-CCS 
initial concentrations (µM)  equilibrium concentrations (µM)
b
 incubation time Kex 
Cu(I)
a
 D1-CCS D3-CCS  Cu(I)-D1-
CCS 
D1-CCS Cu(I)-D3-CCS 
 
D3-CCS 
 
75 75 75  50 16 14 52 min
c
 0.09 
a
 Cu(I) is present as the [Cu(BCA)2]
3-
 complex prior to addition to the protein mixture [2.5 molar excess of BCA over Cu(I)]. 
b
 Concentrations corrected 
for dilutions. 
c
 Proteins were separated in approximately 2 min. 
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Table 2.3.8 
 Exchange equilibrium constant determinations for Cu(I) exchange between D1-CCS and C244S/C246S-CCS 
proteins initial concentrations (M)  equilibrium concentrations (M)
a
 Kex 
 
Cu(I)-D1-
CCS D1-CCS 
Cu(I)-
C244S/C246S-
CCS 
C244S/C246S-
CCS 
 
Cu(I)-D1-
CCS D1-CCS 
Cu(I)-
C244S/C246S-
CCS 
C244S/C246S-
CCS   
Cu(I)-D1-CCS + C244S/C246S-
CCS (min
b
) 75 25 0 100 
 
36 62 48 56 1.5 
Cu(I)-D1-CCS + C244S/C246S-
CCS (1 h) 75 25 0 100 
 
28 57 42 48 1.8 
Cu(I)-C244S/C246S-CCS + D1-
CCS (min
b
) 0 100 75 25 
 
26 82 32 72 1.4 
Cu(I)-C244S/C246S-CCS + D1-
CCS (1 h) 0 100 75 25 
 
23 78 27 66 1.4 
a
 Concentrations corrected for dilutions. 
b
 Proteins were separated in approximately 2 min. 
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Table 2.3.9 
 Exchange equilibrium constant determinations for Cu(I) exchange between D1-CCS and C22S/C25S-CCS 
proteins initial concentrations (M)  equilibrium concentrations (M)
a
 Kex 
 
Cu(I)-D1-
CCS D1-CCS 
Cu(I)-
C22S/C25S-
CCS 
C22S/C25S-
CCS 
 
Cu(I)-D1-
CCS D1-CCS 
Cu(I)-
C22/C25S-
CCS 
C22S/C25S-
CCS   
Cu(I)-D1-CCS  
+ C22S/C25S-CCS (min
b
) 75 25 0 150 
 
67 30 9 117 0.03 
Cu(I)-D1-CCS  
+ C22S/C25S -CCS (1 h) 75 25 0 150 
 
53 32 10 109 0.06 
Cu(I)-D1-CCS  
+ C22S/C25S -CCS (4 h) 75 25 0 150 
 
58 28 17 97 0.08 
Cu(I)-C22S/C25S-CCS  
+ D1-CCS (min
b
) 0 100 75 75 
 
23 67 65 56 3.4 
Cu(I)-C22S/C25S-CCS  
+ D1-CCS (1
 
h) 0 100 75 75 
 
29 53 46 60 1.4 
Cu(I)-C22S/C25S-CCS  
+ D1-CCS (48
 
h) 0 100 75 75 
 
59 41 24 103 0.16 
a
 Concentrations corrected for dilutions. 
b
 Proteins were separated in approximately 2 min. 
5
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Table 2.3.10 
 Exchange equilibrium constant determinations for Cu(I) exchange between D1-CCS and HAH1 
proteins initial concentrations (M)  equilibrium concentrations (M)
a
 Kex 
 
Cu(I)-
HAH1 HAH1 
Cu(I)-D1-
CCS D1-CCS 
 Cu(I)-
HAH1 HAH1 
Cu(I)-D1-
CCS 
D1-CCS 
  
Cu(I)-HAH1 + D1-CCS (min
b
) 50 50 0 100  24 56 26 56 1.1 
Cu(I)-D1-CCS + HAH1 (min
b
) 0 100 50 50  24 58 26 66 0.95 
a
 Concentrations corrected for dilutions. 
b
 Proteins were separated in approximately 2 min. 
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Table 2.3.11 
Summary of Kex values for Cu(I) partitioning between proteins at pH 6.5 and exchange 
between HAH1 and D1-CCS at pH 7.5 
protein mixture incubation 
time 
Kex Kex
calc
 
a
 
apo-D1-CCS + apo-WT-CCS
b
 min
c
 1.7 1.9 
  1 h 1.7 
 4 h 1.8 
apo-D1-CCS + apo-C244S/C246S-CCS
b
 min
c
 2.1 1.7 
 1 h 1.8 
apo-D1-CCS + apo-C22S/C25S-CCS
b
 min
c
 0.09 0.05 
 1 h 0.13 
 4 h 0.11 
apo-D1-CCS + apo-D3-CCS
b
 min
c
 0.09 0.08 
Cu(I)-HAH1 + apo-D1-CCS min
c
 1.1 0.58 
Cu(I)- D1-CCS + apo- HAH1 min
c
 0.95  
a
 Calculated from the Kb values of the partner proteins using Kex
calc
 = Kb 
(WT-
CCS,C244S/C246S, C22S/C25S-CCS or D3-CCS)
/Kb 
(D1-CCS)
 or Kex
calc
 = Kb 
(D1-CCS)
/Kb 
(HAH1)
. 
b
 Cu(I) was 
added as [Cu(BCA)2]
3-
 to a mixture of apo-proteins. 
c
 Proteins were separated in 
approximately 2 min. 
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Figure 2.3.1 
CD spectra of apo-WT-CCS (blue line), apo-C22S/C25S-CCS (green), apo-
C244SC246S-CCS (red), apo-D1-CCS (black) and apo-Ccs1 (magenta) (all 0.5 mg/ml) 
in 100 mM potassium phosphate pH 6.5. 
 
Figure 2.3.2 
Gel filtration chromatograms for apo-WT-CCS (blue), apo-C22S/C25S-CCS (green), 
apo-C244SC246S-CCS (red), apo-D1-CCS (black) and apo-Ccs1 (magenta) (100 M) in 
20 mM Mes pH 6.5 containing 200 mM NaCl. Absorbance measured at 280 nm except 
for D1-CCS (240 nm) and the absorbance values for Ccs1 have been divided by 3. 
Elution volumes and apparent molecular weights listed in Table 2.3.2. 
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Figure 2.3.3 
Gel filtration chromatograms for apo- (A) and Cu(I)-bound (0.5 (B) and 1.0 (C) 
equivalents) WT-CCS (100 M) in 20 mM Mes pH 6.5 containing 200 mM NaCl, with 
absorbance measured at 280 nm. Protein eluting at ~ 9.7 ml (~ 64 kDa) correspond to 
dimer and those eluting at ~ 8.6 ml (~ 100 kDa) to tetramer.  
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Figure 2.3.4 
Gel filtration chromatograms for apo-C244S/C246S-CCS (A), apo-C22S/C25S-CCS (B) 
and Cu(I)-bound (1 equivalent) C244S/C246S-CCS (C) and (0.5 equivalent) 
C22S/C25S-CCS (D) (100 M) in 20 mM Mes pH 6.5 containing 200 mM NaCl, with 
absorbance measured at 280 nm. Protein eluting at ~ 9.7 ml (~ 64 kDa) correspond to 
dimer and those eluting at ~ 8.6 ml (~ 100 kDa) to tetramer. 
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Figure 2.3.5 
Gel filtration chromatograms for apo- (A) and Cu(I)-bound (0.5 (B) and 1.0 (C) 
equivalents) C22S/C25S-CCS (10 M) in 20 mM Mes pH 6.5 containing 200 mM NaCl, 
with absorbance measured at 280 nm. Protein eluting at ~ 9.7 ml (~ 64 kDa) corresponds 
to dimer and that at ~ 8.6 ml (~ 100 kDa) to tetramer.  
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Figure 2.3.6 
Gel filtration chromatograms of WT-CCS (200 M Cu(I)-protein) (A) and C22SC25S-
CCS (200 M protein plus 100 M Cu(I)) (B) in 20 mM Mes pH 6.5 containing 200 mM 
NaCl. Copper (□) and protein (○) content of tetrameric and dimeric, fractions 29-35 and 
36-45 respectively, is shown in each case. The addition of 1.0 and 0.5 equivalents of Cu(I) 
to WT-CCS and C22SC25S-CCS respectively ensures partial Cu(I)-occupancy of the 
domain 3 site in both cases. 
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Figure 2.3.7 
Titrations of Cu(I) into apo-WT-CCS (A), apo-C22S/C25S-CCS (B), apo-
C244S/C246S-CCS (C) and apo-D1-CCS (D) (10 M) in 20 mM Mes pH 6.5 containing 
200 mM NaCl and 50 M BCA.  
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Figure 2.3.8  
Titrations of Cu(I) into apo-WT-CCS (A), apo-C22S/C25S-CCS (B), apo-
C244S/C246S-CCS (C) and apo-D1-CCS (D) (10 M) in 20 mM Hepes pH 7.5 
containing 200 mM NaCl and 500 M BCA.  
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Figure 2.3.9 
Titration of Cu(I) into apo-Ccs1 (10 M) (A) in 20 mM Hepes pH 7.5 containing 200 
mM NaCl and 500 M BCA. Titration of Cu(I) into apo-D3-CCS (10 M) (B) in 20 
mM Mes pH 6.5 containing 200 mM NaCl and 30 M BCA and apo-BACE1-CTD (10 
M) (C) in 20 mM Hepes pH 7.5 containing 200 mM NaCl and 500 M BCA. 
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Figure 2.3.10 
Titration of BCS into Cu(I)-WT-CCS (10 M) plus excess apo-WT-CCS (10 M) in 20 
mM Mes pH 6.5 containing 200 mM NaCl is shown in (A). Titrations of BCS into 
Cu(I)-WT-CCS (5 M) plus excess apo-WT-CCS (15 M) (B) and Cu(I)-WT-CCS (10 
M) plus excess apo-WT-CCS (10 M) (C) in 20 mM Hepes pH 7.5 containing 200 mM 
NaCl. Lines show fits of data, to equation (6.1), giving Kb values of (5.4± 0.2) × 10
16
 
(A), (5.5± 0.3) × 10
17
 (B) and (5.2 ± 0.1) × 10
17
 (C) M
-1
. 
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Figure 2.3.11 
Titrations of apo-C244S/C246S-CCS into [Cu(BCS)2]
3- 
(10 M) plus 20 M at pH 6.5 
(A) and plus 140 M BCS at pH 7.5 (B), respectively. Titrations of BCS into Cu(I)-
C244S/C246S-CCS (10 M) plus apo-C244S/C246S-CCS (10 M) at pH 6.5 (C) and 
pH 7.5 (D), respectively. Lines show fits of data, to equations (6.2) (A and B) and (6.1) 
(C and D), giving Kb values of (5.0± 0.4) × 10
16
 (A), (5.6± 0.1) ×10
17
 (B), (5.5 ± 0.1) × 
10
16
 (C) and (4.4 ± 0.2) × 10
17
 M
-1
 (D). 
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Figure 2.3.12 
Titrations of apo-D1-CCS into [Cu(BCS)2]
3- 
(10 M) plus 5 M at pH 6.5 (A) and plus 
100 M BCS at pH 7.5 (B), respectively. Titrations of BCS into Cu(I)-D1-CCS (10 M) 
plus apo-D1-CCS (10 M) at pH 6.5 (C) and pH 7.5 (D), respectively. Lines show fits of 
data, to equations (6.2) (A and B) and (6.1) (C and D), giving Kb values of (4.1± 0.1) × 
10
16
 (A), (6.3± 0.3) × 10
17
 (B), (6.0 ± 0.1) × 10
16
 (C) and (4.8 ± 0.2) × 10
17
 (D) M
-1
. 
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Figure 2.3.13 
Titrations of BCS into Cu(I)-Ccs1 (10 M) plus apo-Ccs1 (10 M) at pH 6.5  (A) and 
pH 7.5 (B). Titration of BCS into Cu(I)-BACE1-CTD (10 M) plus apo-BACE1-CTD 
(10 M) at pH 7.5 is shown in (C). The lines show fits of the data to equation (6.1) 
giving Kb values of (1.6 ± 0.1) × 10
16 
(A), (2.8 ± 0.1) × 10
17
 (B) and (1.8 ± 0.1) ×10
17
 M
-
1
 (C). 
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Figure 2.3.14 
Titrations of apo-D1-CCS into [Cu(BCA)2]
3-
 (10 M) plus 1580 M at pH 6.5 (A) and 
plus 7480 M BCA at pH 7.5 (B), respectively. The titration of BCA into Cu(I)-D1-CCS 
(5 M) plus excess apo-D1-CCS (5 M) at pH 6.5 is shown in (C). The lines show fits 
of the data, to equations (6.2) (A and B) and (6.1) (C), with Kb kept constant (5.6 × 10
16
 
and 5.5 × 10
17
 M 
-1
 at pH 6.5 and 7.5, respectively) giving β values for [Cu(BCA)2]
3-
 of 
(5.3 ± 0.2) × 10
16
 (A) and (5.7 ± 0.1) × 10
16
 (C) M 
-2
 at pH 6.5 and (5.9 ± 0.2) × 10
16
 M 
-
2
 at pH 7.5 (B). 
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Figure 2.3.15 
Titration of BCA into Cu(I)-WT-CCS (5 M) plus apo-WT-CCS (15 M) 20 mM Mes 
pH 6.5 containing 200 mM NaCl. Line shows fit of data, to equation (6.1) giving a Kb 
value of (8.9± 0.9) × 10
16
 M
-1
. 
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Figure 2.3.16 
Titrations of apo-C244S/C246S-CCS (A) and apo-C22S/C25S-CCS (B) into 
[Cu(BCA)2]
3-
 (10 M) in the presence of 1180 and 140 M BCA respectively. Titrations 
of BCA into Cu(I)-C244S/C246S-CCS (5 M) plus apo-C244S/C246S-CCS (5 M) (C) 
and Cu(I)-C22S/C25S-CCS (10 M) plus apo-C22S/C25S-CCS (10 M) (D). All 
titrations were performed in 20 mM Mes pH 6.5 plus 200 mM NaCl. The lines show fits 
of the data to equations (6.2) (A and B) and (6.1) (C and D), giving Kb values of (8.8 ± 
0.6)  1016 (A), (2.2 ± 0.6)  1015 (B), (1.0 ± 0.1)  1017 (C) and (3.0 ± 0.4)  1015 M-1 
(D). 
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Figure 2.3.17 
Titrations of apo-D3-CCS into [Cu(BCA)2]
3- 
(10 M) plus 340 M (A) and plus 1980 
M BCA (B) in 20 mM Mes pH 6.5 and 20 mM Hepes pH 7.5 containing 200 mM 
NaCl,  respectively. Lines show fits of data, to equations (6.2) giving Kb values of (5.0± 
0.4) × 10
15
 (A) and (4.4 ± 0.3) × 10
16
 M
-1
 (B). 
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Figure 2.3.18 
Cu(I) removal from Cu(I)-C22S/C25S-CCS (20 M) by BCA (500 M) in 20 mM Mes 
pH 6.5 containing 200 mM NaCl (A). Cu(I) removal from Cu(I)-bound (0.5 (solid), 1.0 
(dot) and 2.0 (dash) equivalents) WT-CCS (B), C244S/C246S-CCS (C) and C22S/C25S-
CCS (D) (10 M) in 20 mM Mes pH 6.5 containing 200 mM NaCl and 2.5 mM BCS. 
The final point in (A) gives a Kb value of 3.9 × 10
15
 M
-1
. 
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2.4  Discussion 
The affinities measured for WT-CCS (first copper equivalent), C244S/C246S-CCS and 
D1-CCS must be for Cu(I) bound to the CXXC motif of D1, with the pH dependence 
due to protonation of the Cys ligands (see chapter 3).(28) The data for C244S/C246S-
CCS highlight that the loss of the Cys residues in D3 does not affect the binding of Cu(I) 
to D1 of CCS, therefore D1 binds Cu(I) independently of D3. The first equivalent of 
Cu(I) bound to Ccs1 from S. cerevisiae has a similar affinity to D1 of CCS at pH 6.5, 
and the Cu(I) affinity has a similar dependence on pH as that for D1 for CCS and 
therefore, presumably, involves the CXXC site of D1. These Cu(I) affinities are in the 
same range as values reported for the CXXC-containing copper metallochaperones 
elsewhere for HAH1 (28,32) Atx1 (S. cerevisiae and Synechocystis PCC 6803),(30,33) 
CopZ (B. subtilis),(34) and also to that for the BACE1-CTD peptide which also contains 
a CXXC motif. The Cu(I) affinities determined for C22S/C25S-CCS and D3-CCS are 
very similar and must be for Cu(I) bound to the CXC motif of D3. The Cu(I) affinities 
for C22S/C25S-CCS and D3-CCS are both an order of magnitude lower than those for 
the CXXC of D1 both at pH 6.5 and 7.5 and therefore, the CXC motif in D3 is a 
significantly lower affinity copper site compared to D1.  
The Kex values for Cu(I) partitioning and transfer between the proteins are in 
good agreement with those calculated based on Cu(I) affinities. The Kex for Cu(I) 
partitioning between D1-CCS and C244S/C246S-CCS, and also between D1-CCS and 
WT-CCS, is consistent with the CXXC site having similar Cu(I) affinities in these 
proteins. The Kex for Cu(I) partitioning between D1-CCS and C22S/C25S-CCS, and also 
between D1-CCS and D3-CCS, confirms that the CXC motif of D3 has a Cu(I) affinity 
at least 10-fold lower than that of the D1 CXXC site.  
The high Cu(I) affinity of D1, compared to D3, suggests that the Atx1-like 
domain of CCS must be involved in the acquisition and protection of Cu(I). A pool of 
copper exists in the eukaryotic cytosol,(2,27,41) and the matched Cu(I) affinities of CCS 
(D1) and HAH1, and of Ccs1 (D1) and Atx1 (although the Kb of Ccs1 determined here 
at pH 7.5 indicates a slightly weaker affinity for Cu(I) compared to reported values for 
Atx1 of 5.0 × 10
17
 M
-1
 and 1.6 × 10
18
 M
-1
 at pH 7.0 and 8.0 respectively (32,33)), along 
with similar protein levels (quantified in S. cerevisiae (2,42)) demonstrates that 
thermodynamically these metallochaperones can compete for available copper. It has 
been suggested that CCS and HAH1 may obtain Cu(I) from the same location in the 
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cytosol, possibly the high affinity copper importer Ctr1.(43) However, in vivo studies in 
S. cerevisiae have indicated that Ccs1 and Atx1 do not acquire copper directly from 
metal transporters,(44) although Ctr1-bound copper can be transferred to Atx1 in 
vitro.(33) The surface properties, particularly in the vicinity of the CXXC motifs, differ 
between these two copper metallochaperones, and in vivo complementation assays in S. 
cerevisiae demonstrate that D1 of Ccs1 and Atx1 are not interchangeable,(3) 
highlighting the importance of protein interactions for copper trafficking pathways.(45) 
The altered surface features of these two copper metallochaperones reflect very different 
targets; Atx1 interacts with the copper-transporting ATPase Ccc2 whereas Ccs1 delivers 
directly to a copper-requiring enzyme. A similar situation may exist for HAH1 and CCS 
as comparison of the surface features of HAH1 with D1-CCS (Figure 2.4.1) shows that 
D1 of CCS lacks the positively charged surface patch near the CXXC motif. It remains 
to be discovered from where these metallochaperones acquire copper. 
The transfer of copper observed between D1-CCS and HAH1 suggests these 
copper trafficking pathways can equilibrate via the metallochaperones, with the 
availability of, and copper uptake by, SOD1 and the copper-transporting ATPases being 
factors that will favor passage of the metal down either route. In support of this idea, it 
has recently been shown that macrophage cells exposed to hypoxia respond by 
increasing copper flow to the secretory pathway via enhanced expression of ATP7A, 
with a resulting decrease in SOD1 activity.(46) This is accompanied by a lowering of the 
expression levels of CCS, signifying that a link between the secretory and cytosolic 
copper trafficking pathways does exist. Furthermore recent studies have shown that 
mouse fibroblasts with a CCS deletion result in increased expression of metallothionein 
and ATP7A with a concomitant reduced expression of the Ctr1 copper importer.(46) 
Copper allocation in a cell is particularly important considering that copper metabolism 
has been associated with neurodegenerative disorders, including AD.(12-15) BACE1 
catalyses the first step in the processing of the amyloid precursor protein to yield Aa 
major constituent of senile plaques in the brains of AD patients. It has been shown, by 
two-hybrid assays, that the BACE1-CTD can interact with D1 of CCS (28) and also 
HAH1 (47), and Cu(I) binding to BACE1 may modulate the production of A.(28) The 
Cu(I) affinity of the BACE1-CTD is weaker than those of D1-CCS and HAH1, which 
will decrease competition with the metallochaperones for cytosolic copper under 
equilibrium conditions.  
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The CXXC motif of D1 of Ccs1 is ~ 35 Å from the copper site of Sod1 in the 
crystal structure of the complex (Figure 1.8B), whereas the D3 Cys residues are ideally 
placed for shuttling Cu(I) to the buried active site.(20) The D3 CXC motif is also 
involved in disulfide bond formation during the CCS activation of SOD1.(9-11) The 
mechanism of activation of this enzyme appears to differ in humans and S. cerevisiae, 
and a CCS-independent pathway of SOD1 activation exists in humans.(49-51) In certain 
organisms the D1 CXXC motif is missing, and CCS can still activate SOD1 under 
copper replete conditions.(51,52) In S. cerevisiae D1 is only essential under copper 
deplete conditions,(3) but it has clearly been shown for human CCS that D1 and the 
CXXC motif are essential for SOD1 activity in vivo under both copper replete and 
limiting conditions.(25) The Cu(I) affinities that have been determined demonstrate that 
when CCS docks with SOD1, particularly under copper-limiting conditions, copper is 
much more likely to be bound to D1 (Figure 2.4.2), which is probably also the case for 
Ccs1. Copper loading of SOD1 by CCS will require metal bound at D1 to be transferred 
to D3, which is thermodynamically unfavorable. However, the relative Cu(I) affinity of 
SOD1(27) is ~ 10-fold tighter than that of D1 of CCS, and therefore > 100-fold tighter 
than the Cu(I) affinity of D3. Two-coordinate Cu(I) bound to the D1 CXXC site will be 
co-ordinatively unsaturated and susceptible to attack from another 
ligand,(6,7,17,39,45,53,54) such as a Cys residue from D3, facilitating Cu(I) transfer via 
ligand exchange reactions. Cu(I) transfer does occur in vitro between D1 and D3, and 
the Cu(I) affinity and buried nature of the SOD1 copper site may drive the reaction. The 
ability of the largely unstructured D3 to access the active site of the target enzyme and 
insert copper seems to be more important than its affinity for Cu(I). Currently known 
copper metallochaperones usually either traffic copper or insert the metal into the target 
enzyme.(7,27,55) CCS has evolved to possess both of these functionalities providing an 
entropic advantage for copper uptake by SOD1, due to the vital role of this enzyme in 
maintaining a healthy cell. 
 
 
 
 
 
 
 
 
81 
 
Figure 2.4.1  
Qualitative representation of the electrostatic surface properties surrounding the CXXC 
Cu(I)-binding motifs for D1-CCS (A) (from section 3.3.4) and HAH1 (B) (PDB 
accession code 1TL5 (HAH1)) drawn in Pymol. The surfaces of the proteins are color 
coded according to the electrostatic potential (red is negative, white is zero and blue is 
positive) with the positions of the Cys residues of the CXXC motifs and Arg71 and 
Lys60 residues of D1-CCS and HAH1 respectively, indicated. Surface generated in 
Pymol using protein contact potential. 
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Figure 2.4.2 
The proposed roles of D1 and D3 of CCS in Cu(I) loading of SOD1 during the activation 
of the reduced copper-free protein (E,Zn-SOD1), with both CCS and SOD1 shown as 
monomers. 
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Chapter 3 
Modulation of the Cys pKa’s and Copper Affinities of the CXXC and 
CXC Motifs of Human CCS 
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3.1 Introduction 
Most known copper metallochaperones, especially Atx1’s and the metal binding domains 
(MBDs) of the copper-transporting ATPases, contain the CXXC motif that provides the 
two Cys residues responsible for binding Cu(I) with high affinity.(1,2) The CXXC motif is 
also employed by enzymes that participate in disulfide reduction, isomerisation and 
formation and has been extensively studied within these proteins, providing insights into 
the way in which the reactivity of the two Cys residues be modulated by the surrounding 
protein structure.(3,4) Thioredoxin (Trx) (E. coli) (5,6) is involved in disulfide reduction, 
protein disulfide isomerase (PDI) (S. cerevisiae) (7,8) catalyses the isomersation of 
disulfides and the oxidoreductase DsbA (E. coli) (9) catalyses their formation. The striking 
feature of these three proteins is the variation in reactivity of the same CXXC motif within 
a similar tertiary structure.(10-12) It has been found that the reduction potential of the 
CXXC motif is affected by the nature of the intervening residues and is correlated with the 
acidity (pKa) of the N-terminal Cys (CysN).(4) In DsbA an unusually low pKa of 3 for the 
CysN of the CXXC motif has been determined and results from a stabilising interaction of 
the CysN thiolate with an adjacent His residue.(13) The stabilisation of the reduced form of 
the protein leads to a thermodynamic driving force for oxidation of the thiols of the 
enzymes substrate. This family of proteins demonstrates that the properties of the Cys 
residues within a CXXC motif can therefore be modulated by the surrounding protein 
scaffold and so optimise the Cys residues reactivity for a particular function.  
It is now emerging that the two Cys residues of the CXXC motif in the copper 
metallochaperone proteins can also be fine tuned for their role in binding copper and 
transferring the metal to partner proteins. The presence of a residue located on loop 5 of 
various Atx1 metallochaperones and copper-transporting ATPase MBDs that is in close 
proximity to and interacts with the metal binding loop region containing the CXXC motif 
has been reported (Figure 3.1.1).(14) In Atx1 from prokaryotic and eukaryotic organisms 
the residue is typically a Tyr and Lys, respectively. In the MBDs of ATP7A and ATP7B 
(human copper-transporting ATPases), and also the yeast homologue Ccc2, the residue is a 
Phe. In human HAH1 the Lys60 residue is within hydrogen bonding distance of the C-
terminal Cys (CysC) of the CXXC motif in and has been implicated in affecting Cu(I) 
transfer from Cu(I)-HAH1 to the ATP7A and ATP7B MBDs.(15-18) The pH dependence 
of the Cu(I) affinities of wild-type (WT) HAH1 and a Lys60Ala mutant differ and at pH 
7.0 a threefold difference in Cu(I) affinity is observed.(18) In a Lys60Ala HAH1 mutant 
an increase of the pKa of the CysC residue is observed relative to that for WT HAH1. The 
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difference in Cu(I) affinities for WT and Lys60Ala HAH1 occurs as a result of the 
lowering of the pKa of the CysC residue of the CXXC motif in WT HAH1. This is brought 
about due to the stabilization of the CysC thiolate through a hydrogen bonding interaction 
with the Lys60 side chain. The Cu(I) affinity of the ATP7A MBD1 also has a pH 
dependence and the thermodynamic gradient for Cu(I) transfer between HAH1 and MBD1 
is therefore dependant on pH. The importance of the pH dependence of the Cu(I) affinities 
is highlighted by the presence of a shallow but favourable thermodynamic gradient for 
Cu(I) transfer between HAH1 and ATP7A MBD1 at physiological pH (pH 7.0-7.4) which 
becomes unfavourable at lower pH’s (pH < 7).(18, 19) It is notable that other Cu(I) 
trafficking pathways also have shallow gradients for copper transfer at physiological 
pH(20) and therefore, in instances where the cell cytosol becomes acidic, for example 
during apoptosis or disease, the copper trafficking pathways could potentially be 
compromised and metal dishomeostasis result.(21-23) 
The pKa’s of the Cys residues also allow the relative nucleophilicities, and leaving 
group abilities, of the Cu(I)-binding Cys residues of the copper metallochaperones to be 
assessed. In general the lower the pKa of a Cys residue the better a leaving group it 
becomes and therefore a lower pKa Cys residue in the donor is favoured for Cu(I) transfer 
to the acceptor. This was found in the case of Cu(I) transfer from HAH1 to ATP7A MBD1 
where the relative nucleophilicities of the Cu(I)-binding Cys residues would lower the 
activation barrier for transfer from HAH1 to ATP7A MBD1.(18)  Therefore, the kinetics 
of copper transfer are affected by the pKa’s of the Cys residues of the Cu(I)-binding motifs 
and can be tuned to provide a low activation energy barrier for copper transfer between 
partner proteins. 
It is also interesting to note that the majority of the Atx1 metallochaperones and 
MBDs also have a conserved Met residue located 1 amino acid upstream of the CXXC 
motif (Figure 3.1.2).(14) This residue has been found to stabilise the metal binding loop 
region and although it does not appear to affect the affinity of the site for Cu(I) it has been 
implicated in modulating the kinetics of Cu(I) transfer.(24,25) It was found that Cu(I) 
abstraction from HAH1 was slower in a Met11Ala mutant. Therefore, amino acid residues 
other than those of loop 5, can also modulate the Cu(I)-binding characteristics of the 
Atx1s.  
The presence of residues that modulate the Cu(I) affinity and transfer 
characteristics of CXXC motif of the Atx1 metallochaperones, poses the question of 
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whether analogous residues are present in the Atx1-like domains of the CCS 
metallochaperones, particularly for Ccs1 (S. cerevisiae) and CCS (human). D1 of Ccs1 
contains the conserved CXXC motif and is similar in overall fold to that observed for the 
Atx1 metallochaperones and contains a loop analogous to loop 5 for HAH1.(26) In the 
crystal structure of Ccs1 the Lys66 residue is analogous to Lys65 and Lys60 found in 
HAH1 and Atx1, respectively, and is also located on loop 5 and orientates towards the 
CXXC motif (Figure 3.1.1). In human CCS, however, the corresponding residue 
determined by sequence alignment with HAH1, Atx1 and Ccs1 is Arg71 (Figure 3.1.2). 
The CXC motif of domain 3 (D3) of CCS is retained in all known homologues and it is 
interesting whether any residues in this domain other than the Cys residues affect Cu(I)-
binding characteristics. However, the lack of structural data for D3 makes it difficult to 
identify any residues that are likely to interact with the Cys residues of this domain.(27) 
Sequence alignment of D3 from various organisms indicates multiple conserved residues 
(Figure 3.1.3) but it is currently unknown what purpose these residues serve.  
In this Chapter, work that shows the pH dependence of the Cu(I) affinities of the 
D1 CXXC and D3 CXC motifs is presented. The crystal structure of D1 confirms the 
anticipated binding of Cu(I) by the CXXC motif of this domain of CCS and the 
involvement of the Arg71 residue in an interaction with the Cys residues of the  Cu(I)-
binding CXXC motif. The Arg71Ala D1-CCS mutant has been characterized and the 
effect of the loss of the Arg71 residue on the pKa of the Cys residues of the CXXC motif 
and the pH dependence of the Cu(I) affinity is investigated. The pKa’s of the Cys residues 
of the metal binding motifs in full length CCS Cys to Ser mutants of the CXXC and CXC 
motifs are also determined from the pH dependence of their Cu(I) affinity. Implications for 
Cu(I) transfer between CCS and its target Cu,Zn-Superoxide Dismutase (SOD1), with 
respect to the pKa’s of the metal binding Cys residues are discussed.  
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Figure 3.1.1  
Structures of HAH1 (A) and D1 of Ccs1 (B) (PDB accession codes 1TL5 and 1JK9 
respectively) drawn in Pymol. The co-ordinating Cys residues of the CXXC Cu(I)-
binding motifs of both HAH1 and Ccs1, and the Lys residues of loop 5, are shown as 
stick representations. 
 
Cys12 
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Lys60 
Cys17 
Cys20 
Lys66 
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Figure 3.1.2  
Sequence alignment of D1 CCS, with HAH1, Atx1 and D1-Ccs1 generated by ClustalW using protein sequences obtained from the NCBI Protein 
Database. The residues 1-79 and 1-77 of CCS and Ccs1, respectively, corresponding to the Atx1-like D1, were considered. Conserved residues are 
highlighted red while the Cys residues of the CXXC Cu(I)-binding motif are highlighted orange. The residues located in loop 5 of the protein fold are 
highlighted blue and the conserved residues within this loop region are highlighted red. 
 
 
 
Figure 3.1.3  
Sequence alignment of D3-CCS from various organisms obtained using ClustalW using protein sequences obtained from the NCBI Protein Database. 
Conserved residues are highlighted red while the conserved Cys residues of the CXC Cu(I)-binding motif are highlighted orange. 
 
9
2
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3.2 Experimental 
3.2.1 Mutagenesis and Cloning  
The Arg71Ala D1-CCS mutation was prepared by Quikchange mutagenesis 
(Stratagene). The plasmid pGEMT_D1-CCS (section 2.2.1) was used as template for the 
mutagenesis reaction using the forward and reverse primers 5’-
ggcacgggggcgcaggcggtactcaagggc-3’ and 5’-gcccttgagtaccgcctgcgcccccgtgcc-3’, 
respectively, giving the construct pGEMT_R71A-D1-CCS. DNA sequencing was used 
to verify the Arg71Ala mutation and the gene was then cloned using the BamH1/Nde1 
restriction sites into pET29a giving pET29a_R71A-D1-CCS.  
 
3.2.2 Expression and Purification of Proteins 
The proteins D1-CCS, Arg71Ala D1-CCS, C244S/C246S-CCS and C22S/C25S-CCS 
were expressed and purified as described in section 6.1.  
 
3.2.3 Protein Reduction and Quantification 
The proteins D1-CCS, Arg71Ala D1-CCS, C244S/C246S-CCS and C22S/C25S-CCS 
(200-800 M) were reduced by incubation with 10 mM dithiothreitol (DTT) in 20 mM 
tris(hydroxymethyl)aminomethane (Tris) pH 7.5 in an anaerobic chamber (Belle 
Technology, O2 << 2 parts per million), typically for 2-3 hours. These samples were then 
desalted and exchanged into the required buffer using a PD10 column (GE Healthcare). 
Thiol quantification using Ellman’s assay, as described in section 6.15, was used for 
determining the concentration of Arg71Ala-D1-CCS assuming three free thiols per 
monomer, according to the amino acid sequence. Bradford assays of Arg71Ala D1-CCS 
using BSA standards required a correction factor of 2.3 compared to concentrations 
determined from Ellman’s assays. The concentrations of D1-CCS, C244S/C246S-CCS 
and C22S/C25S-CCS were determined as described in section 2.2.4.  
 
3.2.4 Cu(I) Binding Stoichiometry of Arg71Ala D1-CCS 
Cu(I) stock solutions and Cu(I)-proteins were prepared as described in section 6.16. 
Titrations of Cu(I) into protein samples (10 M) in the presence of 500 M 
bicinchoninic acid (BCA) were performed in 20 mM 4-(2-hydroxyethyl)piperazine-1-
ethanesulfonic acid (Hepes) pH 7.5 containing 200 mM NaCl, in a septum sealed gas 
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tight cuvette (Hellma). Copper concentrations were determined using either 
bathocuproine disulfonic acid (BCS) or BCA, and occasionally by AAS as described in 
section 6.16.1  
 
3.2.5 Crystallization, Data Collection, Structure Determination and Refinement 
for D1-CCS 
Cu(I)-D1-CCS was prepared by addition of 1 equivalent of Cu(I) to apo D1-CCS in 5 mM 
Tris pH 7.5. The protein was then concentrated to ~5 mg/ml in the same buffer using a 
Vivaspin 500 concentrator (Millipore). Crystals were prepared (aerobically) using the 
sitting drop method of vapour diffusion using 200 nL of the Cu(I)-bound protein solution 
and 100 nL of well solution (50 mM Mes pH 6.5 containing 5 mM ZnCl and 10 % w/v 
PEG 6000). The crystal trial tray, containing the crystallisation mixture drop and well 
solution, was incubated for 5 mins in an anaerobic chamber prior to sealing and diffraction 
quality crystals (~ 3) typically appeared after 1-2 weeks of incubation at room 
temperature. Crystals were harvested and frozen, aerobically, using paratone-N as the 
cryoprotectant by Dr Susan Firbank. All diffraction data were collected at 100 K using 
synchrotron radiation (DLS, Oxford, U.K.). The collection of data and processing, the 
structure solution, model building and refinement were performed by Dr Arnaud Basle. 
The data were scaled using Scala.(28) The phase problem was solved by copper-SAD 
(single anomalous diffraction) using shelxC/D/E pipeline (29) and the model was built 
using coot and refined with the phenix suite.(30,31) The data collection and processing 
statistics are shown in Table 3.3.1. 
 
3.2.6 pH Dependence of Cu(I) Affinities 
Cu(I) affinities (Kb values) were determined by competition assays with BCS and BCA 
using the approach described in section 6.16.3 and refs (18,32-3). The buffers 2-(N-
morpholino)ethanesulfonic acid (Mes) (pH 5.5-6.8), Hepes (pH 7.0-8.0), N-
tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid (Taps) (pH 8.0-9.0), 2-(N-
cyclohexylamino)ethanesulfonic acid (Ches) (pH 9.0-10.0) and 3-(cyclohexylamini)-1-
propanesulfonic acid (Caps) (pH 10.0-11.0) were used to obtain Kb values in the pH 
range 5.9-10.6. Experiments were performed in 20 mM buffer containing 200 mM NaCl. 
The overall stability constant ( value) for [Cu(BCS)2]
3-
 at various pH values was 
calculated assuming a pKa of 5.7 and using the maximal  value of 6.3 × 10
19
 M
-2
 (pH ≥ 
8.0).(20) The β value for [Cu(BCA)2]
3-
 of (5.4 ± 2.7) × 10
16
 M
-2
 (section 2.3.5) was used 
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in the pH range 6.5 to 10.3 for all Kb determinations involving BCA. The pH 
dependence of Kb was fit to equations for single, equation (3.1), or double, equation 
(3.2), ionization models as appropriate.(18) 
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In which Kb is the affinity constant for the protein at a specified pH, Kb
max
 is the 
maximal Cu(I) affinity of the protein, Ka1 and Ka2 are the acid dissociation constants of 
the Cys residues whose ionization influences the Kb and [H
+
] is the proton concentration. 
 
3.2.7 Cys pKa Determination by UV Spectroscopy 
pKa values of the Cys residues present in apo-D1-CCS and Arg71Ala apo-D1-CCS were 
determined by measurement of the extinction coefficient at 240 nm as a function of pH 
by Dr Adriana Badarau.(35,36) Reduced apo-proteins (25 M) were prepared in 50 mM 
buffer (vide supra) containing 200 mM NaCl within the pH range 4 to 10.5 with the 
corresponding absorbance at 240 nm measured. Spectra for the apo-proteins were 
measured against a solution of the buffer minus the protein at each pH value. The data 
were fitted using equation (3.3) to determine the pKa values of the Cys residues. 
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In which εapp is the apparent extinction coefficient at a particular pH, ε1, ε2 and ε3 are the 
extinction coefficient of the PH PH2 and PH3 species, Ka1, Ka2 and Ka3 are the acid 
dissociation constants of the Cys residues, respectively, and [H
+
] is the proton 
concentration. The pH dependence of the ε240 for Cu(I)-bound  D1-CCS and Arg71Ala 
D1-CCS were also measured to enable the pKa of the third non-Cu(I) ligating Cys 
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residue to be estimated and demonstrate the involvement of the two lower pKa cysteine 
residues of the CXXC motif in Cu(I)-binding.  
 
3.3 Results 
3.3.1 Purification and the Initial Characterization of Arg71Ala D1-CCS 
The purity of Arg71Ala D1-CCS variant was determined by SDS-PAGE to be > 90 % 
and the molecular weight determined by matrix assisted laser desorption Ionisation time-
of-flight (MALDI) mass spectrometry (MS) to be 8131 Da which corresponds to the 
protein minus its N-terminal Met residue (the calculated value based on the amino acid 
sequence is 8130). Arg71Ala D1-CCS was isolated with negligible copper and zinc as 
determined by AAS.  
 
3.3.2  Analytical Gel Filtration of Arg71Ala D1-CCS 
The analytical gel filtration chromatograms for Apo and Cu(I)-bound Arg71Ala D1-CCS 
(Figure 3.3.1) are very similar to those obtained for D1-CCS (Table 2.3.2) and the 
elution volumes correspond to an apparent molecular mass of ~14-15 kD. The high 
apparent mass of the protein, as found for D1-CCS, is likely due to the asymmetrical 
dimensions of this domain.(26) 
 
3.3.3 Cu(I) Binding Stoichiometry of Arg71Ala D1-CCS 
The high affinity Cu(I)-binding stoichiometry of Arg71Ala D1-CCS was determined by 
titrating Cu(I) into apo-protein in the presence of BCA. Arg71Ala D1-CCS binds a 
single equivalent of Cu(I) with high affinity under these conditions (Figure 3.3.2). The 
data is very similar to that obtained for D1-CCS and C244SC/C246S-CCS (section 
2.3.4) and is indicative of the Cu(I) ion binding to the CXXC motif.  
 
3.3.4 Crystal Structure of Cu(I)-bound D1-CCS 
The crystal structure of Cu(I)-bound D1-CCS has been determined and represents the 
first structure of an Atx1-like domain of CCS to be obtained in the presence of copper. 
Cu(I)-bound D1-CCS crystallizes as a head-to-head dimer with an interface composed of 
two copper ions coordinated by the Cys residues of the CXXC motif of each monomer 
(Figure 3.3.3). As expected the overall-fold of the domain is that of a βαββαβ fold with 
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the CXXC motif located between β1 and α1 (Figure 3.3.3).(1) Each copper ion is ligated 
by Cys22 and Cys25 of one monomer and Cys25 from the adjacent monomer with Cys 
to copper distances of 2.3-2.4 Å. The copper to copper distance is 2.9 Å. As indicated by 
the sequence alignment data (vide supra) Arg71 is located in close proximity to the 
metal binding motif of each monomer and is within hydrogen bonding distance of Cys25 
(3.0-3.1 Å) of the same monomer and Cys22 (3.6-3.8 Å) of the adjacent monomer. The 
third Cys of the protein (Cys12) is located ~30 Å away from the CXXC motif on β1 of 
the protein and does not participate in Cu(I) binding. 
 
3.3.5 CD Spectra of Proteins 
Far-UV CD spectra of the apo-proteins were obtained within the pH range 6.5-10.5 to 
determine the stability and suitability of the proteins for Cu(I) affinity measurements 
within  extremes of pH and to determine if the Arg71Ala D1-CCS mutant is folded. The 
similarity of the far-UV CD spectra of Arg71Ala D1-CCS and D1-CCS (Figure 3.3.5) 
indicates the Arg71Ala mutation does not perturb the secondary structure of the protein 
and the spectra of both proteins change little in the pH range 6.5 to 10.5 (Figure 3.3.6).  
The Far-UV CD spectra of C244S/C246S-CCS and C22S/C25S-CCS remain similar 
between pH 6.5 and 8.5 but change significantly, more so for C22S/C25S-CCS, above 
pH 8.5 indicating the secondary structure is perturbed at high pH (Figure 3.3.6). The 
stability of the D1 constructs relative to the two full length CCS variants suggests the 
secondary structure of D2/D3 is compromised at high pH. 
 
3.3.6 The pH dependence of the Cu(I) Affinity of the D1 CXXC Motif 
The Cu(I) affinity of Arg71Ala D1-CCS determined by titration of apo-protein into 
[Cu(BCS)2]
3-
 plus excess BCS and of BCS into Cu(I)-protein plus excess apo-protein at 
pH 6.5 and 7.5 (Figure 3.3.7) show that the Kb values from the titrations in either 
direction agree within 30 %. The Cu(I) affinity of (5.8 ± 1.8) × 10
17
 M
-1
  determined at 
pH 7.5 from several titrations is very similar to those determined for D1-CCS and 
C244S/C246S-CCS at the same pH (section 2.3.5). The Cu(I) affinities of the three 
proteins are dependent on pH (Tables 3.3.2 to 3.3.4 and Figures 3.3.8 to 3.3.11). The pH 
dependence of the Cu(I) affinity for D1-CCS and C244S/C246S-CCS is similar between 
pH 5.9 and 10.6. The pH dependence of the Cu(I) affinity for D1-CCS and 
C244S/C246S-CCS is first order with respect to [H
+
] within the pH range 6 to ~8 after 
which the Cu(I) affinity plateaus in both cases to similar values (Figure 3.3.8). The Cu(I) 
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affinity of CXXC motif is primarily influenced by the pKa of the Cys ligands. The first 
order dependence of Cu(I) affinity on [H
+
] for D1-CCS and C244S/C246S-CCS is 
indicative of the deprotonation of a single Cys residue of the Cu(I)-binding CXXC 
motif. Fitting the data for both proteins to a single ionisation model gives determinations 
of the maximal Cu(I) affinities of (30 ± 2) and (32 ± 4) × 10
17
 M
-1 
and Cys pKa’s of 8.1 
and 8.3 for D1-CCS and C244S/C246S-CCS, respectively (Figure 3.3.10 and Table 
3.3.6). The second Cys residue of the CXXC motif cannot be determined from this data 
as the pKa of this residue is lower than pH 6 (vide infra). The Cu(I) affinity for 
Arg71Ala D1-CCS is also first order with respect to [H
+
] within the pH range 7.0 to 8.5 
and plateaus at high pH but at a higher overall affinity than D1-CCS and C244S/C246S-
CCS (Figure 3.3.11). The Cu(I) affinity of this protein, however, has a second order 
dependence on [H
+
] below pH 7.0 which is not observed for either of the other proteins. 
Fitting of the data for this variant to a double ionisation model gives a maximal Cu(I) 
affinity of (75 ± 8) × 10
17
 M
-1 
and pKa’s for the two Cys residues of 6.8 and 8.5 (Figure 
3.3.11 and Table 3.3.6). The pKa of 8.5 is similar to those obtained for D1-CCS and 
C244S/C246S-CCS but the maximal Cu(I) affinity is higher.  
 
3.3.7 The pH dependence of the Cu(I) Affinity of the D3 CXC Motif 
The Cu(I) affinity of C22S/C25S-CCS also depends on pH (Table 3.3.5 and Figure 
3.3.12) The Cu(I) affinity of C22S/C25S-CCS was determined over the pH range 6.0 to 
10.3 using BCA (Table 3.3.5), the use of the ligand BCA, as opposed to BCS used in 
section 3.3.6, is explained in section 2.3.5. The Cu(I) affinity has a second order 
dependence on [H
+
] below pH 7.0 with a first order dependence between pH 7 to 9 and 
then plateaus at higher pH (Figure 3.3.13). The data was fitted to a double Cys 
protonation model which gives a maximal Cu(I) affinity of (20 ± 5) × 10
17
 M
-1 
and pKa’s 
for the two Cys residues of 6.3 and 9.4 (Figure 3.3.13 and Table 3.3.6). The maximal 
Cu(I) affinity is lower and one Cys pKa is higher and the second is similar to those 
determined for the CXXC containing D1-CCS and C244S/C246S-CCS. There is an 
order of magnitude difference between  the Cu(I) affinities of C22S/C25S-CCS and D1-
CCS (and also C244S/C246S-CCS) in the pH range ~6 to ~8 after which the Cu(I) 
affinities become more similar at pH 10.3 (Figure 3.3.14). 
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3.3.8 Determination of pKa Values for the CXXC Motif Cys Residues 
An independent determination of the pKa’s of the CXXC motif Cys residues in D1-CCS 
and Arg71Ala D1-CCS was made to verify those obtained from the Cu(I) affinity 
measurements in 3.3.6. The pKa’s were determined by measuring the extinction 
coefficient at 240 nm (ε240) of the apo-proteins as a function of pH for each protein as 
thiolates absorb strongly in this region of the UV spectrum (36). Both D1-CCS and 
Arg71Ala D1-CCS have three Cys residues of which two form the CXXC motif with the 
third located ~30 Å away on β1 (vide supra). The data obtained for D1-CCS and 
Arg71Ala D1-CCS shows the presence of three Cys residues (Figure 3.3.15). A fit of the 
data to a model that considers the three ionisations enables the pKa of each Cys residue 
to be determined. The fit of the data for D1-CCS yields Cys pKa’s of 5.7, 8.4 and 10.3 
(Figure 3.3.15 and Table 3.3.7). The pKa of 8.4 corresponds to that of the pKa 
determined for one of the Cys residues from the pH dependence of the Cu(I) affinity 
data. The data for Arg71Ala D1-CCS fits to the same model, however, an initial fit 
allowing all parameters to vary gave pKa values which were different to those obtained 
with D1-CCS (Appendix Figure 2). Since the highest pKa determination is prone to 
greater uncertainty due to the absence of data and a clear end point at this extreme of pH, 
some of the parameters were constrained and refitted. A fit of the data with the two 
higher pKa’s constrained to the values obtained for D1-CCS yielded a pKa of 6.8 which 
is identical to that of the lower Cys pKa determined from the pH dependence of Cu(I) 
affinity data (Figure 3.3.15 and Table 3.3.7). Similar experiments performed on the 
Cu(I)-bound forms of the two proteins show that binding of a single equivalent of Cu(I) 
in each case shields the Cys of the CXXC motif from protonation but the third higher 
pKa Cys is still observed indicating that this residue does not participate in metal binding 
(Figure 3.3.16). Therefore the higher pKa Cys in the above determinations corresponds 
to the Cys residue not involved in the CXXC motifs of D1-CCS and Arg71Ala D1-CCS.  
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Table 3.3.1  
Data collection and processing statistics for Cu(I)-D1-CCS crystal structure 
 Cu(I)-D1-CCS high resolution Cu edge 
Beamline  DLS I24 DLS IO2 
Date   22.2.2010 14.2.2010 
Wavelength (Å) 0.9780  1.3790   
Resolution (Å) 32.78-1.60 (1.69-1.60) 44.72-2.19 (2.31-2.19) 
Space group  P212121 P212121 
Unit-cell parameters     
   a (Å) 44.35  44.23  
   b (Å)  44.80  44.72 
   c (Å) 65.56 65.54 
   α, β, γ (°) 90.0 90.0 
Unit-cell volume (Å3) 130260 130260 
Solvent content (%)   40 40 
No. of measured reflections 62656  91254  
No. of independent reflections 17690  7119  
Completeness (%)   99.2 (99.3) 99.8 (100.0)  
Redundancy 3.5 (3.5) 12.8 (13) 
Rmerge (%)   6.2 (38.4) 7.8 (15) 
<I!/<σ(I)!   11.6 (3.4) 22.9 (13.6) 
Anomalous Completeness (%) N/A 99.9 (100.0) 
Anomalous Redundancy N/A 7.0 (6.9) 
   
 Refinement statistics  
   
Rwork (%)   14.54  N/A 
Rfree# (%)   22.67 N/A 
   No. of non-H atoms     
  No. of protein, atoms 1097 N/A 
  No. of water molecules 122  N/A 
  No. of ions atoms  7 N/A 
R.m.s. deviation from ideal values   
  Bond length (Å) 0.008  N/A 
  Angle distance (Å)    1.129  N/A 
Average B factor (Å2)   
  Protein   27.15 N/A 
  Ions   22.86  N/A 
  Solvent water 37.14  N/A 
Ramachandran plot+, residues in 100 N/A 
allowed and most    
favoured regions (%)     
   
*(Values in parenthesis are for the highest resolution shell). 
#5% of the randomly selected reflections excluded from refinement. 
+Calculated using MOLPROBITY. 
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Table 3.3.2 
The pH dependence of the Cu(I) affinity (Kb) for D1-CCS measured by competition 
titrations with BCS in 20 mM buffer containing 200 mM NaCl. 
pH Kb (M
-1
) log10 Kb 
5.89 1.60 × 10
16
 16.20 
6.32 5.30 × 10
16
 16.72 
6.53 8.20 × 10
16
 16.91 
7.02 2.70 × 10
17
 17.43 
7.51 5.20 × 10
17
 17.72 
7.91 1.04 × 10
18
 18.02 
8.40 1.91 × 10
18
 18.28 
9.02 2.53 × 10
18
 18.40 
9.40 3.11 × 10
18
 18.49 
10.3 3.17 × 10
18
 18.50 
 
 
Table 3.3.3 
The pH dependence of the Cu(I) affinity (Kb) for C244S/C246S-CCS measured by 
competition titrations with BCS in 20 mM buffer containing 200 mM NaCl 
pH Kb (M
-1
) log10 Kb 
5.92 1.10 × 10
16
 16.04 
6.62 6.70 × 10
16
 16.83 
7.51 4.30 × 10
17
 17.63 
8.54 1.90 × 10
18
 18.28 
9.47 2.40 × 10
18
 18.38 
10.59 4.10 × 10
18
 18.61 
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Table 3.3.4 
The pH dependence of the Cu(I) affinity (Kb) for Arg71Ala D1-CCS measured by 
competition titrations with BCS in 20 mM buffer containing 200 mM NaCl 
pH Kb (M
-1
) log10 Kb 
5.92 2.30 × 10
15
 15.36 
6.26 1.30 × 10
16
 16.11 
6.49 3.50 × 10
16
 16.54 
7.03 1.70 × 10
17
 17.23 
7.45 6.20 × 10
16
 17.79 
7.87 1.31 × 10
18
 18.12 
8.25 3.12 × 10
18
 18.49 
9.04 5.13 × 10
18
 16.71 
9.40 5.92 × 10
18
 18.77 
10.3 9.31 × 10
18
 18.97 
 
 
Table 3.3.5 
The pH dependence of the Cu(I) affinity (Kb) for C22S/C25S-CCS measured by 
competition titrations with BCA in 20 mM buffer containing 200 mM NaCl 
pH Kb (M
-1
) log10 Kb 
5.9 1.90 × 10
14
 14.28 
6.5 1.20 × 10
15
 15.08 
7.0 6.40 × 10
15
 15.81 
7.5 1.90 × 10
16
 16.28 
8.0 5.60× 10
16
 16.75 
8.5 2.90 × 10
17
 17.46 
9.5 9.80 × 10
17
 17.99 
10.3 1.80 × 10
18
 18.26 
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Table 3.3.6 
Maximal Cu(I) affinity (Kb
max
) and pKa values determined from the pH dependence of Kb 
profile data for D1-CCS, Arg71Ala D1-CCS, C244S/C246S-CCS and C22S/C25S-CCS 
Protein Kb 
max
 (× 10
17 
M
-1
) pKa (1,2) 
D1-CCS 30 ± 2 8.1 ± 0.1 (1) 
Arg71Ala D1-CCS  75 ± 9 8.5 ± 0.1 (1), 6.8 ± 0.1 (2) 
C244S/C246S-CCS 32 ± 4 8.3± 0.1 (1) 
C22S/C25S-CCS 20 ± 5 9.4± 0.2 (1), 6.3± 0.2 (2)  
 
 
Table 3.3.7 
pKa values determined from abs 240 nm data for D1-CCS and Arg71Ala D1-CCS 
 D1-CCS Arg71Ala D1-CCS 
pKa1 5.7 ± 0.1 6.8 ± 0.2 
pKa2 8.4 ± 0.1 8.4 
a
 
pKa3 10.3 ± 0.1 10.3 
a
 
ε1 (mM cm
-1
) 3.5 ± 0.1 3.8 ± 0.2 
ε2 (mM cm
-1
) 6.6 ± 0.1 6.5 ± 0.4 
ε3 (mM cm
-1
) 10.2 ± 0.2 11.4 ± 0.2 
a
 pKa1 and pKa2 for the fit of the data for Arg71Ala (Figure 3.3.15) were constrained to 
values obtained for D1-CCS. 
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Figure 3.3.1  
Chromatograms for apo (A) and Cu(I)-bound (B) (1.0 equivalent) Arg71Ala D1-CCS (100 
M) in 20 mM Mes pH 6.5 containing 200 mM NaCl. Absorbance was measured at 240 
nm and protein eluting at 13.4 (± 0.1) ml, corresponds to an apparent mass of 15 (± 0.5) 
kDa. 
 
Figure 3.3.2 
Titration of Cu(I) into Arg71Ala apo-D1-CCS (10 M) in 20 mM Hepes pH 7.5 
containing 200 mM NaCl and 500 M BCA.  
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Figure 3.3.3 
Crystal structure of Cu(I)-bound D1-CCS showing key residues at the metal binding site drawn in Pymol. The two monomers are shown in blue and red 
with the copper ions represented as gold spheres at the dimer interface. The copper coordinating Cys residues of the CXXC motifs of both monomers, the 
third non-copper ligating Cys residue (Cys12), and the conserved Arg residue of loop 5 are shown as stick representations. 
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Cys25 Arg71 
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Cys12 
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1
0
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Figure 3.3.4 
Stick representation of the copper site structure of Cu(I)-D1-CCS with Cys residues 
coordinating the copper ions (orange spheres) and Arg residues indicated and colour coded 
according to their association with each monomer (blue and red; see Figure 3.3.3) of the 
dimeric crystal structure drawn using PyMol. The interactions between the conserved Arg 
and Cys residues (A) and between the copper and Cys residues (B) are indicated in Å 
units. 
 
 
 
 
 
 
 
 
 
3.8 
3.1 
2.3 
2.3 
2.3 
2.3 
2.4 
3.6 
3.0 
2.2 Arg71 
Cys22 
Arg71 
Cys22 
Cys25 
Cys25 
107 
 
Figure 3.3.5 
Far-UV CD spectra of Arg71Ala apo-D1-CCS (solid) and D1-CCS (dotted) (0.5 mg/ml) 
in 20 mM Mes pH 6.5 containing 200 mM NaCl. 
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Figure 3.3.6 
Far-UV CD spectra of apo D1-CCS (A), Arg71Ala D1-CCS (B) , C244S/C246S-CCS 
(C) and C22S/C25S-CCS (D) (0.5 mg/ml at different pH values). The lines colored 
black, red, green, blue and cyan indicate spectra measured at pH 6.5, 7.5, 8.5, 9.5 and 
10.5 respectively.  
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Figure 3.3.7 
Titrations of Arg71Ala apo-D1-CCS into [Cu(BCS)2]
3- 
(10 M) plus 40 M BCS at pH 
6.5 (A) and plus 140 M BCS at pH 7.5 (B). Titrations of BCS into Arg71Ala Cu(I)-D1-
CCS (10 M) plus Arg71Ala apo-D1-CCS (10 M) at pH 6.5 (C) and pH 7.5 (D). Lines 
show fits of data, to equations (6.2) (A and B) and (6.1) (C and D), giving Kb values of 
(3.5 ± 0.1) × 10
16
 (A), (6.1 ± 0.2) × 10
17
 (B), (2.5 ± 0.1) × 10
16
 (C) and (5.3 ± 0.1) × 10
17
 
M
-1
 (D). 
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Figure 3.3.8 
Titrations of apo-D1-CCS into [Cu(BCS)2]
3- 
(10 M) plus 140 M BCS at pH 7.5 (A) 
and plus 480 M BCS at pH 10.3 (C). Titrations of BCS into Cu(I)-bound 
C244S/C246S-CCS (5 M) plus apo C244S/C246S-CCS (5 M) at pH 6.5 (C) and pH 
10.6 (D). Lines show fits of data, to equations (6.2) (A and C) and (6.1) (B and D), 
giving Kb values of (5.4 ± 0.1) × 10
17
 (A), (4.4 ± 0.4) × 10
17
 (B), (31.6 ± 0.9) × 10
17
 (C) 
and (40.6 ± 1.4) × 10
17
 M
-1
 (D). 
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Figure 3.3.9 
Titrations of Arg71Ala apo-D1-CCS into [Cu(BCS)2]
3- 
(10 M) plus 140 M BCS at pH 
7.5 (A) and plus 480 M BCS at pH 10.3 (C). Lines show fits of data to equation (6.2) 
giving Kb values of (6.1 ± 0.2) × 10
17
 (A), (93.1 ± 2.4) × 10
17
 M
-1
 (B). 
 
 
Figure 3.3.10 
Plots of log10 Kb against pH for D1-CCS (open circles) and C244S/C246S-CCS (closed 
circles). The lines show fits of the data to equation (3.1) giving Kb
max
 and pKa values 
listed in Table 3.3.6.  
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Figure 3.3.11 
Plots of log10 Kb against pH for D1-CCS (open circles) and Arg71Ala D1-CCS (closed 
circles). The lines show fits of the data to equation (3.1) for D1-CCS and (3.2) for 
Arg71Ala D1-CCS, giving the Kb
max
 and pKa values listed in Table 3.3.6.  
 
 
Figure 3.3.12 
Titrations of apo-C22S/C25S-CCS into [Cu(BCA)2]
3- 
(10 M) plus 880 M BCA at pH 
7.5 (A) and plus 480 M BCS at pH 10.6 (C). Lines show fits of data to equation (6.2) 
giving Kb values of (1.9 ± 0.1) × 10
16
 (A) and (17.9 ± 0.8) × 10
17
 M
-1
 (B). 
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Figure 3.3.13 
Plot of log10 Kb against pH for C22S/C25S-CCS. The line shows a fit of the data to 
equation (3.2) giving the Kb
max
 and pKa values listed in Table 3.3.6.  
 
Figure 3.3.14 
Comparison of log10 Kb against pH data for D1-CCS (black open circles), 
C244S/C246S-CCS (black open squares), Arg71Ala D1-CCS (black closed circles) and 
C22S/C25S-CCS (black closed squares). The lines show fits of the data to equation (3.1) 
for D1-CCS and C244S/C246S-CCS and (3.2) for Arg71Ala D1-CCS and C22S/C25S-
CCS. 
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Figure 3.3.15 
Plots of ε240nm as a function of pH for apo-D1-CCS (A) and Arg71Ala apo-D1-CCS (B). 
The lines show fits of the data to equation (3.3) giving the pKa and Δε values listed in 
Table 3.3.7.* 
 
*Data in above figure was acquired by Dr Adriana Badarau 
 
Figure 3.3.16 
Plots of ε240nm as a function of pH for Cu(I)-D1-CCS (A) and Arg71Ala Cu(I)-D1-CCS 
(B).  
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3.4  Discussion 
The crystal structure of Cu(I)-bound D1-CCS represents the first Cu(I)-bound structural 
determination of D1 of CCS. The overall fold is similar to that of D1 of the analogous 
domain in Ccs1 and also to that of the Atx1-like metallochaperones HAH1 and 
Atx1.(26,37-39) The structure reveals that, as expected, the Cys residues of the CXXC 
motif are involved in ligation to the bound metal and also that Arg71 of loop 5 is within 
hydrogen bonding distance of Cys22 (CysC) of the motif. Unexpectedly, however, the 
protein has crystallised as a dimer with the two D1-CCS monomers (each binding a single 
Cu(I) ion) interacting head-to-head through the bound Cu(I) ions. This is unexpected as 
gel filtration shows Cu(I)-bound D1-CCS to elute as for apo-D1-CCS which is 
monomeric. The structure, however, is not unprecedented as crystal structures of the 
Cu(I)-bound Atx1-like metallochaperones ScAtx1 (Synechocystis) and CopZ (B. Subtilis) 
demonstrate formation of dimeric and trimeric proteins, respectively, with Cu(I)-Cys 
cluster formation.(40-42) Such species have been proposed to be involved in the transfer 
of Cu(I) between proteins, in the cases of ScAtx1 and CopZ specifically transfer of Cu(I) 
to their cognate Cu(I)-transporting ATPases. It is unclear whether the Cu(I)-bound D1-
CCS dimer observed in the crystal structure is of any  relevance for CCS in vivo due to full 
length CCS being present as a dimer and the absence of any Cu(I)-dependent 
oligomerisation for C244S/C246S-CCS (section 2.3.3). 
The Cu(I) affinities for D1-CCS and C244S/C246S-CCS have a similar 
dependence on  pH and indicate that the Cu(I) affinity of the CXXC motif of D1 of CCS is 
modulated by residues residing in this domain of CCS alone. The Cu(I) affinities of D1-
CCS and the Arg71Ala variant are similar at physiological pH (pH 7.0-7.4) but differ 
markedly above and below this range. At pH ~ 6 the Cu(I) affinity of the Arg71Ala variant 
is almost an order of magnitude lower while at pH 10.3 it is over 2-fold greater 
demonstrating the significant role of the Arg71 residue in affecting the Cu(I)-binding 
characteristics of the CXXC motif. The Cu(I) affinities of C22S/C25S-CCS are almost an 
order of magnitude lower than that of D1-CCS between pH ~6 to 8 but become similar at 
pH 10.3. The CXC motif therefore has a significantly lower affinity for Cu(I) than the 
CXXC motif under the ranges of pH that is experienced in the cell cytosol.(19,23) 
The pH dependence of the Cu(I) affinities are the result of competition between 
protons and Cu(I) for the Cys residues of the CXXC and CXC motifs.(18,43) In the pH 
range studied the Cu(I) affinities are dependent on the protonation of a single residue for 
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D1-CCS and C244S/C246S-CCS and on two residues for Arg71Ala D1-CCS and 
C22S/C25S-CCS. The pKa’s for the two CXXC Cys residues have been measured as 5.7 
and 8.4 and 6.8 and 8.4 for D1-CCS and the Arg71Ala variant respectively. The lowering 
of one of the Cys pKa‘s by ~1 pH unit is likely due to a thiolate stabilizing hydrogen bond 
interaction between Arg71 and Cys25 (CysC) side-chains that is observed in the crystal 
structure of Cu(I)-D1-CCS. The structure therefore allows for the assignment of the pKa’s 
to the Cys residues of the CXXC motif for D1-CCS and Arg71Ala D1-CCS with the lower 
pKa in each case corresponding to CysC. Similar assignments of the Cys pKa’s for the 
CXXC motif in HAH1, MNK1, MerP and MerA have been reported.(18,44,45) In HAH1 
the pKa of CysC is  lowered by ~1.5 pH units by an interaction with Lys60 located on the 
loop analogous to that on which Arg71 is situated in D1 of CCS.(18) The pKa’s obtained 
for C22S/C25S-CCS cannot be assigned to specific Cys residues of the CXC motif due to 
a lack of structural data for this domain of CCS. It is unusual that one Cys pKa of the CXC 
motif is very high while the second is low. There are multiple residues within the D3 
sequence, including Arg and Lys residues, which could participate in stabilising 
interactions with one the Cys thiolates of the CXC motif that could lower one of the Cys 
residues pKa (Figure 3.1.3). Alternatively interactions with either D1 or D2 or both could 
be present due to the flexibility of this domain and interactions have been proposed 
between Cu(I)-bound D3 and D2.(26,37,46) Another possibility is that deprotonation of 
one of the Cys could result in a thiolate that interacts with the adjacent thiol to effect a 
stabilizing hydrogen bond. This would favour the formation of the thiolate but oppose the 
removal of a subsequent proton from the neighbouring thiol giving low and high pKa’s for 
the two Cys residues. A stabilising interaction between the two Cys residues is the most 
likely cause of high and a low pKa’s of for the CXC motif of D3. 
It has been shown that the nucleophilicity series of the coordinating Cys residues 
of the HAH1 and MNK1 CXXC motifs is CysN (HAH1) ~ CysN (MNK1) > CysC (MNK) 
> CysC (HAH1) based on their pKa values.(18) This nucleophilicity series is supported by 
the structure of the Cu(I)-bound HAH1/MNK1 heterocomplex where the lower pKa CysC 
of HAH1 does not participate in coordination to the Cu(I) ion.(15) In addition, the 
structure of the Cu(I)-bound Atx1/Ccc2 heterocomplex shows the CysC of Atx1, analogous 
to CysC of HAH1, is also non-coordinating.(47) It has been shown that the rate 
determining step for transfer of Cu(I) between two CXXC motifs is likely to be the 
conversion of a three coordinate heterocomplex from a more reactant like form, where 
CysC of the donor is coordinating, to a more product like form, where CysC of the acceptor 
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is coordinating.(48) It has been proposed that the more nucleophillic CysC in the Cu(I) 
acceptor and less nucleophillic CysC in the donor will favour the transfer of the Cu(I).(18) 
This would ensure that the activation energy for Cu(I) transfer from source to target is 
lowered and promote vectorial Cu(I) transfer to the target protein. The lowering of the pKa 
for CysC in D1 of CCS caused by an interaction with Arg71 located within the same 
domain enhances the leaving group ability of this Cys residue. The pKa of one of the Cys 
residues of the D3 CXC motif, however, appears to be optimised for enhanced 
nucleophilicity. The lower pKa of one of the D3 CXC Cys may also be important for the 
disulfide isomerase function of CCS which is involved in facilitating the formation of the 
intramolecular disulfide in SOD1.(49) The nucleophilicities of the CXXC and CXC 
residues based on their pKa values is Cys1 (D3) ~ CysN (D1) > Cys2 (D3) > CysC (D1). 
This would suggest that in the case of CCS, CysC of the D1 CXXC motif will be the best 
leaving group in an intermediate/transient complex of CCS:SOD1, proposed in section 2.4, 
where Cu(I) is co-ordinated by Cys residues in both D1 and D3 for transfer of Cu(I) from 
D1 to D3 for subsequent insertion into the SOD1 copper site. Therefore the Cys pKa‘s of 
the two metal binding motifs of CCS appear to be such as to lower the activation barrier 
for vectorial copper transfer from D1 to D3 for ultimate copper incorporation into SOD1.  
The Cu(I) affinity pH profiles for the CXXC and CXC motif-containing proteins 
indicate that within the physiological pH range of the cytosol a thermodynamic gradient is 
for copper transfer exists between D1 and D3 which is in favour of Cu(I)-binding to the 
D1 CXXC motif. Therefore, according to the model proposed in section 2.4, during 
heterocomplex formation between Cu(I)-bound CCS and apo-SOD1 the Cu(I) bound to 
D1 is attacked by a Cys residue from D3. The subsequent concerted attack of the second 
Cys of D3 and dissociation of CysC of D1 would then occur before final dissociation of 
CysN of D1 to enable the insertion of Cu(I) bound by D3 into the apo-SOD1 active site. 
The high affinity of D1 ensures Cu(I) is bound to CCS that complexes with apo-SOD1 but 
the pKa of the Cys of the CXXC and CXC motifs,  however, ensure that Cu(I) transfer is 
kinetically favoured in the direction of the CXC motif of D3. The Cu(I)-binding domains 
of CCS therefore appear optimised for facilitating vectorial Cu(I) transfer from CCS to 
SOD1 by providing a low activation energy pathway. The results presented within this 
chapter highlight the potential importance of the kinetics of Cu(I) transfer in the 
mechanism of action of the CCS metallochaperone. 
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Chapter 4 
The Quaternary Structure of Human CCS and its Interaction with 
Cu,Zn-Superoxide Dismutase is Affected by Zinc Binding to Domain 2 
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4.1 Introduction 
A key feature of CCS is the presence of the Cu,Zn-superoxide dismutase (SOD1) like 
domain 2 (D2).(1-3) This domain is the largest of CCS and connects the Cu(I)-binding 
domains 1 (D1) and 3 (D3) and serves as a region for dimerization of the protein and the 
interaction with SOD1.(3-7) The structure of the D2 in human CCS consists of an 8 
stranded antiparallel β-barrel and is similar in overall fold and shares many features with 
SOD1 (1,8) (Figure 4.1.1). In particular key features of the loop regions of SOD1 are 
conserved in CCS. In loop 4 a region corresponding to the intramolecular disulfide and 
zinc binding site of SOD1 is present. The residues Cys141 and Cys227 are involved in a 
disulfide bond analogous to that between Cys57 and Cys146 of SOD1, which is essential 
for function of the enzyme. The zinc-binding residues His147, His155, His164 and 
Asp167 are also conserved and bind a single zinc ion in a distorted tetrahedral geometry. 
Although three of the four His residues (His130, His132 and His147), which correspond to 
copper ligands of SOD1 are present, the fourth His is replaced by Asp201, and CCS is not 
thought to bind copper at this potential metal binding site. Loop 7 of D2 in CCS 
corresponds to the electrostatic channel loop of SOD1, which guides superoxide to the 
copper for dismutation, and is of similar length and position in both proteins, but in CCS is 
missing several of the catalytically important residues.  
The dimer interface of CCS is located on the opposite side to the loop regions 
(Figure 4.1.1) containing the zinc-binding site and is very similar in both structure and 
amino acid content to that for SOD1.(1-3,8) Residues involved in dimerization include 
Gly135, Gly195 and Arg232 that form hydrogen bonds to the opposite monomer at the 
interface and there are also a number of residues that contribute to hydrophobic contact 
regions. In the yeast Ccs1 structure D2 has a fold similar to SOD1, and also yeast Sod1, 
but lacks the Cys residues of the disulfide, the entire zinc loop and the copper binding 
residues. Ccs1, in contrast to CCS, binds no metals within D2.(2, 3) The loop of Ccs1 
corresponding to the electrostatic channel loop of SOD1 is also much shorter and 
positioned differently to that for CCS, SOD1 and Sod1. Despite these differences Ccs1 
does retain a dimer interface that is analogous to that observed in Sod1 and CCS and 
contains the residues that participate in hydrogen bonding and hydrophobic contacts.  
Although D2 of CCS and Ccs1 are observed as dimers in their crystal structures 
their behaviour in solution is distinct. CCS exists as a dimer when apo for copper, whereas 
apo Ccs1 is monomeric.(5,6,7,10) In both cases the binding of copper leads to 
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oligomerisation; CCS existing as a mixture of dimer and tetramer whereas Ccs1 is present 
as a mixture of monomer and dimer. Ccs1 and Sod1 form a heterodimer in solution, both 
in the absence and presence of copper.(6,7) The crystal structure of the Ccs1:H48F-Sod1 
heterodimer shows how the interface of Ccs1, used for homodimerisation, associates with 
the corresponding interface of Sod1 to form what is widely regarded as the complex that 
promotes copper transfer to and disulfide oxidation of Sod1.(3,11,12) Because of these 
observations, and the fact that D2 of CCS is required for SOD1 activation, it is assumed 
that the role of D2 is for target recognition and orientation of the copper binding domains 
D1 and D3 for efficient transfer of the metal into the copper binding site of 
SOD1.(4,5,9,10,12)  
Zinc-binding and the intramolecular disulfide in human SOD1 have been shown to 
stabilise of the dimeric enzyme.(13-15) Loop 4 that contains the copper and zinc metal 
binding residues and Cys57 of the disulfide contributes to the dimer interface region. The 
Cys57-Cys146 disulfide also links this loop to the β-barrel fold and ordering of this loop 
region by both metal binding and the disulfide stabilise a conformation of the protein that 
favours dimerization.(16-18) Mutations to the zinc binding residues, that prevent zinc 
binding, affect the structuring of this region of SOD1 and lead to a loss of SOD1 activity 
in vivo (19).  It has been shown that mutation of the zinc-binding residues His147 and 
Asp167 in CCS have an effect in vivo resulting in a growth-retarding phenotype for yeast 
(ΔCcs1) expressing the mutant CCS.(20) In addition the effects are more pronounced 
under copper limiting conditions and are attributed to a reduced activity of SOD1 due to a 
loss of CCS dependent activation. It appears, therefore, that zinc binding to CCS plays an 
important role in the maturation of CCS itself and is required for proper functioning of the 
protein. Due to the similarities between D2 of CCS and SOD1, the role of zinc binding 
might be expected to be similar; namely stabilising a particular conformation of the 
protein fold that results in an active enzyme. 
Understanding the role of metal binding to D2 for the functioning of human CCS 
has not been studied in vitro. The significance of the differences observed for the 
structures and oligomerisation behaviour of CCS and Ccs1 when activating what appear to 
be very similar target proteins has also received little attention. SOD1 and Sod1 require 
the same post-translational processing that includes acquisition of both copper and zinc 
and formation of the essential disulfide between Cys57 and Cys146.(3, 8) Therefore it is 
unusual that CCS contains a zinc binding site, but Ccs1 does not, and it is currently 
unknown what propose this metal serves in the functioning of CCS. The work presented in 
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this chapter details an investigation of the nature of zinc binding to D2 of CCS and the 
effect on both the quaternary structure of CCS and its interaction with, and activation of, 
SOD1.  
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Figure 4.1.1  
Crystal structures of D2 of human CCS (A) and human Cu,Zn-SOD1 (B) (one monomer 
of dimer shown) (PDB accession codes 1DO5 and 1SPD, respectively) drawn in Pymol. 
The zinc and copper ions are shown as grey and gold spheres, respectively, and the co-
ordinating residues and the Cys residues of the disulfide are shown in stick 
representations. Regions corresponding to the SOD1 zinc loop (CCS loop 4) and the 
SOD1 electrostatic channel loop (CCS loop 7) are highlighted in green and blue, 
respectively. 
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4.2 Experimental 
4.2.1 PCR and Cloning of SOD1 
The gene for SOD1 was cloned from pCLneo_SOD1 (see section 6.8) by PCR using the 
forward and reverse primers 5’- GAACATATGGCGACGAAGGCCGTGTGCG -3’ and 
5’-GAAGAATTCTTATTGGGCGATCCCAATTACACC-3’, respectively, giving the 
construct pGEMT_SOD1 with the gene insert present as an Nde1/EcoR1 fragment. DNA 
sequencing was used to verify the product by sequencing both strands of the plasmid. The 
gene was then cloned using the Nde1/EcoR1 restriction sites into pET29a giving 
pET29a_SOD1. 
 
4.2.2 Expression and Purification of Proteins 
WT-CCS, C244S/C246S-CCS, C22S/C25S-CCS, D1-CCS and SOD1 were expressed 
and purified as described in section 6.10.  
 
4.2.3 Preparation of Zn-depleted WT-CCS  
The removal of zinc from as-isolated WT-CCS was achieved through use of a modified 
protocol reported for demetallation of Sod1.(5) As-isolated WT-CCS (10-20 mg) in 5 ml 
of 20 mM tris(hydroxymethyl)aminomethane (Tris) pH 7.5 containing 1 mM dithiothreitol 
(DTT) was dialysed against 500 ml of 50 mM acetate at pH 4.5 containing 50 mM 
ethylenediaminetetraacetic acid (EDTA) to remove bound zinc at 4 
o
C. Dialyses required 
two buffer exchanges of ~3 hours and one left overnight. The protein was then exchanged, 
by further dialysis, into 20 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid 
(Hepes) pH 7.5 containing 200 mM NaCl and 1 mM DTT using 3 buffer exchanges (~3 
hours each). The protein was then concentrated (Amicon Ultra 4, 10 kDa MWCO, 
Millipore) and injected onto a Superdex 75 column (10/300 GL, GE Healthcare) pre-
equilibrated in 20 mM Hepes pH 7.5 containing 200 mM NaCl and 1 mM DTT. Fractions 
corresponding to monomeric WT-CCS (vide infra) were collected and combined and the 
final sample of Zn-depleted WT-CCS assayed for copper and zinc by AAS. 
 
4.2.4 Protein Reduction and Quantification 
As-isolated SOD1 (E,Zn-SOD1) (200-800 M) was reduced by incubation with 10 mM 
DTT in 20 mM Tris pH 7.5 in an anaerobic chamber (Belle Technology, O2 << 2 parts 
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per million) typically for 12 hours. DTT treated SOD1 was then desalted and exchanged 
into the required buffer using a PD10 column (GE Healthcare). The concentration of 
E,Zn-SOD1 was determined by using an epsilon value at 280 nm (ε280) of 5,500 M
-1
 cm
-1 
.(21) Free thiols were assessed by Ellman’s assay as described in section 6.15. A 
correction factor of ~1.2 was required for Bradford assays of E,Zn-SOD1 relative to 
concentrations determined by the epsilon value at 280 nm. The concentration of as-
isolated WT-CCS and its variants (including Zn-depleted WT-CCS) were determined as 
described in section 2.2.4.  
 
4.2.5 Cu(I) Binding Stoichiometry of Zn-depleted WT-CCS 
Preparation of Cu(I) stock solutions, Cu(I)-proteins and the determination of the  high 
affinity Cu(I)-binding stoichiometry of Zn-depleted WT-CCS was performed as 
described in sections 6.16.1 and 6.16.2. Copper concentrations were determined using 
bathocuproine disulfonic acid (BCS) and occasionally by AAS also described in section 
6.16.1.  
 
4.2.6 Cu(I) Affinity of Zn-depleted WT-CCS 
The Cu(I) affinity (Kb value) of Zn-depleted WT-CCS was determined by competition 
assays with BCS using the approach described in section 6.16.3. Titrations were 
performed by adding BCS into Cu(I)-protein (5 M) containing an excess of apo-protein 
(5 M) in 20 mM Hepes pH 7.5 containing 200 mM NaCl.  
 
4.2.7  Zn(II) Reconstitution of Zn-depleted WT-CCS 
Zn(II) from a 1 mM aqueous stock of ZnSO4, was added slowly to Zn-depleted WT-CCS 
(10-20 M) in 20 mM Tris pH 7.5 containing 200 mM NaCl in an anaerobic chamber. 
Samples were incubated for 5 minutes to ~12 hours and assayed for dimerisation using gel 
filtration chromatography. Samples (150 L) were injected onto a Superdex 75 column 
(10/300 GL, GE Healthcare) pre-equilibrated in 20 mM Hepes pH 7.5 containing 200 mM 
NaCl (with and without 1 mM DTT). Buffers were purged with N2 and protein elution was 
monitored by measuring the absorbance at 280 nm. 
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4.2.8  Cu(II) Loading of E,Zn-SOD1 
Copper loaded SOD1 (Cu,Zn-SOD1) was prepared from E,Zn-SOD1 (50-100 M) by the 
addition ~1.4 molar equivalents of Cu(II) from a 1 mM aqueous stock of Cu(NO3)2 in 20 
mM Tris pH 7.5 containing 200 mM NaCl. The copper-bound protein was then exchanged 
into fresh buffer, to remove adventitiously bound copper, by performing three buffer 
exchanges of 10-fold dilution and subsequent concentration (Vivaspin 500, 5 kDa 
MWCO, Sartorius). The concentration of the protein in the final sample was determined 
by Bradford assays using E,Zn-SOD1 as described in 4.2.4. Metal content of the final 
Cu,Zn-SOD1 sample was determined by AAS. 
 
4.2.9 Interaction between as-isolated and Zn-depleted WT-CCS and SOD1 
The interactions between the as-isolated and Zn-depleted WT-CCS (with and without 
bound Cu(I)) and E,Zn-SOD1 were investigated by gel filtration chromatography. 
Typically Zn-depleted WT-CCS, as-isolated WT-CCS (both with and without 1 molar 
equivalent of Cu(I) at 10 or 50 M protein concentration) was mixed with an equimolar 
amount of E,Zn or Cu,Zn-SOD1 under anaerobic conditions. Mixtures were then 
incubated for ~5 minutes prior to injection (~150 L) on a Superdex 75 column (10/300 
GL, GE Healthcare) pre-equilibrated in 20 mM Hepes pH 7.5 containing 200 mM NaCl. 
1 mM DTT was added to the column buffer for analysis of samples under reducing 
conditions. All column buffers were purged with N2 and protein elution was monitored 
by measuring the absorbance at 280 nm.
 
 
4.2.10 Activation of E,Zn-SOD1 by as-isolated and Zn-depleted WT-CCS 
The ability of Zn-depleted WT-CCS and as-isolated WT-CCS to activate SOD1 was 
assayed using a SOD1 activity determination kit (Fluka). The assay utilizes 2-(4-
Iodophenyl)-3-(4-nitophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt 
(WST-1), that produces a formazan dye, with a λmax at 440 nm, upon reduction with 
superoxide. The assay measures the ability of SOD1 to inhibit the reduction of the WST-
1 dye by superoxide generated by xanthine oxidase. By measuring the absorbance at 450 
nm the ability of CCS to activate E,Zn-SOD1 was measured. Reaction mixtures 
consisted of Cu(I)-protein (Zn-depleted WT-CCS or as-isolated WT-CCS, 
C244S,C246S-CCS, C22SC25S-CCS and D1-CCS) (5 M) with an excess of the protein 
apo for copper (5 M) mixed with E,Zn-SOD1 (10 M) in 20 mM Hepes pH 7.5 
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containing 200 mM NaCl plus 50 M BCS. Mixtures were incubated for 10 minutes in 
an anaerobic chamber and diluted 50-fold in the same buffer prior to the activity assay. 
Controls included measuring the activity of E,Zn-SOD1 and also Cu,Zn-SOD1 prepared 
in 4.2.8. 
 
4.3 Results 
4.3.1 Purification and the Initial Characterisation of E,Zn-SOD1 
The purity of E,Zn-SOD1 was determined by SDS-PAGE to be > 90 % and matrix 
assisted laser desorption ionization mass spectrometry (MALDI-MS) analysis showed 
peaks of 15,995 and 15,797 kDa corresponding to the protein with and without the N-
terminal Met (calculated values of 15,996 and 15,806 kDa for the full length and N-
terminal Met cleaved proteins). The protein was isolated with negligible copper but 
contained 1.0 ± 0.2 zinc ions per monomer as determined by AAS. Gel filtration on a 
Superdex 75 column shows the protein to elute predominantly as a dimer (Figure 4.3.1 
and Table 4.3.1). There is a shoulder present, however, at lower protein concentrations 
that corresponds to a monomeric form. Since zinc binding or Cys oxidation results in the 
stabilization of dimeric SOD1 this proportion of SOD1, which migrates as the 
monomeric form, may be either disulfide reduced or not contain bound zinc.(13) Free 
thiol determinations of E,Zn-SOD1 indicated the presence of ~1 thiol per monomer 
whereas overnight incubation with an excess of DTT results in the presence of ~2 thiols. 
There are a total of 4 Cys residues in SOD1 of which two, Cys57 and 147, form the 
conserved disulfide. In Cu,Zn-SOD1, Cys6 and Cys111 are not solvent 
accessible.(22,23) Therefore, the Cys thiols observed for DTT reduced E,Zn-SOD1 may 
correspond to Cys57 and Cys147. This assignment seems the most likely as no 
significant peaks were observed for gel filtration of E,Zn-SOD1 that ran heavier than 
dimer. The Far-UV CD spectrum of E,Zn-SOD1 (Figure 4.3.2) is similar to that reported 
elsewhere for E,Zn-SOD1 and indicates substantial β-sheet content as expected based on 
solution and crystal structures of this form of SOD1.(13,15,18) 
 
4.3.2 Preparation of Zn-depleted WT-CCS 
Zn-depleted WT-CCS was prepared by dialysis of as-isolated WT-CCS against an excess 
of EDTA at pH 4.5 to remove the zinc ion bound in D2 and then separated from the 
presence of minor higher order oligomers and impurities by gel filtration chromatography. 
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The final purified sample of Zn-depleted WT-CCS was found to contain negligible copper 
and zinc by AAS with the concentration of the protein determined using an ε280 value for 
as-isolated WT-CCS. Analytical gel filtration chromatography of Zn-depleted WT-CCS 
showed the protein eluting as a single peak at a volume corresponding to an apparent 
molecular mass of ~41 kDa indicating the zinc-depleted WT-CCS protein is monomeric 
(Figure 4.3.3). Neither increased concentration nor reducing conditions alters the elution 
volume of the protein (Figure 4.3.3). The Far-UV CD spectrum for Zn-depleted WT-CCS 
is almost identical to that for as-isolated WT-CCS (Figure 4.3.4), indicating that the 
removal of the zinc ion from D2 does not alter the secondary structure of the protein. Free 
thiol determination for Zn-depleted WT-CCS indicated 7.0 ± 1.0 thiols per monomer and 
the sample was stable, with regards to thiol oxidation and oligomerisation, under anaerobic 
conditions for at least several days.  Therefore, the removal of zinc destabilises the dimer 
and also results in an increase in the number of detectable thiols compared to that for as-
isolated WT-CCS (section 2.3.1). WT-CCS contains a total of 9 Cys residues with 4 of 
these contained within D2, of which two of these are involved a disulfide (Cys141 and 
Cys227).(1) It was found previously (section 2.3.1) that only the Cys residues of D1 and 
D3 appear to be solvent accessible in as-isolated WT-CCS; 3 in D1 and 2 in D3. This 
means that the 4 Cys residues present in D2 are either involved in a stable disulfide or 
buried. That zinc removal causes an increase in the number of detectable thiols by two 
suggests that the disulfide of this domain may become exposed and reduced by DTT or 
that the previously buried Cys residues become solvent accessible.  
 
4.3.3 Cu(I) Binding Stoichiometry of Zn-depleted WT-CCS  
The high affinity Cu(I)-binding stoichiometry of Zn-depleted WT-CCS was determined 
by titrating Cu(I) into the protein in the presence of BCA (Figure 4.2.5). Zn-depleted 
WT-CCS binds up to 3 equivalents of Cu(I) tightly under these conditions. The first two 
equivalents of Cu(I) are bound in a site, or sites, with a much higher affinity than BCA. 
The third equivalent of Cu(I) is bound less tightly and is similar to that observed for the 
second equivalent of Cu(I) bound to as-isolated WT-CCS and for the first bound to 
C22S/C25S-CCS (section 2.3.4). Zinc removal from D2 has resulted in the formation of 
a second high affinity Cu(I)-binding site within zinc-depleted WT-CCS. This second 
high affinity Cu(I)-binding site is coincident with the appearance of two additional thiols 
in Zn-depleted WT-CCS. Both D1 and D3 recruit copper through two Cys residues and 
it may be possible that the two additional thiols recruit the additional copper ion in zinc-
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depleted WT-CCS. UV/Spectra of Cu(I) titration of Zn-depleted CCS gives rise to 
charge transfer bands characteristic of Cu(I)-thiolate binding for up to at least three 
equivalents of added Cu(I) (Appendix A Figure 3), indicating all three Cu(I) ions are 
bound to metal sites involving Cys ligation of the metal. 
 
4.3.4 Cu(I) Affinity of Zn-depleted CCS  
In order to quantify the Cu(I) affinity (Kb) for Zn-depleted WT-CCS competition 
experiments with BCS were performed at pH 7.5 (Figure 4.3.6). An average Kb value of 
(5.6 ± 0.9) ×10
17
 M
-1
 was determined from multiple titrations for the first equivalent of 
Cu(I) bound to the protein. The affinity of Cu(I) for the Zn-depleted WT-CCS is identical 
to those determined for as-isolated WT-CCS, C244S/C246S-CCS and D1-CCS (section 
2.3.5) where Cu(I) binds to the CXXC motif in D1. The Kb value for Zn-depleted WT-
CCS suggests that the CXXC motif of D1 remains the higher affinity copper site.  
 
4.3.5  Zn(II) Reconstitution of Zn-depleted CCS 
In order to determine whether zinc-binding by D2 of CCS is reversible, Zn-depleted WT-
CCS was incubated with zinc and samples assayed for dimer formation by gel filtration 
chromatography (Figure 4.3.7). After 5 minutes of incubation with 0.5 and 1.0 equivalents 
of zinc the chromatograms show the appearance of a significant peak at the same elution 
volume to that obtained for dimeric as-isolated WT-CCS. In addition, the peak intensity 
correlates with the amount of added zinc. Increasing the incubation period up to 6 hours 
results in chromatograms where the majority of the protein, especially for the sample 
treated with an equimolar amount of zinc, runs as the dimeric form. Interestingly, the 
sample with 0.5 equivalents of added zinc displays a monomer-dimer equilibrium that 
strongly favours the dimeric state.  Leaving samples for longer periods does not alter the 
monomer-dimer equilibrium further and the equilibrium is unaffected by the presence of 
reductant indicating the dimer is unlikely to be the result of a disulfide linked form of 
CCS. Therefore the addition of Zn(II) to Zn-depleted WT-CCS appears to reform the as-
isolated WT-CCS dimer. 
 
4.3.6 Interaction between Zn-depleted and as-isolated WT-CCS and E,Zn-SOD1 
The interaction of Zn-depleted and as-isolated WT-CCS with E,Zn-SOD1 was assessed by 
gel filtration chromatography. The proteins can be assayed by this technique due to the 
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significant difference between the elution volumes for as-isolated and Cu(I)-bound SOD1 
(Figure 4.3.8) and CCS (with or without Cu(I) and Zn(II)). The incubation of as-isolated 
WT-CCS with E,Zn-SOD results in a chromatogram with peaks corresponding to both 
homodimeric proteins but also shows the appearance of a new peak at an elution volume 
corresponding to that for a CCS:SOD1 heterocomplex (Figure 4.3.9 and Table 4.3.2). The 
chromatogram for Cu(I)-bound as-isolated WT-CCS also shows the heterodimeric 
CCS:SOD1 complex peak but also a peak corresponding to a CCS tetramer formed by 
copper binding to the D3 CXC as observed in section 2.3.3. The chromatograms for Zn-
depleted WT-CCS or Cu(I)-bound Zn-depleted WT-CCS with E,Zn-SOD1 is missing the 
peak for heterodimeric CCS:SOD1, and the Cu(I)-bound Zn-depleted form shows a peak 
at an elution volume corresponding to dimeric CCS (Figure 4.3.9 and Table 4.3.2). Similar 
results for all of the above mixtures are obtained under reducing conditions, however the 
peaks corresponding to tetrameric Cu(I)-bound as-isolated WT-CCS and Cu(I)-bound 
dimeric Zn-depleted WT-CCS are absent indicating that DTT prevents copper dependent 
oligomerisation of both proteins (Figure 4.3.10 and Table 4.3.3). As the heterodimeric 
CCS:SOD1 complex is unaffected by reducing conditions the complex likely results from 
non-covalent interactions between dimerisation interfaces of CCS and SOD1. Identical 
results are also obtained at 5-fold higher protein concentrations (Figure 4.3.11 and Table 
4.3.4). Zinc binding to D2 of CCS, therefore, appears to stabilise the CCS:SOD1 complex. 
A mixture of as-isolated WT-CCS and Cu,Zn–SOD shows that the fully metallated form 
of SOD1 does not form a heterocomplex with CCS (Figure 4.3.12).  
 
4.3.7 Activation of E,Zn-SOD1 by as-isolated and Zn-depleted CCS 
In order to determine if Zn-depleted WT-CCS is an active metallochaperone an assay for 
SOD1 activation by CCS was performed (Figure 4.3.13). The activation of E,Zn-SOD1 
was similar for both Cu(I)-bound as-isolated and Zn-depleted WT-CCS and resulted in the 
activation of SOD1 within similar levels observed for Cu,Zn-SOD1 prepared in 4.2.8. The 
activation of E,Zn-SOD1 by Cu(I)-bound C22S/C25S-CCS, missing the CXXC Cys 
residues of D1, was also similar to that observed for Cu(I)-bound as-isolated WT-CCS. 
The activation of E,Zn-SOD1 by both Cu(I)-bound D1-CCS and C244S/C246S-CCS 
however, was significantly lower indicating that, as expected, the loss of the D3 CXC 
motif Cys residues results in loss of CCS activation of SOD1. In vitro Zn-depleted WT-
CCS can therefore still activate E,Zn-SOD1. Time course measurements for the activation 
of E,Zn-SOD1 (Appendix A, Figure 4) show that the kinetics for activation were similar 
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for as-isolated and Zn-depleted WT-CCS, and also C22S/C25S-CCS,indicating that Zn-
depletion of CCS, under the conditions of the assay, does not affect kinetics of activation 
of E,Zn-SOD1. The time course measurements for D1-CCS and C244S/C246S-CCS 
showed kinetics for activation that are significantly slower than for WT-CCS, as expected, 
due to the absence of the essential CXC motif of D3.(4,10) 
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Table 4.3.1 
Elution volumes and apparent molecular weights for E,Zn-SOD1 and Zn-depleted WT-
CCS determined on a Superdex 75 10/300 GL column in 20 mM Mes pH 6.5 containing 
200 mM NaCl. 
protein elution volume(s)  
(± 0.1 ml) 
apparent mass 
a
 
(kDa) 
E,Zn-SOD1 (50 M) 11.4, 12.4 33 (± 1), 22 (± 1) 
E,Zn-SOD1 (100 M) 11.4 33 (± 1) 
Zn-depleted WT-CCS (10 M) 10.8 41 (± 1) 
Zn-depleted WT-CCS (50 M) 10.8 41 (± 1) 
a
 The errors indicated for the apparent masses of proteins are deduced from the error in 
the measurement of the elution volumes and therefore will be significantly lower than 
the real error observed (See section 6.4). 
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Table 4.3.2 
Elution volumes and apparent molecular weights for mixtures of as-isolated and Zn-
depleted WT-CCS (with and without 1 equivalent of bound Cu(I)) with E,Zn-SOD1 
(both 10 M)  on a Superdex 75 10/300 GL Column in 20 mM Hepes pH 7.5 Containing 
200 mM NaCl.  
protein / protein mixture elution volume  
(± 0.3 ml) 
apparent mass 
a
 
(kDa) 
As-isolated WT-CCS + E,Zn-SOD1 9.7 
10.4 
11.0 
b
 
64 (± 7) 
48 (± 5) 
38 (± 4) 
Cu(I)-bound as-isolated WT-CCS  
+ E,Zn-SOD1 
8.8 
b
 
9.7 
10.4 
11.0
 b
 
92 (± 10) 
64 (± 7) 
48 (± 5) 
38 (± 4) 
Zn-depleted WT-CCS + E,Zn-SOD1 11.0 38 (± 4) 
Cu(I)-bound Zn-depleted WT-CCS  
+ E,Zn-SOD1 
9.6
 b
 
11.0 
67 (± 7) 
38 (± 4) 
a
 The errors indicated for the apparent masses of proteins are deduced from the error in 
the measurement of the elution volumes and therefore will be significantly lower than 
the real error observed (See section 6.4). 
b
 Minor peaks. 
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Table 4.3.3 
Elution volumes and apparent molecular weights for mixtures of as-isolated and Zn-
depleted WT-CCS (with and without 1 equivalent of bound Cu(I)) with E,Zn-SOD1 
(both 10 M)  on a Superdex 75 10/300 GL Column in 20 mM Hepes pH 7.5 Containing 
200 mM NaCl plus 1 mM DTT.  
protein / protein mixture elution volume  
(± 0.3 ml) 
apparent mass 
a
 
(kDa) 
As-isolated WT-CCS + E,Zn-SOD1 9.7 
10.4 
11.0
 b
 
64 (± 7) 
48 (± 5) 
38 (± 4) 
Cu(I)-bound as-isolated WT-CCS  
+ E,Zn-SOD1 
9.7 
10.4 
11.0
 b
 
64 (± 7) 
48 (± 5) 
38 (± 4) 
Zn-depleted WT-CCS + E,Zn-SOD1 11.0 38 (± 4) 
Cu(I)-bound Zn-depleted WT-CCS  
+ E,Zn-SOD1 
11.0 (Broad) 38 (± 4) 
a
 The errors indicated for the apparent masses of proteins are deduced from the error in 
the measurement of the elution volumes and therefore will be significantly lower than 
the real error observed (See section 6.4). 
b
 Minor peaks. 
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Table 4.3.4 
Elution volumes and apparent molecular weights for mixtures of as-isolated and Zn-
depleted WT-CCS (with and without 1 equivalent of bound Cu(I)) with E,Zn-SOD1 
(both 50 M)  on a Superdex 75 10/300 GL Column in 20 mM Hepes pH 7.5 Containing 
200 mM NaCl.  
protein / protein mixture elution volume  
(± 0.2 ml) 
apparent mass 
a
 
(kDa) 
Zn-depleted WT-CCS 11.0 38 (± 4) 
As-isolated WT-CCS 9.7 64 (± 7) 
as-isolated WT-CCS + E,Zn-SOD1 9.7
 b
 
10.4 
11.0
 b
 
64 (± 7) 
48 (± 5) 
38 (± 4) 
Cu(I)-bound as-isolated WT-CCS 
+ E,Zn-SOD1 
9.0
 b
 
9.7 
10.4 
11.0
 b
 
85 (± 9) 
64 (± 7) 
48 (± 5) 
38 (± 4) 
Zn-depleted WT-CCS + E,Zn-
SOD1 
11.0 38 (± 4) 
Cu(I)-bound Zn-depleted WT-CCS 
+ E,Zn-SOD1 
11.0 38 (± 4) 
a
 The errors indicated for the apparent masses of proteins are deduced from the error in 
the measurement of the elution volumes and therefore will be significantly lower than 
the real error observed (See section 6.4). 
b
 Minor peaks. 
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Figure 4.3.1 
Gel filtration chromatograms for E,Zn-SOD1 [50 M (A) and 100 M (B)] in 20 mM 
Hepes pH 7.5 containing 200 mM NaCl. Absorbance measured at 280 nm. Protein 
eluting at 11.4 ml (~ 33 kDa) corresponds to dimeric SOD1 and the shoulder present in 
(A) at 12.4 ml (~ 22 kDa) corresponds to monomeric SOD1. 
 
 
Figure 4.3.2 
Far-UV CD spectra for as-isolated E,Zn-SOD1 in 20 mM Hepes pH 7.5 containing 200 
mM NaCl. 
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Figure 4.3.3 
Gel filtration chromatograms for Zn-depleted WT-CCS [10 M (A) and 50 M (B)] and 
under reducing conditions (10 M) (C). Gel filtration chromatogram for Cu(I)-bound 
Zn-depleted WT-CCS [1 molar equivalent Cu(I)] is shown in (D).  All chromatograms 
obtained in 20 mM Hepes pH 7.5 containing 200 mM NaCl, except for (C) which 
contained 1 mM DTT. Absorbance measured at 280 nm. Elution volumes of ~10.8 and 
~9.7 ml correspond to apparent molecular masses of ~41 and ~64 kDa for the 
monomeric and dimeric forms of CCS, respectively. 
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Figure 4.3.4 
Far-UV CD spectra for Zn-depleted WT-CCS (solid) and as-isolated WT-CCS (dotted) 
(both 0.5 mg/ml) in 20 mM Hepes pH 7.5 containing 200 mM NaCl. 
 
Figure 4.3.5 
Titration of Cu(I) into Zn-depleted WT-CCS (10 M) in 20 mM Hepes pH 7.5 containing 
200 mM NaCl and 500 M BCA. 
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Figure 4.3.6 
Titration of BCS into Cu(I)-bound Zn-depleted WT-CCS (10 M) plus excess Zn-
depleted WT-CCS (10 M) in 20 mM Hepes pH 7.5 containing 200 mM NaCl. The line 
shows a fit of the data to equation 5.1, giving a Kb value of (5.2 ± 0.4) × 10
17
 M
-1
. 
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Figure 4.3.7 
Gel filtration chromatograms for Zn-depleted WT-CCS (10 M) reconstituted with 0.5 
(solid line) and 1 (dashed line) equivalents of Zn(II) after 5 minutes (A) and 6 hours (B) 
of incubation. Gel filtration chromatogram for Zn-depleted WT-CCS (10 M) 
reconstituted with 1 equivalent of Zn(II) after overnight incubation (C). All 
chromatograms obtained in 20 mM Hepes pH 7.5 containing 200 mM NaCl except for 
(C) which also contained 1 mM DTT. Absorbance measured at 280 nm. Elution volumes 
of ~10.8 and ~9.7 ml correspond to apparent molecular masses of ~41 and ~64 kDa for 
the monomeric and dimeric forms of CCS, respectively. 
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Figure 4.3.8 
Gel filtration chromatograms for E,Zn-SOD1 (10 M) (A) and Cu,Zn-SOD1 (10 M) 
(B) in 20 mM Hepes pH 7.5 containing 200 mM NaCl. Absorbance measured at 280 nm. 
Elution volume of ~11.4 ml corresponds to an apparent molecular mass of ~33 kDa for 
dimeric SOD1. 
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Figure 4.3.9 
Gel filtration chromatograms for as-isolated WT-CCS and E,Zn-SOD1 (A), Cu(I)-bound 
as-isolated WT-CCS and E,Zn-SOD1 (B), Zn-depleted WT-CCS and E,Zn-SOD1 (C) 
and Cu(I)-bound Zn-depleted WT-CCS and E,Zn-SOD1 (D) (all 10 M) in 20 mM 
Hepes pH 7.5 containing 200 mM NaCl. Absorbance measured at 280 nm. Elution 
volumes and apparent molecular weights are listed in Table 4.3.2. 
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Figure 4.3.10 
Gel filtration chromatograms for as-isolated WT-CCS and E,Zn-SOD1 (A), Cu(I)-bound 
as-isolated WT-CCS and E,Zn-SOD1 (B), Zn-depleted WT-CCS and E,Zn-SOD1 (C) 
and Cu(I)-bound Zn-depleted WT-CCS and E,Zn-SOD1 (D) (all 10 M) in 20 mM 
Hepes pH 7.5 containing 200 mM NaCl plus 1 mM DTT. Absorbance measured at 280 
nm. Elution volumes and apparent molecular weights are listed in Table 4.3.3. 
 
 
 
 
 
 
 
 
 
 
147 
 
Figure 4.3.11 
Gel filtration chromatograms for Zn-depleted WT-CCS (A) as-isolated WT-CCS (B) as-
isolated WT-CCS and E,Zn-SOD1 (C), Cu(I)-bound as-isolated WT-CCS and E,Zn-
SOD1 (D),  Zn-depleted WT-CCS and E,Zn-SOD1 (E) and Cu(I)-bound Zn-depleted 
WT-CCS and E,Zn-SOD1 (F) (all 50 M) in 20 mM Hepes pH 7.5 containing 200 mM 
NaCl. Absorbance measured at 280 nm. Elution volumes and apparent molecular 
weights are listed in Table 4.3.4. 
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Figure 4.3.12 
Gel filtration chromatogram for as-isolated WT-CCS and Cu,Zn-WT-SOD1 (both 10 
M) in 20 mM Hepes pH 7.5 containing 200 mM NaCl. Absorbance measured at 280 
nm. Elution volumes of ~11.4 and ~9.7 ml correspond to apparent molecular masses of 
~33 and ~64 kDa for the dimeric forms of SOD1 and CCS, respectively. 
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Figure 4.3.13 
CCS activation of SOD1 assayed by xanthine oxidase WST-1 reduction inhibition. Assay 
of SOD1 activity for reaction mixtures containing Cu(I)-bound CCS (5 M) and excess 
apo-CCS (5 M) with E,Zn-SOD1 (10 M) in 20 mM Hepes pH 7.5 containing 200 mM 
NaCl and 50 M BCS for Zn-depleted WT-CCS, as-isolated WT-CCS, C22S/C25S-CCS, 
C244S/C246S-CCS and D1-CCS.  
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4.4 Discussion 
Demetallation of as-isolated WT-CCS at low pH in the presence of excess metal chelators 
yields Zn-depleted WT-CCS. In contrast to the zinc-bound dimeric form, Zn-depleted 
WT-CCS is a monomer. Despite the change in oligomeric state, from dimer to monomer, 
the Zn-depleted form of WT-CCS retains the same secondary structure as the zinc-bound 
as-isolated (copper free) WT-CCS as determined by CD spectroscopy. Therefore changes 
to the proteins tertiary structure, due to the binding of zinc in D2, affect monomer-dimer 
stability of CCS. Zn-depleted copper free WT-CCS binds up to three equivalents of Cu(I) 
with high affinity with the first two equivalents binding tightly but the third more weakly. 
This compares with the binding of two equivalents of Cu(I) for the as-isolated zinc-bound 
WT-CCS which has one high and one low affinity sites. The affinity of the first bound 
Cu(I) to zinc-depleted WT-CCS is similar to that determined for the D1 CXXC motif 
(section 2.3.5) and indicates that the CXXC-containing D1 likely represents one of the 
high affinity Cu(I) sites in zinc-depleted WT-CCS. The additional 2 thiols in the zinc-
depleted WT-CCS indicate that changes to the D2 structure includes exposure of 
previously buried Cys residues. D2 of CCS contains 4 Cys residues of which 3 are located 
in close proximity to each other with two of these involved in a disulfide (Cys141 and 
Cys227).(1) It is possible that the Cys residues of the disulfide may become exposed and 
reduced upon demetallation resulting in the formation of an additional high affinity Cu(I) 
site in zinc-depleted WT-CCS.  The Cu(I)-binding characteristics of the third copper are 
similar to those observed for Cu(I)-binding to C22S/C25S-CCS (section 2.3.4) and suggest 
that this third copper binds to the CXC motif of D3. 
D2 of CCS shares many features with SOD1 including a similar protein fold, zinc 
binding site and a conserved intramolecular disulfide and so it is possible to propose a 
hypothesis for the effects of zinc binding to CCS by considering the available SOD1 
structures.(1,8,17,18) Structures for SOD1 that are apo for both copper and zinc typically 
display disorder in the metal binding regions. The binding of zinc re-orients the loop 
regions of SOD1, specifically loop 4 on which the majority of the metal binding residues 
are located, and contributes to the positioning of the anti-parallel β-strands that are 
involved in the formation of a stable homodimer.(18) Zinc binding to monomeric apo 
reduced SOD1 shifts the equilibrium towards the formation of the dimer.(13)  The 
conserved Cys residues (Cys57 and Cys146) also have a significant effect on the 
quaternary structure with apo oxidized SOD1 existing as a dimer in both crystal structures 
and solution.(13,14,17,18) The disulfide connects loop 4 to β-sheet 8 of the β-barrel fold 
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and contributes to the overall arrangement of the β-sheets. Both zinc binding and Cys 
oxidation in SOD1 stabilise the homodimer. Zinc-binding to Zn-depleted WT-CCS results 
in a homodimer suggesting that similar changes to the loop regions upon metallation of the 
protein contribute to dimer stabilisation. In SOD1, apo for copper and zinc, the zinc 
binding residues are solvent exposed and ready to bind the zinc ion.(17) A similar 
conformation of the metal binding site for Zn-depleted WT-CCS seems likely given the 
reversibility of zinc binding. 
The interaction between CCS and the E,Zn-SOD1 is either abolished or severely 
disrupted upon removal of zinc from CCS, which indicates that zinc-binding is a 
prerequisite for formation of a stable CCS:SOD1 heterocomplex. This heterocomplex is 
proposed to be an intermediate in the pathway for CCS activation of SOD1.(3) Therefore 
the binding of zinc to D2 of CCS not only stabilises homodimer formation but also 
optimises the tertiary structure of CCS for interaction with E,Zn-SOD1. The structure of 
E,Zn-SOD1 shows that the vacant copper binding site region remains disordered and 
exposed.(18) Therefore the binding of zinc to CCS and SOD1 would both promote 
heterodimer formation and subsequent transfer of copper through the opening up of the 
copper binding site in SOD1. It is noteworthy that we also show that WT-CCS, with Zn 
bound in D2, does not form a heterocomplex with Cu,Zn-SOD1. The dimerisation 
interface of CCS appears to distinguish between E,Zn-SOD1 and Cu,Zn-SOD1. The 
structure of E,Zn-SOD1 is more similar to that of the Cu,Zn-SOD1 than to E,E-SOD1 with 
only minor changes to the structure upon the binding of copper.(8,17,18) The structural 
changes, however, may be sufficient to abolish the interaction with CCS once the fully 
metallated Cu,Zn-SOD1 enzyme is formed. This specificity of the CCS:SOD1 interaction 
would prevent unnecessary interactions between the fully matured SOD1 protein and CCS. 
It seems likely that the effects of metallation on both CCS and SOD1 affect the tertiary 
structures in a way that optimises the proteins for each stage of the SOD1 maturation 
process. 
Although activation of SOD1 by Zn-depleted CCS in vitro is possible it is not 
known whether Zn-depleted CCS is functional in vivo. Mutations to the zinc co-ordinating 
His147 and Asp167 residues of CCS, however, result in a reduced level of SOD1 
activation in vivo.(20) It was proposed that the reduced level of SOD1 activity was due to 
these residues playing a role in transferring copper to SOD1, or because of a change in 
conformation in CCS that resulted in a loss of interaction between the two proteins. The 
levels of CCS in the cell, however, were reduced for proteins carrying these two 
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deleterious mutations and so this would result in less available CCS for activation of 
SOD1. Although the Zn-depleted WT-CCS is found to be stable in vitro under anaerobic 
conditions, it may be unstable in vivo and lead to protein aggregation or it may be 
processed by the cell. That we see activation of SOD1 in vitro with Zn-depleted WT-CCS 
may mean that although the heterodimeric CCS: SOD1 complex is destabilised it may still 
form, albeit weakly, allowing for CCS activation of SOD1.  
 In S. cerevisiae Sod1 localisation to the mitochondrial IMS is dependent upon the 
presence of Ccs1 which is recruited by the Mia40/Erv1 disulfide relay system through a 
disulfide dependent mechanism.(25,26) It has been shown that the disulfide reduced apo-
Sod1 represents a physiologically important form as the metallated and oxidized forms are 
not transported into the mitochondria.(25) Therefore, only the most immature form of 
Sod1 is taken up into the IMS. A similar immature form of CCS may also be required by 
the Mia40/Erv1 system for mitochondrial uptake, for subsequent activation of SOD1 in the 
mitochondria. It is known that the Cys residues of D1 (Cys27 and Cys64) in Ccs1, that 
form an intramolecular disulfide, are involved in uptake to the mitochondria.(3,27,28) 
CCS does not contain the corresponding Cys residues in D1, however it does have a 
disulfide present in D2, which is absent in Ccs1, and this disulfide may play a role in 
mitochondrial uptake.(1,5) This would indicate that Zn-depleted WT-CCS may represent a 
physiologically relevant form of CCS that is taken up into the mitochondria as the 
disulfide in D2 of this form is likely to be reduced (two extra thiols present in Zn-depleted 
WT-CCS compared to as-isolated (Zn-bound) WT-CCS) in the cell cytosol.  
A model whereby Zn-binding to CCS modulates the interaction of the 
metallochaperone with the SOD1 target could be envisioned. Zn-binding to CCS would 
initially encourage the formation of the CCS: SOD1 heterodimeric complex, a complex 
generally regarded as an important intermediate for copper transfer to and oxidation of 
SOD1.(3) After metallation and disulfide reduction of SOD1 the tertiary structure of 
SOD1 is altered in such a way as to promote dissociation of the heterocomplex and 
formation the active and stabilised SOD1 homodimer and leaving CCS free to turnover 
more SOD1. The results in this chapter provide the first in vitro details for a role of the 
zinc binding site of D2 in human CCS. 
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Chapter 5 
Discussion and Future Work 
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5.1 Discussion 
Intracellular copper availability in eukaryotes is severely restricted due to the potential 
toxicity of the metal(1,2) and copper trafficking pathways have evolved to populate 
copper-requiring proteins.(3,4) These pathways contain soluble copper metallochaperones 
that bind and deliver copper to appropriate cellular targets.(3-8) Atx1 delivers copper to 
the copper-transporting ATPases of the Golgi for incorporation into secreted proteins, 
CCS delivers copper to the antioxidant enzyme Cu,Zn-superoxide dismutase (SOD1) 
while Cox17 is involved in the metallation of cytochrome c oxidase.(1,9-12) The binding 
of Cu(I) by Cys-based sites with exceptionally high affinity allow the metallochaperones 
to bind and retain the metal.(13-16) The predominantly digonal coordination of Cu(I) in 
these sites along with their surface exposed nature and specific protein-protein interactions 
ensure copper transfer by ligand exchange to target proteins.(13-23) Extensive study of the 
Atx1 metallochaperones has contributed significantly to our current understanding of 
copper trafficking.(7,8,24-28) In contrast, despite its biological importance, CCS has 
undergone relatively little study, especially concerning copper-binding and 
delivery.(7,11,29) Furthermore, CCS is unique among the metallochaperones in that it is 
involved in both the chaperoning and insertion of copper into the final target 
protein.(6,7,11) Knowledge of the molecular details of copper-binding by CCS are 
fundamental to an understanding of the mechanism of action of this metallochaperone and 
copper trafficking in eukaryotes. 
The Cu(I) affinities determined for CCS (human CCS) in Chapter 2 demonstrate 
that the CXXC motif of domain 1 (D1) and the CXC motif of domain 3 (D3) have high 
Cu(I) affinities. D1 binds Cu(I) ~10-fold tighter than D3 with an affinity similar to that for 
the structurally homologous metallochaperone HAH1 (human Atx1).(13,30) D1 of CCS 
must play a role similar to that of HAH1, participating in copper acquisition and transfer. 
Communication between copper-trafficking pathways has previously been suggested.(31) 
The observation of in vitro Cu(I) transfer between CCS D1 and HAH1 (Chapter 2) 
demonstrates that the two cytosolic copper-trafficking pathways could interact via the 
metallochaperones.(31) Although D3 is responsible for copper insertion into SOD1 its 
affinity for Cu(I) is lower than that of D1 and the copper site of SOD1(32) highlighting 
that Cu(I) affinities alone are insufficient to describe the mechanism of copper transfer. 
The structural flexibility of D3 and its ability to insert copper into the buried active site of 
SOD1 appear to be more important than its affinity for copper. 
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The Cu(I) affinities of numerous copper metallochaperones and their partner 
proteins are similar and the resulting thermodynamic gradients for copper transfer are not 
always favourable.(13,14,32,33) Other factors, such as the kinetics of copper transfer 
between partners, must be important for copper trafficking.(13,34) The results presented in 
Chapter 3 demonstrate that the pKa’s of the Cys residues of the CXXC and CXC motifs of 
CCS affect Cu(I)-binding. In particular, the pKa of the N-terminal Cys residue of the D1 
CXXC motif is lowered by ~ 1 unit by a thiolate-stabilising hydrogen-bonding interaction 
with Arg71 on loop 5 of the same domain. A similar interaction is present between the 
corresponding Cys residue of HAH1 and Lys60, which also results in a lowering of the 
pKa.(13) Such tuning of the pKa indicates altered nucleophilicity of the Cys ligands and in 
the case of HAH1 has been suggested to lower the activation energy for copper transfer 
from the metallochaperone to the metal-binding domains of the copper-transporting 
ATPases.(13) In CCS, the relative nucleophilicities of the Cu(I)-binding Cys residues of 
the CXXC and CXC motifs, inferred from their pKa’s, also suggests a lowering of the 
activation energy for copper-transfer from D1 to D3. Therefore D1, despite having the 
higher Cu(I) affinity, is kinetically optimised to transfer copper to D3, which ultimately 
inserts copper into SOD1. The ability to tune the reactivity of the copper-binding ligands 
would appear crucial for the function of CCS and further explains the selection of Cys 
rather than Met ligation in copper metallochaperones. 
Protein-protein interactions play a crucial role in ensuring the metallochaperones 
deliver copper to appropriate partner proteins.(20,21,22) Domain 2 (D2) of CCS is 
structurally similar to SOD1.(35) The formation of a heterodimer between CCS and 
SOD1, mediated via D2, is thought to optimally position the copper-binding domains of 
CCS for SOD1 activation.(36) D2 of CCS is unusual in that it maintains the zinc-binding 
site of SOD1.(35) In Chapter 4 the importance of zinc-binding to D2 and its effects on 
CCS oligomerisation and target binding has been investigated. The results demonstrate 
that CCS exists as a monomer in the absence of Zn(II) and that the binding of Zn(II) to D2 
stabilises the dimeric form of the protein. Furthermore, the binding of Zn(II) to CCS is 
required for the formation of a heterodimer with SOD1. It has been shown previously that 
mutations to the zinc-binding residues of D2 of CCS result in significantly attenuated 
activation of SOD1 in vivo.(37) Interestingly, these mutations result in a decrease in the 
amount of soluble CCS (37) indicating a role for Zn(II) in stabilising the protein within the 
cell. The binding of Zn(II) to the structurally similar SOD1 is known to drive the 
dimerization of SOD1 monomers and substantially increases the stability of the protein 
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fold.(38-40) The binding of Zn(II) to D2 of CCS would therefore appear crucial to the 
stability and function of the metallochaperone and likely maintains a tertiary structure that 
favours formation of a CCS homodimer and the CCS:SOD1 heterodimer. The biological 
significance of the CCS monomer is currently unresolved. 
 
5.2  Future Work 
There remain aspects of the CCS copper trafficking pathway that require further study, in 
particular, the mechanism of metal insertion into SOD1 is still poorly understood. It would 
be advantageous to determine the Cu(I) affinity of SOD1, using methods similar to those 
employed for Cu(I) affinity determinations of CCS D1 and D3, to enable reliable 
comparisons of the relative Cu(I) affinities of the two proteins. In addition, since SOD1 
contains four Cys residues, of which two are involved in a intramolecular disulfide in 
close proximity to the copper-binding site, it would be useful to compare the Cu(I) 
affinities for WT SOD1 and Cys to Ser variants in which the four Cys residues are 
systematically mutated to Ser.(41) This would allow for the assessment of the involvement 
of Cys residues within SOD1 that may play a role in the copper insertion mechanism 
facilitated by CCS. Furthermore, the determination of a crystal structure for CCS in 
complex with SOD1, analogous to the complex observed for the homologous proteins 
from S. cerevisiae, but in the presence of Cu(I) would provide significant structural details 
of the mechanism of SOD1 activation.(36) The preliminary data within this work shows 
CCS from S.cerevisiae (Ccs1) to bind comparable amounts of Cu(I) to CCS, however, the 
relative affinities of D1 and D3, for Ccs1, are yet to be determined. This is particularly 
important due to the differences between CCS and Ccs1, which include D1 of CCS being 
absolutely required for CCS function whereas for Ccs1 the same domain is only required 
under copper limiting conditions.(35,42) A comparison of the relative Cu(I) affinities of 
D1 and D3 of Ccs1 would provide important details required to explain the different 
dependencies of D1 for the CCS and Ccs1 metallochaperones.  
In order to verify the Cys residue pKa determinations for the D3 CXC in chapter 3, 
obtained from the pH dependence of the Cu(I) affinity, it is essential that an independent 
determination of the pKa’s is performed as obtained for the D1 CXXC motif. Since the 
protein construct for study of D3 also incorporates D1 and D2 (D1 CXXC Cys residues 
mutated to Ser) the protein contains other Cys residues (1 in D1 and 4 in D2) that may 
interfere with such a determination. Therefore, Cys to Ser mutants of the remaining Cys 
residues contained within D1 and D2 would be required. This would allow for the accurate 
160 
 
measurement of the pKa’s of the two D3 Cys residues for verification of those determined 
from the Cu(I) affinity data to ensure the determined pKa’s are those of the CXC motif. In 
addition, it would be revealing to determine the pH dependence of the Cu(I) affinities of 
other copper-binding proteins present within the cell cytosol. For example, the pH 
dependence of the Cu(I) affinity of BACE1 (section 2.3.5), a membrane bound protein 
involved in copper homeostasis and implicated in Alzheimer’s disease, is unknown.(43) 
An assessment of the pH dependence of the Cu(I) affinity of BACE1 would provide 
insight into both the directionality of copper transfer, under different conditions of pH 
within the cell, and also whether Cu(I)-binding Cys pKa tuning exists for CXXC motif 
containing species other than the Atx1 and CCS metallochaperones.  
The role of zinc-binding to CCS has received little attention despite the 
consequences its binding has for CCS oligomerisation and target protein complex 
formation. Further study is required to reveal the nature and significance of the binding of 
this particular metal for CCS metallochaperone function. This is especially important with 
regard to the role of Zn(II) in CCS: SOD1 heterodimer formation, formation of which is 
considered a crucial step for SOD1 activation by CCS.(36) Zinc-binding to SOD1 and 
CCS itself could represent an important regulatory element for the CCS trafficking 
pathway.(44) Study of this aspect of CCS metal-binding could therefore help identify 
species involved in the activation of CCS itself prior to its participation in the copper 
trafficking pathways of the cell. 
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6.1 Buffer Solutions 
All buffer solutions were prepared using Milli-Q grade water (Millipore “Simplicity” 
water purification system) with a rated resistivity of  ≥ 18M Ωcm.  
 
6.1.1 Tris(hydroxymethyl)aminomethane Buffer 
Tris(hydroxymethyl)aminoethane (Tris) (Sigma) buffer was used primarily in the pH 
range of 7.2-8.0. The pH was adjusted by addition of either HCl (BDH, AnalR) or NaOH 
(Sigma). This buffer was mainly used for the isolation, purification and storage of 
proteins.  
 
6.1.2 Sodium Acetate Buffer 
Sodium acetate (NaOAc) (BDH) buffer was used to buffer protein solutions in the pH 
range 4.0-5.5. The pH was adjusted by addition of either HCl or NaOH. This buffer was 
primarily used for protein Kb measurements at low pH and preparation of Zn-depleted 
WT-CCS. 
 
6.1.3 2-(N-morpholino)ethanesulphonic Acid Buffer 
2-(N-morpholino)ethanesulphonic (Mes) (Sigma) buffer was used to buffer solutions in 
the pH range 5.5-6.5. The pH was adjusted by addition of either HCl or NaOH. This buffer 
was used primarily for protein Kb measurements, Cu(I) partitioning/transfer experiments, 
and protein purification. 
 
6.1.4 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic Acid  Buffer 
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (Hepes) (VWR) was used to buffer 
solutions in the pH range 7.0-8.0. The pH was adjusted by addition of either HCl or 
NaOH. This buffer was used primarily for protein Kb measurements and Cu(I) transfer 
experiments. 
 
6.1.5 N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic Acid Buffer 
N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid (Taps) (Sigma) was used to 
buffer solutions in the pH range 8.0-9.0. The pH was adjusted by addition of either HCl or 
NaOH. This buffer was used for primarily for protein Kb measurements. 
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6.1.6 2-(Cyclohexylamino)ethanesulfonic Acid Buffer 
2-(Cyclohexylamino)ethanesulfonic acid (Ches) (Sigma) was used to buffer solutions in 
the pH range 9.0-10.0. The pH was adjusted by addition of either HCl or NaOH. This 
buffer was used for primarily for protein Kb measurements. 
 
6.1.7 3-(cyclohexylamino)-1-propanesulfonic Acid Buffer 
3-(cyclohexylamino)-1-propanesulfonic acid (Caps) (Sigma) was used to buffer solutions 
in the pH range 10.0-11.0. The pH was adjusted by addition of either HCl or NaOH. This 
buffer was used for primarily for protein Kb measurements. 
 
6.1.8 Phosphate Buffer 
Phosphate buffer was used to buffer solutions in the pH range 6.0 to 8.0. Buffers were 
prepared by mixing stock solutions of 1 M dibasic and monobasic potassium phosphate, 
K2HPO4 and KH2PO4, respectively (Fluka). Dibasic and monobasic phosphates were 
combined in the proportions shown in Table 6.1.1 for a particular pH. Fine tuning of pH 
was achieved by addition of either HCl or NaOH as required.  
 
Table 6.1.1  
Volumes of 1 M stocks of K2HPO4 and KH2PO4 required to prepare 1 L of 0.1 M 
potassium phosphate buffer solutions in the pH range 6.0-8.0.(1) 
K2HPO4 (ml) KH2PO4 (ml) pH 
13.2 86.8 6.0 
19.2 80.8 6.2 
27.8 72.2 6.4 
38.1 61.9 6.6 
49.7 50.3 6.8 
61.5 38.5 7.0 
71.7 28.3 7.2 
80.2 19.8 7.4 
86.6 13.4 7.6 
90.8 9.2 7.8 
94.0 6.0 8.0 
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6.2 Measurement of pH Values 
Measurement of pH values for buffer solutions were made using an Orion 420A pH meter 
connected to a Russell glass pH electrode (Thermo, type KCMAW11). The pH meter was 
calibrated prior to use with two standard buffer solutions of either pH 4.0 and 7.0 or 7.0 
and 10.0 (Sigma) depending on pH range measured.  
 
6.3 Ion-Exchange Chromatography 
Ion-exchange chromatography was used for purification of proteins and separation of 
proteins for Cu(I) partitioning/transfer experiments. Diethylaminoethyl (DEAE) sepharose 
(GE Healthcare) fast flow (FF) column material was used to prepare anion exchange 
columns for the purification of WT-CCS, C244S/C246S-CCS, C22S/C25S-CCS, D1-CCS, 
Arg71Ala D1-CCS and SOD1 proteins. Sulfopropyl (SP) sepharose (GE Healthcare) FF 
column material was used to prepare cation exchange columns for the purification of Ccs1. 
Resource Q (6 ml) columns (GE Healthcare) were used for purification of WT-CCS, 
C244S/C246S-CCS and C22S/C25S-CCS proteins. HiTrap Q (HP, 1 ml) columns (GE 
Healthcare) were used for separation of proteins for Cu(I) partitioning/transfer 
experiments.  
 
6.3.1 Equilibration of Ion-Exchange Column Material 
Ion-exchange column material (DEAE and SP sepharose FF) was washed with 2 L of 
buffer solution prior to use of column for protein purification. The pH of the eluate was 
checked to ensure equilibration of column. All columns were ran and stored at 4 
o
C. 
 
6.3.2 Loading and Elution of Protein on Ion-Exchange Column Material 
Proteins were loaded onto DEAE and SP sepharose FF columns in the same buffer as that 
of the column material. Elution of proteins was achieved by increasing the ionic strength 
of the buffer by providing a NaCl gradient between 0-500 mM NaCl by mixing two 
buffers with and without the salt. 
 
6.3.3 Regeneration of Ion-Exchange Column Material 
DEAE and SP sepharose FF column material was regenerated by washing with 500 ml of 
2 M NaCl (contact time ~ 30 mins) to remove bound proteins. The column material was 
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then washed with 1 L of distilled water followed by 500 ml of 1 M NaOH (contact time 
~30 mins). The material was then washed with distilled water until the pH was neutral. 
Column materials were stored in 20 % ethanol at 4
o
C. 
 
6.3.4 Ion-Exchange Chromatography using Resource Q Column  
Resource Q columns, attached to an AKTA Prime or Purifier (GE Healthcare), were 
equilibrated with 5 column volumes of buffer solution. Proteins were loaded in the same 
buffer as that of the column and eluted with a linear 0-300 mM NaCl gradient. The column 
was regenerated by passing 5 column volumes of 1 M NaCl through the column to remove 
any bound proteins. The column was then washed with 5 column volumes of milli-Q water 
followed by 5 column volumes of 0.5 M NaOH. The column was then washed with milli-
Q water until the eluate was neutral. Resource Q columns were stored in 20 % ethanol at 
4
o
C. 
 
6.3.5 Ion-Exchange Chromatography using HiTrap Q Column  
Equilibration and column regeneration were performed as for the Resource Q column in 
section 5.3.4. Protein elution was achieved by applying buffer solutions (by syringe) 
containing increasingly higher concentrations of NaCl within the range 0-400 mM for 
separation of proteins in an anaerobic chamber for Cu(I) partitioning and transfer 
experiments. 
 
6.4 Gel Filtration Chromatography 
Preparative gel filtration chromatography was used for the purification of proteins whilst 
analytical gel filtration chromatography was used to determine the oligomeric state of 
proteins. Masses of proteins, determined on preparative and analytical gel filtration 
chromatography columns, were deduced by comparison of elution volumes against a set of 
protein standards of known molecular weight (see section 6.4.1 and 6.4.2). Due to 
deviations of protein structures from perfect spheres the determined molecular weights are 
apparent molecular weights and as such errors due to the non-spherical nature of the 
proteins, in addition to those from measuring protein elution volumes, are present for all 
determinations shown in chapters 2, 3 and 4. Consequently, the method employed is 
suitable for determining protein oligomerisation state but unreliable for determining the 
absolute molecular mass. 
169 
 
6.4.1 Preparative Gel Filtration Chromatography 
A Supderdex 75 (16/60 HiLoad, GE Healthcare, 120 ml) column attached to an AKTA 
prime or purifier (GE Healthcare) was used for purification of proteins by gel filtration 
chromatography. A buffer of 20 mM Tris pH 7.5 containing 200 mM NaCl and 1 mM 
DTT was used as the column buffer. Injection volumes were typically ≤ 2 % of the column 
volume and eluted at a flow rate of 1 ml/min.  Elution of proteins was typically monitored 
at 280 nm and 240 nm (AKTA purifier) or 280 nm (AKTA prime). The column was 
calibrated using a low molecular weight calibration kit (GE Healthcare) containing: blue 
dextran (2000 kDa), conalbumin (75 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 
kDa), ribonuclease A (13.7 kDa) and aprotinin (6.5 kDa). 
 
6.4.2 Analytical Gel Filtration Chromatography 
Analytical gel filtration chromatography of apo and metal-bound protein samples was 
performed using a Superdex 75 column (10/300 GL GE Healthcare, 24 ml). A buffer of 20 
mM Mes pH 6.5 or 20 mM Hepes pH 7.5 containing 200 mM NaCl (with or without 1 
mM DTT) was used as column buffer.  Buffers were purged prior to and during 
experiments with N2 from an oxygen-free cylinder. Injection volumes were typically ≤ 2 % 
of the column volume and proteins eluted at a flow rate of 0.8 ml/min. Elution of proteins 
was typically monitored at 240 or 280 nm. The column was calibrated using a LMW 
calibration kit (GE Healthcare) as described in section 6.4.1. 
 
6.5 Ultrafiltration 
6.5.1 Centrifugal Ultrafiltration 
Amicon ultra 4 (10 kDa MWCO (molecular weight cut-off), Millipore) and Vivaspin 500 
(5 kDa MWCO, Sartorius) centrifugal concentrators were used to concentrate protein 
solutions and remove adventitiously bound metals through buffer exchange. Exchanging 
buffer involved concentrating the protein solution and then diluting the sample 10-fold in 
the concentrator and repeating this process 3 times. A fixed angle rotor operating at ~ 16 k 
x g was used to centrifuge samples. 
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6.5.2 Amicon Stirred Cell Ultrafiltration 
An Amicon stirred cell (10 or 200 ml cell, Amicon) fitted with an appropriate regenerated 
cellulose membrane (3-30 kDa MWCO, Millipore) was used to perform buffer exchanges 
during the purification of proteins. A pressure of approximately 3-4 bar supplied from an 
N2 oxygen-free cylinder was applied during operation of the stirred cell. 
 
6.6 Dialysis 
6.6.1 Preparation of Dialysis Tubing 
Dialysis tubing (14 kDa MWCO, Sigma) was prepared by soaking the tubing for 1 hour in 
an aqueous solution of 1 % acetic acid followed by exchange into distilled water and 
stirring for several minutes. The tubing was then placed into a solution of 1mM 
ethylenediaminetetraacetic acid (EDTA) and 1 % sodium carbonate and stirred for a 
further ~3 minutes. The solution was then refreshed and the dialysis tubing heated to ~60 
o
C and then allowed to cool to room temperature over a period of 30 minutes. The above 
heating process was repeated once more and dialysis tubing exchanged into Milli-Q water 
and heated again to 60 
o
C and allowed to cool before storing in fresh Milli-Q water (at 
4
o
C).(2) 
 
6.6.2 Dialysis of Protein Solutions 
Dialysis was used for buffer exchange during the preparation of Zn-depleted WT-CCS. 
Dialysis tubing was washed thoroughly prior to use in buffer to be used during dialysis. 
Protein solutions were sealed in tubing and dialysed against buffer solution at 4
o
C for 3-4 
hours, and also o/n, with stirring. The buffer solution (50-100 × sample volume) was 
typically changed 3 times.  
 
6.7 Electrophoresis 
6.7.1 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
A 12.5 % or 15 % acrylamide/bis-acrylamide (BioRAD) running gel containing 375 mM 
Tris pH 8.8, 0.1 % SDS, 0.1 % ammonium persulfate (APS, Aldrich) and 0.05 % 
N,N,N’,N’-tetramethylene diamine (TEMED, Aldrich) was prepared in deionised water 
and allowed to set for 30 mins. The stacking gel, 5 % acrylamide/bis-acrylamide 
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containing 100 mM Tris pH 6.8, 0.1 % SDS, and 0.1 % APS and 0.1 % TEMED in 
deionised water, was poured directly on top of the running gel. A comb containing 10 
ridges was inserted into the stacking gel to produce wells for sample loading. The stacking 
gel was allowed to set for 45 mins. Protein samples for electrophoresis were prepared in 
cracking buffer [50 mM Tris pH 6.8, 1 % SDS (Aldrich), 15 % glycerol (Sigma), 2 % -
mercaptoethanol (Aldrich) and 0.025 % bromophenol blue (BDH) in water. Protein 
samples in cracking buffer were heated at 95
o
C for 5 mins. Typically 10 L of this protein 
in cracking buffer was loaded into the wells of the gel. Broad range molecular weight 
marker (BioRAD) was loaded onto most gels as a reference. The SDS-PAGE buffer was 5 
mM Tris pH 8.8 containing 200 mM glycine (Sigma) and 0.1 % SDS. All electrophoresis 
experiments were performed using a Mini-Protean II Cell from BioRAD with a constant 
voltage of 150-200 V and current of ~60 mA per gel applied from a powerpack. Gel 
staining was achieved by incubating the running gel in a solution of Instant Blue 
(Expedian) and the gel was subsequently destained in distilled water. 
 
6.7.2 Agarose Gel Electrophoresis 
Agarose (0.8-1.5 %) (Melford) in electrophoresis buffer, Tris-acetate-EDTA (TAE; 40 
mM Tris, 40 mM acetate and 1mM EDTA pH 8.0) was heated in a microwave oven until 
all of the agarose dissolved. This molten agarose solution was then cooled (~ 50-55 °C) 
and poured into a tray with a comb with 8 or 15 fingers. After ~ 60 min the set agarose 
was transferred to an electrophoresis tank and covered with TAE buffer. DNA samples 
were was mixed with 5× loading buffer (20 % Ficoll 400, 0.1 M EDTA, 1 % SDS and 
0.25 % bromophenol blue) and applied to a well in the agarose gel. A voltage of 100 V 
was applied and electrophoresis was carried out until the bromophenol blue approached 
the edge of the agarose gel. The Agarose gel was then stained by incubation in a solution 
of ethidium bromide (10 g/mL in TAE buffer) for ~ 20 mins. Excess ethidium bromide in 
the gel was removed by incubating the gel in the same buffer minus ethidium bromide for 
~ 10 min. DNA in agarose gels was detected using an ultraviolet trans-illuminator (UV 
Tec). When DNA fragments in the agarose gel were required they were excised using a 
scalpel and purified from the agarose gel using the GeneElute Miniprep Kit (Sigma). 
 
6.8 DNA Cloning and Mutagenesis 
The pGEMT_WT-CCS and pGEMT-WT-CCS construct was received from Prof. Colin 
Dingwall, Kings College London, UK. The pCLneo_SOD1 construct was received from 
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Prof. Christopher Miller, Kings College London, UK. pJG4.5_Ccs1 was received from Dr 
Katie Freeman, Comparative Genomics, GlaxoSmithKline, Pennsylvania 19426, USA. All 
of the constructs used and prepared in this project are listed in Table 6.8.1.   
Table 6.8.1  
Plasmid constructs used in this project 
plasmid containing protein  source 
pGEMT_WT-CCS WT-CCS Colin Dingwall 
pGEMT_C22S/C25S-CCS C22S/C25S-CCS this project 
pGEMT_C244S/C246S-CCS C244S/C245S-CCS this project 
pGEMT_D1-CCS D1-CCS this project 
pCLneo_SOD1 SOD1 Christopher Miller 
pJG4.5_Ccs1 Ccs1 Katie Freeman 
pGEMT_SOD1 SOD1 this project 
pGEMT_Ccs1 Ccs1 this project 
pET29a_WT-CCS WT-CCS this project 
pET29a_C22S/C25S-CCS C22S/C25S-CCS this project 
pET29a_C244S/C246S-CCS C244S/C245S-CCS this project 
pET29a_D1-CCS D1-CCS this project 
pET29a_Ccs1 Ccs1 this project 
pET29a_SOD1 SOD1 this project 
 
6.8.1 Isolation of Plasmid DNA from E. coli 
Plasmid DNA was isolated and purified from E. coli using the GenElute Plasmid Miniprep 
Kit (Sigma). E. coli containing the plasmid were grown in 10 mL fresh Luria broth (LB; 
10 g/L tryptone, 5 g/L yeast extract and 10 g/L NaCl) with 100 µg/mL ampicillin or 100 
µg/mL kanamycin, o/n at 37 °C and 250 rpm after 100-fold dilution of pre-culture (a 10 
mL culture of LB containing 100 µg/mL ampicillin or 100 µg/mL kanamycin,  inoculated 
with a single colony of the fresh transformant and grown for ~ 8 h at 37 °C and 250 rpm). 
A 5 mL volume of the o/n culture was used to purify plasmid DNA. The purity of plasmid 
DNA was judged by measuring the UV spectrum and using the relative absorbance’s at 
260 and 280 nm, where an A260/A280 ratio of 1.5-1.8 usually indicated a suitably pure DNA 
sample with little RNA contamination.  
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6.8.2 Determination of Plasmid DNA Concentration 
The concentration of plasmid DNA was determined by measuring the absorbance of a 
sample at 260 nm and using the relationship that 1 OD260 unit is equal to 50 g/mL of 
double stranded DNA. The concentration of primers purchased from MWG/Sigma was 
based on the DNA synthesis report provided by the companies. 
 
6.8.3 Plasmid DNA Digestion 
The digestion of plasmid DNA (from Section 6.8.1) was carried out using restriction 
enzymes (EcoR1, BamH1 and Nde1, New England Biolabs) according to the 
manufacturer’s instructions to provide restriction sites for ligation reactions. Typically 
~1000-3000 ng of plasmid DNA to be digested in a 40 L solution containing the required 
restriction enzymes was incubated at 37 
o
C for 2 hours followed by heating at 80 
o
C to 
inactivate the restriction enzymes. Smaller amounts of DNA (~ 100s of ng plasmid DNA) 
were used when only confirmation of fragment sizes was required. Digested plasmid was 
then used directly in ligation reactions or loaded onto an agarose gel for DNA size 
determination and excision where required. 
 
6.8.4 Ligation Reactions of Plasmid and Insert DNA 
Ligation of digested plasmid DNA (pGEMT, Promega or pET29a, Novogen (lab stocks)) 
and insert DNA was achieved using the T4 DNA ligase kit (Promega) according to the 
manufacturer’s instructions. Required amounts of plasmid and insert DNA in 10-60 L of 
T4 DNA ligase buffer with the appropriate amount of T4 DNA ligase were typically 
incubated at 4 °C o/n for ligation reaction. The ligation reaction sample was then 
transformed into fresh E. coli (JM101) TSS competent cells. 
 
6.8.5  Gene Amplification 
Polymerase chain reaction (PCR) was used to amplify the gene sequence for SOD1 and 
Ccs1 from pClneo_SOD1 and pJG4.5_Ccs1 to incorporate Nde1/EcorR1 and 
Nde1/BamH1 restriction sites, respectively, for ligation into pET29a vector. The PCR 
reaction contained 2 ng of template plasmid DNA, 0.4 mM deoxyribonucleotide 
triphosphates (dNTPs) mix (Promega), 125 ng of each primer (forward and reverse), 1 unit 
of Pfu polymerase (Stratagene, UK) and 1 L of 10x Pfu buffer made up to 10 L volume 
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by addition of H2O. The PCR conditions were as for manufacturer’s instructions for Pfu 
polymerase. 
 
6.8.6 Site-directed Mutagenesis 
Mutations in plasmid DNA for were carried out using the Quickchange site-directed 
mutagenesis kit (Stratagene). Typically, reactions (10-60 L) contained 5-20 ng of 
template plasmid DNA, 125 ng of each primer (forward and reverse), 0.5 mM dNTPs mix, 
1-5 units of Pfu polymerase (as appropriate for reaction volume) and Pfu buffer made up 
to volume with H2O. The reaction conditions were as for the specified Quikchange 
manufacturers protocol and performed in a PCR machine. Te restriction enzyme Dpn1 was 
added to reaction mixtures after PCR to digest template plasmid DNA. The reaction 
mixture was then transformed into E. coli (XL1 Blue) for growing and subsequent 
extraction of plasmid for sequencing to confirm mutation of the template DNA sequence.  
 
6.8.7 DNA Sequencing 
DNA sequencing was used to verify mutated and amplified genes in plasmid DNA. Size 
and purity of DNA was typically assessed by agarose gel electrophoresis and measurement 
of absorbance of samples at 260 and 280 nm. DNA sequence analysis was then 
commissioned to Lark Technology. 
 
6.9 Growing of E. coli  
6.9.1 Preparation of Competent E. coli Cells  
LB (10 ml of 10 g/L of NaCl and Tryptone (Melford) and 5g/L Yeast extract (Melford)) 
was inoculated with a single colony of E. coli and incubated overnight at 37
o
C with 
shaking (250rpm). The o/n culture was then diluted 100-fold into fresh LB (10ml) and 
grown for a further 2 hours under the same conditions. Cells were then spun down at 
~1500 × g for 10 mins and the cell pellet resuspended in ice cold TSS (1ml of a solution 
of 85% LB, 10% PEG, 5% DMSO and 50mM MgCl).(3) 
 
6.9.2 Transformation of E.coli  
To 100 μL of competent cells 1-3 μL of plasmid DNA was added and incubated on ice 
for 20 minutes before heat shocking at 42
o
C for ~1 min. The solution was incubated on 
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ice for a further 2 mins before adding 900 μL of LB and incubating at 37oC with shaking 
(250rpm) for 1 hour. After incubation dilutions were made and plated onto freshly 
prepared LB/Agar plates (LB with 1.8 % w/w agar and appropriate antibiotics 
(100μg/mL ampicillin or 50μg/mL kanamycin as required)). Plates were incubated o/n at 
37 
o
C. (3) 
 
6.9.3 Expression Studies; Total Cell Protein 
In order to determine the growing period for optimal protein expression (as judged by 
SDS-PAGE) small-scale trials were carried out with the pET29a expression plasmid, 
containing the required protein gene insert, transformed into E.coli strain BL21 (DE3).  
LB (10 ml containing 100 μg/mL kanamycin plus 100 mM Zn(II) for WT-CCS 
C244S/C246S-CCS, C22S/C25S-CCS and SOD1) was inoculated with a single colony 
containing the expression plasmid and grown o/n at 37 
o
C with shaking (250 rpm). The 
next day a 100-fold dilution of each culture into LB (50 ml containing 100 μg/mL 
kanamycin plus 100 mM Zn(II) for WT-CCS C244S/C246S-CCS. C22S/C25S-CCS and 
SOD1) was made and incubated for 2 hours at 37 
o
C with shaking (i.e. until the OD600 
had reached ~0.6-0.8). Isopropyl β-D-1-thiogalactopyranoside (IPTG) was then added to 
an effective concentration of 1 mM. Samples (5 ml) of the cultures were taken at times 
of 0, 2, 4, 6 hours and over night after induction with IPTG. The samples were spun 
down at 13.2 k rpm in a desktop centrifuge for ~ 5 mins, the supernatant removed and 
the cell pellet resuspended in SDS-PAGE loading buffer volumes of 100, 150, 300, 500 
and 500 μl, respectively, and frozen at –20oC. Samples were loaded onto SDS-PAGE 
gels for analysis of total protein expression.  
 
6.9.4 Expression Studies; Detection of Soluble Cell Protein 
To determine the growing period that resulted in the largest yield of soluble protein when 
using pET29a as an expression vector the amount of soluble expressed protein was also 
assessed in E.coli strain BL21 (DE3). LB (10 ml containing 100 μg/mL kanamycin plus 
100 mM Zn(II) for WT-CCS C244S/C246S-CCS. C22S/C25S-CCS and SOD1) were 
inoculated with a single colony of BL21 (DE3) containing the expression vector and 
grown o/n at 37 
o
C with shaking (250 rpm). The next day a 100-fold dilution of o/n culture 
into LB (50 ml containing 100 μg/mL kanamycin plus 100 mM Zn(II) for WT-CCS 
C244S/C246S-CCS. C22S/C25S-CCS and SOD1) was made and incubated for 2 hours at 
37 
o
C with shaking (i.e. until OD600 had reached ~0.6-0.8). IPTG was then added to an 
176 
 
effective concentration of 1 mM. Samples (5 ml) of the cultures were taken at times of 0, 
2, 4, 6 hours and o/n after induction with IPTG. Samples from cultures were sonicated and 
100μl was removed for total protein content. The remaining solution was pelleted at ~ 16 k 
x g in a desktop centrifuge for ~ 5 minutes and 100μl of the supernatant removed for 
soluble protein content. 20μl of 5x SDS-PAGE loading buffer was added to both the total 
and soluble protein samples which were frozen at -20 
o
C. Samples were then analysed by 
SDS-PAGE to judge an optimal cell harvesting time after protein induction.  
 
6.10 Expression and Purification of Proteins from E. coli BL21 
6.10.1 Expression and Purification of WT-CCS and the Cys to Ser Mutants 
A modified protocol was used for the purification of WT-CCS and the Cys to Ser 
variants was used.(4) E. coli BL21 (DE3) transformed with either pET29a_WT-CCS, 
pET29a_C22S/C25S-CCS or pET29a_C244S/C246S-CCS was grown in LB containing 
antibiotics and 100 M Zn(II) at 37 oC until an OD600 of 0.6-0.8 was reached (~ 2 
hours). Protein expression was induced by the addition of 1 mM IPTG and cells were 
incubated for a further 6 hours before harvesting, with pellets stored at -20 
o
C. Cells 
were resuspended in 20 mM Tris pH 7.5 containing 4 mM EDTA and 4 mM 
dithiothreitol (DTT), sonicated and centrifuged at 35000 g for 20 min. The supernatant 
was diluted 4-fold with Milli-Q water prior to loading onto a DEAE Sepharose FF 
column (~40 mL, GE Healthcare) and eluted with a linear NaCl gradient (0-300 mM) in 
5 mM Tris pH 7.5 containing 1 mM EDTA and 1 mM DTT. Fractions containing CCS 
[identified by SDS-PAGE] were combined and exchanged via ultrafiltration [Amicon 
stirred cell with a 30 kDa MWCO membrane] into 5 mM Tris pH 7.5 containing 1 mM 
DTT. The final purification step used a Resource Q column (6 mL, GE Healthcare) with 
a 0-300 mM NaCl gradient, and fractions containing pure protein (≥ 90% pure as judged 
by SDS-PAGE) were combined. 
 
6.10.2 Expression and Purification of D1-CCS 
D1-CCS was expressed and purified as for the full length protein except that the final 
purification step involved a Superdex 75 column (16/60 GE Healthcare) in 20 mM Tris 
pH 7.5 containing 200 mM NaCl and 1 mM DTT. D1-CCS eluted from this column as a 
single peak and the fractions containing pure protein (≥ 90% pure as judged by SDS-
PAGE) were combined. 
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6.10.3 Expression and Purification of Ccs1 
Expression of Ccs1 was achieved as for CCS, and purification used a modified version 
of a reported procedure.(5) Thawed cell pellets were re-suspended in 80 mM Mes pH 6.0 
containing 4 mM EDTA and 4 mM DTT, sonicated and centrifuged at 35000 g for 20 
min, and the supernatant diluted 4-fold prior to loading onto a SP Sepharose FF column 
(~40 mL, GE Healthcare). The protein was eluted with a linear NaCl gradient (0-500 
mM) in 20 mM Mes pH 6.0 containing 1 mM EDTA and 1 mM DTT. Fractions 
containing Ccs1 (identified by SDS-PAGE) were combined and exchanged using 
ultrafiltration (Amicon stirred cell with a 10 kDa MWCO membrane) into 20 mM Tris 
pH 7.5 plus 200 mM NaCl and 1 mM DTT. The final purification step involved a 
Superdex 200 column (16/60 GE Healthcare) in 20 mM Tris pH 7.5 plus 200 mM NaCl 
and 1 mM DTT. Ccs1 eluted from this column as a single peak and the fractions 
containing pure protein (≥ 90% pure as judged by SDS-PAGE) were combined. 
 
6.10.4 Expression and Purification of SOD1 
SOD1 was expressed and purified as for WT-CCS with modifications to the final stage 
of the purification procedure. E. coli BL21 (DE3) transformed with either 
pET29a_SOD1 was grown in LB containing antibiotics and 100 M Zn(II) at 37 oC until 
an OD600 of 0.6-0.8 was reached (~ 2 hours). Protein expression was induced by the 
addition of 1 mM IPTG and cells were incubated for a further 6 hours before harvesting, 
with pellets stored at -20 
o
C. Cells were resuspended in 20 mM Tris pH 7.5 containing 4 
mM EDTA and 4 mM DTT, sonicated and centrifuged at 35000 g for 20 min. The 
supernatant was diluted 4-fold with Milli-Q water prior to loading onto a DEAE 
Sepharose FF column (~40 mL, GE Healthcare) and eluted with a linear NaCl gradient 
(0-300 mM) in 5 mM Tris pH 7.5 containing 1 mM EDTA and 1 mM DTT. Fractions 
containing CCS [identified by SDS-PAGE] were combined and exchanged via 
ultrafiltration [Amicon stirred cell with a 10 kDa MWCO membrane] into 5 mM Tris pH 
7.5 containing 1 mM DTT. The final purification step involved a Superdex 75 column 
(16/60 GE Healthcare) in 20 mM Tris pH 7.5 plus 200 mM NaCl and 1 mM DTT. SOD1 
eluted from this column as a single peak and the fractions containing pure protein (≥ 
90% pure as judged by SDS-PAGE) were combined. 
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6.11 Determination of the Molecular Weight of Proteins 
The molecular weight (MW) of proteins was determined with either an Applied 
Biosystems Voyager-DE STR matrix assisted laser desorption ionisation time-of-flight 
(MALDI-TOF) or a Thermo LTQ fourier transform ion cyclotron resonance (FT-ICR) 
mass spectrometer (MS) system by Dr J. Gray (Pinnacle, Newcastle University, UK).  
 
6.12  UV/Vis Spectroscopy 
All UV/Vis spectra were acquired on a Perkin-Elmer λ35 spectrophotometer. 
Measurements were mainly made using 10 mm path length quartz cuvette (anaerobic 
cuvettes were used when anaerobic conditions required). 
 
6.13 CD Spectroscopy 
Far-UV circular dichroism (CD) spectra (185-250 nm) of proteins were obtained on a 
Jasco J-810 spectrometer using a 0.2 mm path length quartz cuvette. The cuvette 
compartment was maintained at a temperature of 20 
o
C during all measurements and 5 
scans were accumulated per for both blank and protein sample spectra. 
 
6.14 Atomic Absorption Spectroscopy 
Atomic absorption spectroscopy (AAS) was performed on a Thermo Electran M Series 
AA Spectrometer to determine the copper and zinc content of purified proteins and to 
verify copper and zinc concentrations in solutions of the metals. All samples were 
measured against a set of calibration standards of 0.2-1.0 ppm copper and zinc (Fluka) 
 
6.15 Protein Thiol Quantification  
Thiol quantification using 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB, Ellman’s reagent) 
was routinely used for the assessment of the number of thiols in all proteins. The 
extinction coefficient ( value) of the thio(2-nitrobenzoate) (TNB2-) product of the 
reaction of DTNB with thiols (14150 M
-1
cm
-1
 at 412 nm (6)) was verified using a 
solution of cysteamine of known concentration. Thiol quantification was typically 
carried out anaerobically in 100 mM potassium phosphate plus 1 mM EDTA at pH 8.0 
containing 500 M DTNB. 
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6.16 Spectrophotometric Determination of Cu(I) Binding to Proteins 
All experiments were performed under anaerobic conditions in an anaerobic chamber 
(Belle Technology, O2 << 2 parts per million). Septum sealed gas-tight quartz cuvettes 
(Hellma) were used to allow for measurements of samples outside the chamber and all 
titrations were performed using a gas tight syringe (Hamilton). 
 
6.16.1 Preparation of Cu(I) Stock Solutions and Cu(I)-Proteins.  
Cu(I)-proteins were made by the addition of the desired amount of Cu(I) from a 1 mM 
Cu(I) stock prepared from a 50-fold dilution of 50 mM [Cu(CH3CN)4]PF6 (Sigma) in 
100% acetonitrile into the appropriate buffer. Copper concentrations were determined 
using either bathocuproine disulfonic acid (BCS) or bicinchoninic acid (BCA) (Both 
supplied by Sigma), and occasionally by AAS. For measurements using BCS and BCA, 
483 and 562 values of 12500 and 7700 M
-1
cm
-1
, respectively, for [Cu(BCS)2]
3-
 and 
[Cu(BCA)2]
3-
 were used. These were determined by titrating a [Cu(CH3CN)4]PF6 
solution (standardized with AAS) into BCS or BCA (40 M) in 20 mM Mes pH 6.5 
containing 200 mM NaCl and measuring the increase in absorbance at 483 and 562 nm 
to determine the molar extinction coefficients for BCS and BCA, respectively.(7-9)  
 
6.16.2 Cu(I) Binding Stoichiometries  
High affinity Cu(I) binding stoichiometries were determined by measuring the 
competition between proteins and BCA for Cu(I). Titrations of Cu(I) into protein 
samples (10 M) in the presence of 30-500 M BCA were performed with measurement 
of the increase in absorbance at 562 nm due to the formation of [Cu(BCA)2]
3-
. Titrations 
were performed in 20 mM Mes pH 6.5 or 20 mM Hepes pH 7.5 containing 200 mM 
NaCl.  
 
6.16.3 Cu(I) Affinity Determinations 
Cu(I) affinities (Kb values) were determined by competition assays with BCS and BCA 
using an approach described previously.(7,8,10,11) Titrations were performed by adding 
either BCS or BCA (25 to 100 mM) into a solution of Cu(I)-protein (5-20 M) 
containing an excess of apo-protein [5-20 M, with ≤ 0.5 equivalents of Cu(I) in all 
cases]. Apo-protein (300-800 M) was also titrated into a solution of [Cu(BCS)2]
3-
 or 
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[Cu(BCA)2]
3-
 (10-15 M) with an excess of BCS or BCA (10 M to ~10 mM). After 
each addition of BCS/BCA or protein the absorbance at 483 or 562 nm was measured, 
for determination of the concentrations of [Cu(BCS)2]
3-
 or [Cu(BCA)2]
3-
 respectively, 
after equilibration (typically 10-30 mins).  
All titration data were fit using Origin 7 to a 1:1 Cu(I):protein binding model 
using equations (5.1) and (5.2) below.(7) 
 
 L      CuL    
 b  P - Cu   CuL    CuL  
( Cu - CuL  ) 
    (5.1) 
  
 P    
  Cu - CuL2  ( L -2 CuL2 )
2
 
   CuL2 
   Cu -  CuL2    (5.2) 
 
In equations (5.1) and (5.2), [L] is the total concentration of BCS or BCA, [CuL2] is 
concentration of [Cu(BCS)2]
3-
 or [Cu(BCS)2]
3-
, [P] is the total protein concentration, 
[Cu] is total Cu(I) concentration, Kb is the proteins Cu(I) affinity constant and β is the 
overall affinity constant for formation of [Cu(BCS)2]
3-
 or [Cu(BCA)2]
3-
. [Cu(BCS)2]
3-
 
has an overall stability constant ( value) of 6.3 × 1019 M-2 (at pH ≥ 8.0),(12) and 
alterations in the  value with pH were calculated assuming a pKa of 5.7(12) according 
to equation (5.3).(7)  
 
    
 max
    
    
  
 
         (5.3) 
 
In which β is the overall affinity constant for [Cu(BCS)2]
3- 
for a specified pH, βmax is the 
maximal overall stability constant of [Cu(BCS)2]
3- 
, Ka is the acid dissociation constant 
of BCS and [H
+
] is the proton concentration. A β value for [Cu(BCA)2]
3-
 of (5.4 ± 2.7) × 
10
16
 M
-2
 has been determined (section 2.3.5) at pH 6.5 [no significant difference was 
found at pH 7.5 and therefore the same  value has been used at these pH values].   
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Appendix A 
Figure 1  
Apo-subtracted difference spectra for WT-CCS (43 M) (A), C244S/C246S-CCS (24 M) 
(B) and C22S/C25S-CCS (24 M) (C), in 20mM Tris pH 7.3 containing 200mM NaCl 
titrated with ~ 0.5 and 1.0 (~0,5, 1.0, 1.5 and 2.0 for WT-CCS) equivalents of Cu(I). 
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Figure 2  
Plot of ε240nm as a function of pH for Arg71Ala apo-D1-CCS. The line shows a fit of the 
data to equation (3.3) (no variables constrained) giving pKa‘s of 7.  (± 0.1) 9.0 (± 0.1) 
and 10.6 (±0.1)  and Δε values of 3.9 (± 0.1) 7.8 (±0.2) and 12.9 (± 0.1) mM cm-1. 
 
*Data acquired by Dr Adriana Badarau 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
184 
 
Figure 3  
Apo-subtracted difference spectra for Zn-depleted WT-CCS (10M) in 20 mM Hepes pH 
7.5 containing 200 mM NaCl titrated with ~0.4, 0.8, 1.2, 1.6, 2.0, 2.4, 2.8 and 3.2 
equivalents of Cu(I). 
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Figure 4 
CCS activation of SOD1 assayed by xanthine oxidase WST-1 reduction inhibition. Assay 
of SOD1 activity for reaction mixtures containing Cu(I)-bound CCS (5 M) and excess 
apo-CCS (5 M) with E,Zn-SOD1 (10 M) in 20 mM Hepes pH 7.5 containing 200 mM 
NaCl and 50 M BCS. Traces for Zn-depleted WT-CCS (magenta), as-isolated WT-CCS 
(red), C22S/C25S-CCS (green), C244S/C246S-CCS (blue), D1-CCS (cyan) and E,Z -
SOD1 in absence of CCS (black) are shown as a function of time with absorbance 
measured at 450 nm in a 2 mm path-length cuvette. 
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Appendix B 
Derivation of equations for Cys pKa determinations and copper-binding affinities 
Derivation 1 
Equation for determining pKa of Cys residues from the pH dependence of the copper- 
binding affinity. 
 
The binding of copper (Cu) to a protein (P) giving copper-bound protein (CuP) can be 
expressed as: 
 
Cu  + P    CuP        (1) 
 
With the equilibrium constant (Kb) expressed as: 
 
     
 CuP 
 Cu   P 
        (2) 
 
Since protons H also compete for the copper-binding thiolate of the Cys residues a 
competing reaction shown below occurs:  
 
 H
+
 
 
 + P
  
   HP        (3) 
 
With the equilibrium constant (Ka) expressed as  
 
     
    
        
        (4) 
 
Therefore the amount of protein available (Pf), from the total amount of protein present 
(PT) where [PT] = [CuP]+[P]+[HP], to bind copper under a particular pH is dependent on 
the fraction of ionised thiol residues (α): 
 
                    (5) 
 
Which can be expressed as: 
 
      
    
   
    
  
        (6) 
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The Kb at each pH calculated as: 
 
    
 CuP 
                
       (7) 
 
 
Therefore the pH dependence of the apparent copper-binding affinity, for a single pKa 
dependence can be represented as: 
 
    
     
           
    
  
 
       (8) 
 
or 
 
    
 bmax
1   
 H  
 a
         (9) 
 
where Kbmax is the maximal Cu(I)-binding affinity at full ionisation. 
 
For a two proton dependant model, a two pKa dependence (Ka and Ka2) of the Cu(I)-
binding affinity, the proportion dissociation can be expressed as: 
 
 Pf   
 PT 
1   
 H  
 a
   
 H  
2
 a a2
 
       (10) 
 
And therefore the pH dependence of the Cu(I)-binding affinity is: 
 
    
 bmax
1   
 H  
 a
   
 H  
2
 a a2
 
       (11) 
 
Derivation 2 
Equation for determining pKa of Cys residues from the pH dependence of the extinction 
coefficient at 240 nm (ε240nm) 
 
The equation for the binding of a proton (H
+
) to a thiolate (S
-
) to give a thiol (SH) is: 
 
H
+
 + S
-
    HS        (12) 
 
Therefore, the equilibrium constant for this reaction (Ka) is: 
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 HS 
 H    S  
        (13) 
 
Since the proportion of thiol can be represented as ϴ the proportion of thiolate is (1-ϴ) 
and so the equation can be represented as: 
 
     
 
 1-    H  
        (14) 
 
 
Rearranging the above to represent ϴ as a function of [H+] gives: 
 
    
   H
  
1      H
  
        (15) 
 
The overall extinction coefficient at 240nm (εapp), which depends on the proportion of 
thiol and thiolate, will be as follows: 
 
                                  (16) 
 
where ε1 represents the change in extinction coefficient between the thiolate and the thiol 
and ε0 represents the extinction coefficient of the thiolate. 
 
Hence the expression for the change in overall extinction coefficient at 240 nm can be 
expressed as: 
 
 app   
   H
  
  
    
   
 H  
  
        (17) 
 
For a system where three thiol Ka’s are considered the following expression is used: 
 
 app   
   H
   
         
 
   H
   
      
 
   H
  
   
   
   
 H  
   
  
 H   
      
  
 H   
         
     (18) 
 
Where Ka1, Ka2 and Ka3 correspond to the three thiol Ka’s and ε1, ε2 and ε3 correspond to 
extinction coefficients for each protonated thiol species. 
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Derivation 3 
Equation for determining the Cu(I)-binding affinities of proteins using the Cu(I) 
chelators BCA and BCS.  
 
The binding of Cu(I) (Cu) to a protein (P) giving Cu(I)Protein (CuP) can be expressed 
as: 
 
Cu(I) + P    Cu(I)P       (19) 
 
With the equilibrium constant (Kb) expressed as: 
 
     
 CuP 
 Cu   P 
        (20) 
 
Likewise the binding of Cu(I) to a Cu(I) ligand (L) which binds Cu(I) as a Cu(I)L2 
complex can be expressed as: 
 
   
 CuL  
 Cu  L  
         (21) 
 
Where β is the overall equilibrium constant for formation of CuL2. 
 
Since the total amount of protein (Pt) is: 
 
                        (22) 
 
And the total amount of L (Lt) is: 
 
                         (23) 
 
And under the assumption no mixed P-Cu-L heterocomplexes form and that the amount 
of free Cu (Cuf) is negligible: 
 
                           (24) 
 
The equilibrium constant, Kb, can be expressed as: 
190 
 
 
    
  Cu - CuL2  ( L -2 CuL2 )
2
 
  P - Cu   CuL2   CuL2)
      (25) 
 
Which can be expressed as: 
 
 L 2- 4 L  CuL2   4 CuL2 
2- 
 b  P - Cu   CuL2   CuL2 
( Cu -  CuL2 )β
     (26) 
 
 
The solution to the equation being: 
 
 L  2 CuL2   
 b  P - Cu   CuL2   CuL2 
( Cu - CuL2 ) 
     (27) 
 
In addition the equation can also be expressed as: 
 
 P  
  Cu - CuL2  ( L -2 CuL2 )
2
 
   CuL2 
   Cu -  CuL2     (28) 
 
 
 
 
 
 
 
 
